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ABSTRACT OF THE DISSERTATION 
 
Selective C–H Functionalization of Diamondoids Using Photocatalysis,  
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Diamondoids are a fascinating class of caged hydrocarbons unique in structure with 
properties unlike other alkanes and have proven to be useful scaffolds in medicinal 
chemistry, catalysis and nanomaterials. One inherent property of diamondoids is their 
strong C–H bonds making this class an excellent target for investigating selective and direct 
C–H functionalization. Chapter 1 of this dissertation focuses on previous methods used to 
directly transform adamantanes to functional molecules via radical methods. In Chapter 2, 
a direct and selective alkylation method of adamantanes using a dual-photocatalytic C–H 
activation method is reported. This selective functionalization relies both on a visible light 
absorbing photocatalyst and a quinuclidine based hydrogen atom transfer (HAT) catalyst. 
vi 
Optimization studies, syntheses of adamantane derivatives and an in-depth mechanistic 
study will be discussed. The direct acetylation of the second higher ordered diamondoid, 
diamantane via photocatalytic C–H functionalization, is also investigated. 
In Chapter 3, the total synthesis and structural reassignment of the newly identified 
natural product, malylglutamate, an earthworm metabolite, is reported. A traditional 
peptide coupling approach is utilized for assembling the amide from a protected malate and 
glutamate. Finally, in Chapter 4, the synthesis of a family of bioactive sesquiterpene natural 
products, known as the flavalins, are investigated. The initial proposed synthesis relies on 
a key 6π-electrocyclization as the final step in generating the flavalin core. The synthesis 
of the flavalin precursor, an electron deficient triene, leads to unexpected results during 
typical Suzuki cross-coupling conditions, ultimately precluding the synthesis of these 
natural products. 
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Chapter 1 - Selective Radical Functionalization Methods to Access Substituted 
Adamantanes and Diamondoids 
  
 2 
1.1 - Introduction 
Diamondoids are a fascinating class of caged hydrocarbons unique in structure with 
properties unlike other alkanes. The name originates from the Greek translation of diamond 
as these aliphatic caged hydrocarbons resemble the hydrogen-terminated diamond lattice. 
The lower-ordered members of this family adamantane (1.01), diamantane (1.02) and 
triamantane (1.03) each have a single isomer and of the higher-ordered diamondoids, only 
anti-tetramantane (1.04) has been synthesized, albeit in low yields (Figure 1.1).[1] 
Tetramantane possesses four different isomers, iso-, anti- and two enantiomeric skew-
tetramantanes, shown in Figure 1.1. As the size of the diamondoids increase, so do the 
number of isomers; pentamantane has 10 isomers, hexamantanes have 24 isomers, and 
heptamantane has nearly one hundred isomers.[2–7] In Nature, the formation of these 
diamondoids occur via thermodynamically controlled carbocation rearrangements[8,9] and 
although this method has been used to synthesize the lower ordered members, carbocation 
rearrangements have failed in the production of higher diamondoids. 
 
Figure 1.1 Selected lower- and higher-ordered diamondoids 
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1.1.1 - Background 
In 1933, the first member of the diamondoid family, adamantane, was discovered 
from the Hodonin oil field in Moravia, Czechoslovakia by Landa and Machacek from crude 
oil (Figure 1.2).[10] Naturally occurring diamondoids have been isolated from crude oil, 
natural gas and sediments with the highest member identified as dodecamantane 
(C54H60).
[11] Unfortunately, isolation of these hydrocarbons from the natural source has 
shown to be problematic as diamondoids are scarce and comprises only approximately 
0.0004% of petroleum content.[12] This called for the development of synthetic approaches 
for the diamondoids. Adamantane was first synthesized by Prelog and Seiwerth in 1941; 
however the yield was initially a low 6.5% over multiple steps.[13] Inspired by Nature’s 
way of making these particular scaffolds, Schleyer devised a simplified synthetic route to 
making adamantane via a Lewis acid-promoted rearrangement of 
tetrahydrodicyclopentadiene (1.05) and was able to improve the yield to 60-62% (Figure 
1.2).[14] This process is thought to be thermodynamically controlled and successful due to 
the high stability of adamantane relative to the intermediate 1.05. The mechanism involves 
a series of carbocation intermediates that undergo rearrangements via 1,2 bond migrations 
and hydride shifts.[15]  
The study of adamantane and its functionalization was limited until adamantane 
became more readily available through Schleyer’s synthesis. However, soon following 
Schleyer’s report, a number of adamantyl derivatives were synthesized via halogenations, 
amidations, carboxylations and more.[2-4] The halogenation of adamantanes became an 
attractive target in the late 1950’s due to their ease of functionalization. In 1954, the first 
 4 
bromination of adamantane was performed but it was not until 1959 that 1-
bromoadamantane (1.06) was successfully synthesized and confirmed by Stetter et. al. in 
a reported 85% yield.[16] In 1961, Haaf et. al. reported the first known amidation of 
adamantane using tert-butanol, sulfuric acid and hydrogen cyanide to give the desired 
formamide in 76% yield.[17] This was followed by hydrolysis to give 1-aminoadamantane. 
This led to the discovery of pharmaceutical drugs containing this particular amine 
scaffold.[18]  
1-Aminoadamantane, also formally known as amantadine (1.07), was the first 
pharmaceutical derived from the adamantane scaffold and was found to display potent anti-
influenza A properties in 1964.[19] Amantadine was officially FDA approved for treatment 
in 1967. Following the success of amantadine, other adamantane containing drug 
candidates were quickly synthesized. A year after amantadine was approved for treatment, 
memantine, was synthesized and patented by Eli Lilly and Company in 1968 for its 
antiviral properties. Ultimately, it was approved by the FDA as an anti-dementia drug for 
the treatment of Alzheimer’s disease in 2003.[20]  
 
 
 
 
 
 5 
Figure 1.2 Timeline and history of diamondoids 
 6 
The second member of the diamondoid family, diamantane, originally known as 
congressane[21,22] was first synthesized by Cupas et. al. in 1965 through a [2+2] 
dimerization of norbornene (1.08) followed by a rearrangement using AlCl3 resulting in a 
1% isolated yield (Figure 1.2)[22]; it was not isolated naturally from petroleum until a year 
later in 1966. In 1974, Tabushi and coworkers selectively acetylated diamantane at the 
apical position using biacetyl and UV light.[23] This was followed by selective acetylation 
of the higher diamondoids in 2006 by Schreiner and coworkers.[2,5] The first Giese-like 
addition performed on adamantane using unsaturated compounds, was done by Fukunishi 
and Tabushi in 1988.[24] This reaction allowed for the direct functionalization of C–H bonds 
to generate C–C bonds with high regioselectivity.  
In 1998, Schreiner et. al. invented a selective method for the direct bromination of 
adamantane using phase-transfer conditions. Adamantane and tetrabromomethane were 
refluxed in DCM at 40 ̊C in the presence of 50% aqueous NaOH using 
triethylbenzylammonium chloride as the phase transfer catalyst.[25] Under these reaction 
conditions, a 70% yield of the mono-brominated product was obtained with a 15% yield of 
the byproduct, bis-brominated adamantane. In 2003, Mol et. al. utilized the adamantane 
scaffold in synthesizing N-heterocyclic carbenes (NHC) bearing these substituents.[26]  
Typically, mesityl substituted NHC ligands are commonly used however 
adamantanes’ bulky properties were hypothesized to reduce decomposition of the metal 
catalyst and help induce rapid dissociation of the phosphine ligand on the Grubbs catalyst. 
The direct and selective C–H functionalization of adamantanes has been of interest since 
Schleyer’s method however methods for synthesizing diverse adamantane products in high 
 7 
yield as a single regioisomer has more recently been investigated. One example by Togo 
et. al. reports the functionalization of heteroaromatic bases with adamantane in a selective 
fashion generating the arylated products in high yields (Figure 1.2).[27] 
1.1.2 - Properties of Adamantanes 
Diamondoids are highly symmetrical saturated hydrocarbons that are comprised of 
almost perfectly tetrahedral geometries about their carbon atoms and three or more fused 
cyclohexane rings in the chair conformation. Although not completely strain free, 
diamondoids possess low strain energy resulting in more stable and rigid structures. Since 
all carbon atoms in adamantane are tetrahedral, the molecule is free from angle strain. Also, 
all C–C bonds are staggered making the molecule free from torsional strain.[28] 
Adamantane is a C10H16 molecule with Td symmetry (Figure 1.3) that possesses one type 
of tertiary C–H bond and one type of secondary C–H bond. The bond dissociation energy 
(BDE) of the C–H bonds are relatively high; the secondary position has a BDE of 96 
kcal/mol and the tertiary position has a BDE of 99 kcal/mol. Due to their high C–H BDE’s, 
diamondoids are a compelling substrate class for the investigation of selective C–H 
functionalization 
 
Figure 1.3 Properties of adamantane 
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1.1.3 - Functionalization of Diamondoids 
Adamantane is the most studied member of the diamondoids with applications 
varying from nanomaterials and catalysis to medicinal chemistry and drug delivery.[18,29–
31] Compared to higher members, adamantane is the simplest to functionalize as it possesses 
only one kind of tertiary C–H bond and one secondary. Diamantane is more challenging to 
selectively functionalize because it has two different types of tertiary C–H bonds in which 
six of the positions are about the central cyclohexane and are termed “medial” and two are 
located at both the top and bottom of diamantane and are called “apical”.  
Typical functionalization of diamondoids relies on radical, ionic or oxidative 
transformations for which single electron oxidations are usually the most selective. In this 
chapter, we provide an overview of the different types of C–H to C–C transformations 
using direct functionalization via radical chemistry. Hydrogen atom abstraction methods 
that directly generate the adamantyl radical include halogen and alkoxyl radicals, as well 
as catalytic hydrogen atom transfer (HAT) species such as diarylketone and decatungstate 
photocatalysts (Figure 1.4).[24,32–39] The high reactivity of these abstractors results in 
variable, often low selectivity between different types of C–H bonds, making them 
impractical for many applications.  
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Figure 1.4 C–H Activation species of adamantanes 
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1.2 - Acylations  
Introducing an acyl group to alkanes especially adamantanes was a challenging 
transformation in early organic synthesis.[40] Acyladamantanes are useful intermediates 
that can be further functionalized and are defined here as a compound featuring a direct C–
C bond between adamantane and the carbonyl of a ketone, ester or aldehyde. 
Acyladamantanes have been shown to be useful precursors for compounds possessing 
biological activity.[41,42] While many methods have been developed to synthesize various 
acyladamantanes over the years, most rely on a pre-functionalized adamantyl substrate 
and/or harsh conditions. Currently, there are few reports of direct and selective acylations 
of adamantanes under irradiation or by a radical initiatior.[43,44] Therefore, direct methods 
for forging C–C bonds with adamantanes eliminate the need to use pre-functionalized 
substrates are desirable. Use of the reactive adamantyl radical has been used to achieve 
direct acylations and shall be detailed herein.  
1.2.1 - Chlorocarbonylation 
Tabushi was well known for his early work with functionalizing admantanes via 
acylation reactions. In 1968, Tabushi et. al. reported a free-radical chlorocarbonylation of 
adamantane using oxalyl chloride (1.11) and a benzoyl radical initiator which led to 
chlorocarbonylated intermediate 1.13 (shown in Table 1.1). Following methanolysis, a 
mixture of methyl 1- and 2-adamantanecarboxylates 1.12 and 1.12’ (55:45 r.r., 
respectively) was obtained in an 82% yield based on recovered starting material. After 
statistical correction, this distribution of regioisomers indicated a reactivity ratio of 3.67:1 
 11 
favoring the tertiary adamantyl positions.[45] This preferential tertiary reactivity of 
adamantanes was also observed in prior radical halogenations by Smith and Williams.[46] 
Table 1.1 Chlorocarbonylation of adamantane 
 
1.2.2 - Formylation 
Recently, Kamijo et. al. have reported a photochemically induced method for the 
formylation of unactivated C(sp3)–H bonds in many substrates including adamantane using 
an aldoxime functional group.[47] Using a mercury lamp to generate a photoexcited 4-
benzoylpyridine (4-BzPy) (1.15) to act as the C–H abstractor for adamantane, Kamijo 
showed that the resulting adamantly radical can readily intercept a formylating agent 
(Scheme 1.1). Using an O-benzyl aldoxime with an arylsulfonyl substituent 1.16 as a good 
leaving group leads to adamantyl O-benzylaldoxime precursor (1.17). The aldoxime can 
then be converted to aldehyde (1.18) using a solution of formaldehyde in aqueous HCl. 
Under these conditions the methine position of adamantane was formylated with a high 
regioselectivity (95:5).  
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Scheme 1.1 Formylation of adamantane 
1.2.3 - Acetylation 
Tabushi et. al. selectively acetylated adamantane using an excess of biacetyl 1.18 
under high energy UV irradiation in dichloromethane[48] to give 1-acetyladamantane (1.19) 
as the sole regioisomer (Table 1.2).[43] The C–H abstracting species is believed to be triplet 
biacetyl 1.20 since no acetylation occurred in the presence of pyrene, a known quencher of 
biacetyl phosphorescence via energy transfer.[49] Despite also being a potential quencher, 
oxygen instead increased the rate of acetylation and both the 1- and 2-acetyladamantane 
products were observed as was 1-adamantanol, the autooxidation product.  
The increase in the photoacetylation rate and loss of selectivity is attributed to the 
generation of reactive methyl radicals which are formed in a decarboxylative process after 
oxygen and biacetyl react with each other. In higher ordered diamondoids, photoacetylation 
remains selective for the methine positions. However, unlike adamantane which features 
four equivalent methine positions, higher ordered diamondoids possess multiple 
nonequivalent positions 
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Table 1.2 Photoacetylation of adamantane 
 
. For diamantane featuring two apical and 6 medial positions, photoacetlyation using 
biacetyl favored mono-acetylation at the apical position (1.21) over the medial position in 
a 5.5:1 ratio (17:1 after statistical correction, Figure 1.5). Acetylation of the methylene 
positions and bis-addition products were not observed.[23] This apical selectivity is still 
maintained in even higher ordered tri-, tetra- and pentamantanes (1.22-1.27) despite an 
increase in the number of possible functionalization positions. For instance, despite the 
unique number of different 3º C–H positions increasing from two in diamantane to four in 
triamantane and [121]tetramantane, acetylation of apical position is still favored over the 
other medial positions in an ~5:1 ratio.[2] Even higher apical selectivity is observed in 
[1(2)3]tetramantane and [123]tetramantane despite having six unique C–H positions).[50] 
[1(2,3)4]pentamantane showed near complete apical selectivity and resulted in a significant 
amount of bis-acetylated product as well.  
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Figure 1.5 Selectivity of the photoacetylation of higher diamondoids 
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1.3 - Carbonylation 
1.3.1 - Carboxylation using NHPI 
C–H functionalization of saturated hydrocarbons incorporating carbon monoxide, 
although attractive in synthetic methods, is quite challenging due to challenges of 
selectivity and low conversion of starting material.[51–53] Work done by Ishii in 1998 
showed that oxidation of polycyclic alkanes in the presence of O2 can produce carboxylated 
products using a catalytic free-radical method. N-hydroxyphthalimide (NHPI) is used as a 
radical catalyst to generate PINO radical 1.28 without photoactivation and under mild 
conditions.[33] However, when using adamantane as the hydrocarbon, multiple products are 
generated when O2 or CO is introduced into the reaction as shown in Scheme 1.2. 
 
Scheme 1.2 NHPI-catalyzed oxidation and carboxylation 
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A conceivable mechanism begins with generating the reactive intermediate, 
phthalimide-N-oxyl (PINO) 1.28 from NHPI in the presence of O2. The PINO radical 
formed will then do C–H abstraction preferentially at the tertiary position of adamantane 
(1.01) to give the intermediate, adamantyl radical 1.01a. Radical 1.01a can then react with 
O2 to give the oxygenated products 1-adamantanol 1.29a, 2-adamantanone 1.29b, and 1-
acetoxyadamantane 1.29c. Alternatively, radical 1.01a is readily trapped with CO which 
upon subsequent reaction with O2, eventually generates carboxylic acids 1.29d-f. 
Selectivity varies depending on reaction conditions and in all cases, there is recovery of 
starting material. 
1.3.2 - Photocatalyzed Carbonylation 
 
Scheme 1.3 Photocatalyzed carbobylation using decatungstate 
In 2011, Ryu and Albini reported a three-component coupling reaction using 
photocatalytic methods based on previous work by Albini and others.[38] This multi-
component process generated unsymmetrical ketones with tetrabutylammonium 
decatungstate (TBADT) 1.30 as the photocatalyst and a xenon lamp as their UV light 
source. The carbonylation of adamantane proceeded using a 1:1 mixture of acetonitrile and 
benzene as solvent and 2 equivalents of adamantane resulting in poor selectivity and 
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relatively low yields as shown in Scheme 1.3. A l:1.3 mixture of the 1- and 2- carbonylated 
products 1.31-131’ were obtained with an overall yield of 35% after 48% conversion of 
the alkene starting material. Higher yields and selectivities were reported for non-
adamantane substrates.  
 
Scheme 1.4 TBADT catalyzed carbonylation 
Scheme 1.4 shows the proposed catalytic cycle for the C–H functionalization of 
adamantane using the three-component system. Upon irradiation of TBADT, the excited 
photocatalyst 1.30 abstracts the hydrogen from adamantane 1.01 generating adamantyl 
radical 1.01a. Carbonylation results in the acyl radical 1.32a followed by a Giese-like 
addition to give intermediate 1.32b. Intermediate 1.32b is reduced by the photocatalyst, 
completing the catalytic cycle, and is followed by protonation to afford the desired 
functionalized adamantane product 1.32c.  
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1.3.3 - Transition Metal Carbonylation 
The use of transition metals for C–H activation via carbonylation is an attractive 
method for generating compounds containing carbonyl compounds. However, commonly 
used second- and third- row transition metals such as ruthenium and rhodium are expensive 
and can lead to complicated substrate syntheses limiting their use.[54–56] First row transition 
metals akin to nickel and copper are attractive alternative options due to their low toxicity, 
abundance and low cost.[57]  
With this in mind, Wu et. al. reported the first copper-catalyzed carbonylative C–
H activation in 2016 using a variety of alkanes and amides to generate imides.[58] Wu 
employed a Cu(I) species and di-tert-butyl peroxide (DTBP) to selectively functionalize 
adamantane at the tertiary position; generating imide 1.34 in 31% yield (Scheme 1.5a). 
While other alkanes were used in excess and cyclohexane was used as solvent, a 1:1 ratio 
of adamantane and N-methylacetamide 1.33 gave the desired product when 
(trifluoromethyl)benzene (PhCF3) was used as solvent. The C–H abstracting species is 
likely the tert-butyloxy radical 1.35, although the participation of copper cannot be ruled 
out. 
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Scheme 1.5 Transition metal carbonylation 
Nickel-based catalysis has previously been reported to be successful in the 
activation of inert C(sp3)–H bonds, often through a directing group effect.[59] Recently, Li 
et. al. developed a Ni-catalyzed carbonylation of unreactive alkanes with formanilide to 
obtain amide products.[60] Scheme 1.5b illustrates two selective carbonylations both using 
adamantane. The first reaction uses an equimolar amount of formanilide 1.36 to give a 
modest 68% yield of compound 1.37 while the second utilizes benzohydrazide 1.38 which 
gave the corresponding di-acylhydrazines 1.39 in 53% yield. In both cases, selectivity 
favored the methine position. Similar to the work done by Wu and coworkers, DTBP is 
homolytically cleaved with the help of the transition metal, in this case Ni, to form the key 
reactive intermediate, the tert-butyloxy radical 1.35.  
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1.3.4 - Metal-free Radical Oxidative Carbonylation 
Although transition metal carbonylation is a commonly used approach in C–H 
activation reactions, an alternative to obtaining carbonyl derivatives is via a radical 
carbonylation method.[61] Lei et. al. reported a novel oxidant induced alkane C–H bond 
activation using amide and alcohols as nucleophiles. They obtained a variety of esters and 
imides using carbon monoxide for the carbonylation step and di-tert-butylperoxide (DTBP) 
as oxidant.[62] A variety of alkanes were used to synthesize benzyl esters but Scheme 1.6 
specifically shows carbonylation using adamantane as substrate and benzyl alcohol (1.40) 
as nucleophile. Ultimately, C1 and C2 carbonylated products 1.41 and 1.41’ were obtained 
in a 2:1 r.r. in 77% yield. The key reactive species is considered to be tert-butyloxy radical 
1.35 which abstracts the hydrogen from adamantane generating adamantyl radical 1.01a 
and 1.01b. 
 
Scheme 1.6 Metal free radical oxidative carbonylation 
1.4 - Alkene Additions (Michael / Giese)  
Accessing functionalized adamantanes is challenging due to the necessity of 
performing multiple steps leading to more waste generation. However, directly 
functionalizing adamantane in one step via free radical reactions is of high interest to avoid 
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pre-functionalization. The radical addition of adamantanes to alkenes is a useful process 
especially when it proceeds with high regioselectivity and diastereoselectivity. The first 
Giese-type addition performed on adamantane and substituted adamantanes using different 
unsaturated compounds was done by Fukunishi and Tabushi in 1988 and gave products 
1.42a-e in moderate yields (Table 1.3).[24] The reactive species is once again tert-butyloxy 
radical 1.35 and is generated at high temperatures using di- tert-butylperoxide. 
Table 1.3 Alkylation via olefin functionalization 
 
a-Thiosulfones are convenient synthetic intermediates that can be used for several 
key transformations. e.g. desulfurization[63] and pyrolysis to obtain carbonyl derivatives.[64] 
Albini and coworkers developed a photochemical radical alkylation to access a-
thiosulfones from ketene dithioacetal S,S-dioxides.[34] With stoichiometric amounts of 
benzophenone, 1 eq of (E)-1-(methylthio)-1-[(4-methylphenyl)-sulfonyl)]propene 1.44, 
excess adamantane and UV light, the thiosulfone product 1.45 was obtained in 90% yield 
as a single isomer (Scheme 1.7a). The selectivity of the alkylation was at the tertiary 
bridgehead position and trace amounts of phenyladamantane, bis-adamantane, 1-
adamantanol, and 2-adamantanone was observed. 
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Scheme 1.7 Alkene addition using benzophenone 
Albini et. al. further studied radical additions to olefins with fumaric acid diamides 
and oxazolidine chiral auxiliaries to generate functionalized products with a high degree of 
diastereoselectivity.[35] As shown in (Scheme 1.7b), two oxazolidines, one achiral and one 
achiral, were tested with excess adamantane and benzophenone as photosensitizer. 
Irradiation at 360 nm resulted in the triplet excited state of benzophenone 1.43 which then 
abstracts the hydrogen from adamantane, generating the adamantyl radical 1.01a 
exclusively at the tertiary position. Addition to the fumaryloxazolidines 1.46 gave desired 
functionalized adamantane products 1.47a-b in moderate yields and high 
diastereoselectivity. 
Natural products possessing nitrile moieties, including metabolites, are of interest 
but accessing them directly through radical methods has limitations due to toxicity of the 
cyanide salts used.[65–68] Scheme 1.8a shows work done by Albini’s group who used 
benzophenone to generate the triplet excited state with UV light.[69] Cyanoethyl 
adamantanes were synthesized using 100 mol% photosensitizer, excess adamantane and 
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one equivalent of acrylonitrile resulting in the two regioisomers 1.48 and 1.48’ in a 6:1 r.r. 
ratio. Yields were determined by GC and the isolated yield was somewhat lower. An 
alternative to benzophenone was the use of xanthone (1.49) as photosensitizer. However, 
the reaction was unproductive due to solubility and isolation issues. 
 
Scheme 1.8 Alkene additions using nitriles 
As an alternative to using benzophenone as the photocatalyst, Albini tested TiO2, a 
known photo-oxidant.[70] As shown in Scheme 1.8b isopropylidene malononitrile (1.50) 
and adamantane were treated with TiO2 and irradiated under UV light. This reaction was 
subjected to longer irradiation times than other TiO2-mediated reactions in order to have 
decent conversion. A yield of 35% of product 1.51a was obtained based on recovered 
starting material. Oxygenated products were observed which were attributed to remaining 
oxygen. A higher yield was obtained (1.51b) when using silver sulfate but did require 
longer reaction time.  
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Scheme 1.9 Synthesis of β-cycloalkyl products 
In 2006, Albini and coworkers synthesized β-alkylketones using photomediated 
radical addition (Scheme 1.9).[37] Beginning with the adamantane, the adamantyl radical 
was generated via hydrogen atom abstraction (HAT) by either benzophenone or TBADT. 
When using benzophenone as catalyst, only 1-adamantyl derivatives were observed and 
cyclopentanone product 1.53a was generated in 65% yield while the cyclohexanone 
product 1.53b was obtained in a lower 40% yield. When using the alternative method with 
TBADT as photocatalyst, the yields were lower, with cyclopentanone product 1.54a in 
15% yield and the cyclohexanone product 1.54b in 21% yield. The reaction mechanism 
was hypothesized to be induced by a direct hydrogen abstraction as opposed to energy or 
electron transfer. 
The first catalytic oxyalkylation of alkenes with alkanes was reported by Ishii et. 
al[36] who used the PINO radical 1.28 as the reactive intermediate, cobalt as co-catalyst and 
molecular oxygen. This reaction resulted in two different products in high yields when 
adamantane is used as the hydrocarbon. Under optimized conditions, methyl fumarate and 
adamantane gave 98% conversion with a 78% yield (71/29 ratio of hydroxy product 1.55a 
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versus ketone product 1.55b) (Table 1.4). A variety of alkenes were also tested using 
dimethyl adamantane with yields ranging from modest to excellent however in most cases, 
a mixture of products was observed (1.55b-d). 
Table 1.4 NHPI induced oxyalkylation 
 
A metal free radical-chain functionalization was investigated using an 
oxiranylcarbinyl derivative by Roberts and coworkers.[71] Previously, Roberts used an 
analogue of this reagent as a source of allyloxyl radicals with the intention of doing direct 
C̶ H abstraction. They focused their studies on O-oxiranylcarbinyl O-silyl ketene acetal A 
(Scheme 1.10). This particular acetal was used due to the commercial availability of 
starting material, isophorone oxide, and its inability to do a rearrangement once the radical 
intermediate is generated. The reaction of interest involved excess adamantane, 0.2 eq of 
di-tert-butyl hyponitrite (TBHN) which was used as a source for tert-butoxyl radicals, 1.0 
eq of acetal reagent A, and N-methylmaleimide (NMM) (1.56) as the acceptor. With 
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adamantane, a mixture of two isomers 1.57 and 1.57’ was obtained with a combined yield 
of 50% in a 79:21 ratio favoring the tertiary position. 
 
Scheme 1.10 Metal free C–H functionalization 
More recently, in 2018 Nicewicz and Alexanian proposed a general strategy for 
organic photoredox-catalyzed C–H abstraction which was followed by direct C–H 
diversification to directly convert C–H bonds to a variety of C–N, C–X and C–C bonds 
(Scheme 1.11).[72] Herein, a highly oxidizing acridinium photocatalyst (1.59), shown in 
Scheme 11, was used to oxidatively generate heteroatom-centered radicals capable of 
doing C–H abstraction of aliphatic compounds. In this case, the reactive phosphate radical 
1.60 was generated upon oxidation by the acridinium photocatalyst. When using aryl-
adamantyl derivative 1.62, alkylation was selective for the tertiary position giving product 
1.61 in a 45% yield. 
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Scheme 1.11 Organic photoredox-catalyzed Giese addition 
1.5 - Addition-Fragmentation 
The addition-fragmentation sequence, shown in Scheme 1.12, is a common practice 
in the realm of radical chemistry to effect vinylation, among others.[74] As such, this mode 
of reactivity has been reported in a variety of cases involving the adamantyl radical. 
Generally speaking, this process begins by using some means of H–atom abstraction to 
generate a reactive adamantyl radical intermediate (II). Common radical acceptors will 
feature an electron withdrawing group to aid in stabilizing radical intermediate III as well 
as a leaving group that promotes a facile fragmentation immediately following addition 
giving the desired substituted alkene product IV. In addition to vinylation, examples of 
decarboxylation and allylation reactions are described below. 
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Scheme 1.12 General radical addition-fragmentation sequence 
1.5.1 - Decarboxylative alkylation 
Sun et al. demonstrated that styrenyl adamantanes can be made using cinnamic 
acids (1.63) in the presence of di-tert-butyl peroxide (DTBP) and heat (Scheme 1.13).[75] 
In this case, homolytic thermolysis of DTBP results in tert-butoxy radical 1.35 that acts as 
the C-H abstractor giving rise to the reactive adamantyl radical. This reaction is then 
thought to proceed through a radical addition to give a stabilized benzylic radical 1.64 
followed by decarboxylative fragmentation. This addition-fragmentation process is 
selective for the methine position on adamantane, favoring it over the methylene position 
in an 83:17 ratio and a 59% yield is obtained. 
 
Scheme 1.13 Peroxide promoted decarboxylative alkylation of cinnamic acids to form alkenes or 
ketones 
1.6 - Allylation 
Adamantyl allylation has been demonstrated using 1,2-bis(phenylsulfonyl) propene 
1.66 as an allylating agent (Table 1.5).[76] Using 5 mol% 5,7,12,14-pentacenetetraone (PT, 
1.68) as the photocatalyst, 1.1 equiv K2CO3, excess adamantane and visible light, both the 
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C1 and C2 products (1.67 and 1.67’) can be obtained in 63% yield and 90:10 r.r. The 
reaction tolerates substituted adamantanes giving yields between 42-67% for products 
1.67a-e. 
Table 1.5 Aryl ketone catalyzed radical allylation 
 
The adamantyl radical 1.01a is generated using 5,7,12,14-pentacenetetraone (1.68) 
and a visible light source. The radical generated by irradiating the PT catalyst is a 
competent C–H abstractor leading to semiquinone form 1.68’.[77–79] Adamantyl radical then 
intercepts the sulfonylated propene (1.66) to generate radical intermediate 1.69. 
Fragmentation and re-oxidation of the PT catalyst results in allylated adamantyl 
phenylsulphone, 1.67a. Under these conditions, 1.67a was isolated in 63% yield with the 
allylated methine being favored in a 9:1 ratio over the methylene position. While a strong 
electron-withdrawing group (sulfone) is required on the alkene 1.66, the reaction was 
successful for a range of substituted adamantanes as shown in Table 1.5. 
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Scheme 1.14 Adamantyl allylation using PT 
Wang and coworkers recently developed a method for the directed allylation of 
adamantane using remote amidyl radical 1.73 (Figure 1.6). This remote amidyl radical is 
generated photocatalytically using green LEDs to excite the photocatalyst, eyosin Y (EY) 
(1.70), which undergoes single electron transfer (SET) with a pre-functionalized 
adamantane featuring dinitroaryloxy amide 1.71. The resulting radical anion, 1.72, then 
fragments to give the key amidyl radical 1.73. Similar to a Hofmann–Löffler–Freytag 
reaction, remote amidyl radical 1.73 was used to generate the adamantyl radical 1.74 via a 
1,5 C-H abstraction.[80] Interception of the adamantyl radical by allylic sulphone 1.75 and 
subsequent fragmentation of 1.77 gives the final allylated adamantane 1.76. Like many 
related processes of this type, the reaction was very selective for 1,5-H-atom transfer to 
functionalize either a 3̊ or 2̊ position selectively, depending on the substrate. 
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Figure 1.6 Amidyl radical directed allylation 
1.7 - Arylation 
1.7.1 - Photooxidation of Diamondoids using TCB 
In 1996, Albini proposed an arylation reaction using 1,2,4,5-
benzenetetracarbonitrile (TCB) 1.78.[81,82] TCB was utilized due to its ability to become an 
extremely strong single electron oxidant upon irradiation.[83] Upon irradiation, the radical 
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anion of TCB 1.78’ and the adamantyl radical cation 1.01c is generated. In the presence of 
a base, the adamantyl radical cation is easily deprotonated at the bridgehead position 
resulting in a coupling reaction with the radical anion of TCB.  
 
Figure 1.7 Arylation of diamondoids with TCB 
Irradiation of adamantane and TCB in acetonitrile led to the formation of single 
adamantyl product 1.79. By prolonging the reaction time, although it led to higher 
conversion of starting material, a small amount of the bis-arylated product was observed. 
This arylation method was also used with higher diamondoids, shown in Figure 1.7, to give 
the desired product with high selectivity for the apical position in all cases (1.80-
1.83).[2,5,84] Arylation beyond pentamantane has not been investigated as of yet. 
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1.7.2 - Minisci-Type Arylation of Adamantane 
In 2013, Antonchick and coworkers developed a Minisci-type arylation reaction 
using a selective oxidative cross-coupling approach.[85] One example, shown in Scheme 
1.15, shows the arylation of adamantane using 4,7-dichloroquinoline (1.84) in the presence 
of [bis(trifluoracetoxy)iodo]benzene (PIFA) as oxidant and NaN3, as a critical additive. The 
key H-atom abstractor is likely the azide radical 1.86 and the corresponding arylated 
product 1.85 was obtained in an 84% yield as a single isomer. Overall, Antonchick et. al. 
used this oxidative cross-coupling approach of heteroarenes and alkanes to obtain arylated 
products under mild conditions, with short reaction times and in high yields. 
 
Scheme 1.15 Arylation of adamantane 
1.7.3 - Dual-Catalytic Arylation 
In 2018, another direct arylation was performed by MacMillan and coworkers using 
a dual catalytic system with decatungstate and a nickel catalyst (Scheme 1.16).[39] 
Adamantane derivatives underwent arylation predominantly at the methylene position for 
both 2-adamantanone (1.87) and bromo-adamantanone (1.90) to give a 48% and 53% yield, 
respectively. The high regioselectivity can be rationalized via reversible radical capture 
and selectivity-determining reductive elimination.[86] The proposed mechanism begins 
with the photoexcitation of TBADT followed by intersystem crossing giving the triplet 
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excited state. This is followed by HAT abstraction from a hydrocarbon like adamantanone 
by the excited TBADT catalyst ultimately reducing the catalyst and generating the 
adamantyl radical at the secondary position. Disproportionation of the singly reduced 
decatungstate would regenerate the active HAT catalyst and form a doubly reduced 
decatungstate species. Following single-electron reduction of a nickel catalyst to give Ni0 
species, the alkyl substrate is captured, followed by oxidative addition of the aryl bromide 
1.88, reductive elimination to give the desired cross-coupled arylated product, and a final 
single-electron step between the active nickel catalyst and reduced TBADT catalyst to 
complete both catalytic cycles. 
 
Scheme 1.16 Dual catalytic arylation 
 
1.7.4 - Transition Metal-Free Arylation using Heteroaromatic Bases 
This year, Togo et. al. studied the introduction of heteroaromatic bases onto 
hydrocarbons using benzoyl peroxide, BPO, under transition-metal-free and irradiation-
free conditions.[27] When 5 equivalents of adamantane and 1.3 equivalents of BPO and 
trifluoroacetic acid in benzene was treated with the nitrogen containing compound, lepidine 
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(1.92), the desired methylquinoline product 1.93 was obtained in 75% yield (Scheme 1.17). 
Other heteroaromatic bases also produced the arylated product in good yields (1.94-1.96; 
63%-86%). The reaction relies on the formation of reactive benzoyl radical 1.14 which is 
formed from BPO under thermal conditions which then abstracts the hydrogen generating 
the adamantyl radical. Subsequent nucleophilic radical addition with a protonated 
heteroaromatic base and oxidation of the benzenecarboxyl radical forms the protonated 
product. After quenching with aqueous NaHCO3, the desired arylated product is obtained. 
 
Scheme 1.17 Arylation via thermal conditions 
1.8 - Alkynylation 
Alkynes are valuable building blocks in organic synthesis and are important 
structural compounds in both materials science and chemical biology.[87–89] The use of pre-
functionalized substrates[90,91] or transition-metal-catalyzed alkynylations[92–95] have been 
extensively reported however metal-free conditions are of interest due to the current 
necessity of developing “greener” reactions. 
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1.8.1 - Metal-free Direct Alkynylations 
In 1996, a direct trifluoromethyl radical mediated C–H alkynylation reaction is 
reported by Fuchs et. al. using TIPS-substituted acetylenic triflones.[96,97] The reaction 
proceeds by a radical C–H abstraction with an electrophilic trifluoromethyl radical 
intermediate 1.101 to generate the adamantyl radical. Following the addition into the 
acetylenic triflone 1.97 at the α-position, elimination and fragmentation generates the 
trifluoromethyl radical and the desired alkynylated adamantane product shown in Scheme 
1.18 is obtained in a 60% yield when 0.2 equivalents of AIBN is used as the radical 
initiator. Other substituted triflates gave moderate yields (1.99, 40% yield and 1.100, 50% 
yield). 
 
Scheme 1.18 Alkynylation with acetylenic triflones 
A photochemically induced alkynylation of adamantane was developed by Inoue 
and coworkers.[98] Benzophenone was employed as an oxyl radical precursor and 1-tosyl-
2-(trimethylsilyl)acetylene 1.103 as the alkynylating agent. Upon excitation with UV light, 
an electrophilic oxyl radical is generated which then abstracts a hydrogen atom from the 
tertiary position of adamantane generating the adamantyl radical. This intermediate then 
reacts with the electron-deficient alkyne and subsequent release of the toluenesulfinyl 
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radical generates the alkynylated adamantyl product. When adamantanol (1.102) and Boc 
protected amantadine (1.105) were used, the reaction proceeded exclusively at the tertiary 
position in 86% and 73% yield, respectively with loss of the Boc group. 
 
Scheme 1.19 Alkynylation using benzophenone 1.14 
In 2016, Xu and coworkers investigated an efficient method for the direct 
alkynylation of substrates containing unactivated C(sp3)–H bonds under metal-free 
conditions (Scheme 1.20).[99] Notably, when adamantane was used, C–H functionalization 
was selective for the tertiary position over the secondary and a 59% yield was reported for 
the desired adamantyl product. 1-[(triisopropylsilyl)-ethynyl]-1,2-benziodoxol-3(1H)-one 
was required along with an oxidant and high temperature to generate the adamantyl radical. 
When testing the radical trapping agent, TEMPO, the reaction was completely suppressed 
and the alkyl-TEMPO product was observed suggesting the reaction proceeds via a radical 
intermediate. A plausible mechanism begins with generation of the tert-butoxy radical 
from homolytic cleavage of di-tert-butylperoxide (DTBP) which reacts with adamantane 
giving the adamantyl radical. This is followed by addition to the triple bond of hypervalent 
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iodine reagent 1.107 and subsequent β-elimination gives the final alkynylated product 
1.108. 
 
Scheme 1.20 Alkynylation with ethynylbenziodoxolones 
1.8.2 - Metal-Catalyzed C–H Functionalization 
The first Cu-catalyzed radical addition/cyclization with diaryl(arylethynyl)-
phosphine oxides has been developed by Zhao (Scheme 1.21).[100] Herein, unactivated 
hydrocarbons were used as a general, one-step method to synthesize benzophosphole 
oxides using C-H functionalization in a highly regioselective manner. Using 10 mol% 
CuBr and DTBP, the adamantyl functionalized product was obtained at the tertiary position 
in 42% yield. The reactive intermediate, tert-butoxy radical, was generated when heated 
with the active CuI species. As in previous methods, this radical then abstracts the hydrogen 
from adamantane generating the adamantyl radical which adds to the alkyne and undergoes 
cyclization to give the desired adamantyl-benzo[b]phospholes. 
 
Scheme 1.21 Metal-mediated alkynylation 
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1.9 - Conclusion 
 The direct functionalization of aliphatic C–H bonds is of great interest to the scientific 
community and although there have been significant advances in the area, it is still in need 
of more selective methods that proceed under mild conditions. Since the synthesis of 
adamantane via Schleyers method in 1957, diamondoids have fascinated synthetic organic 
chemists leading to the synthesis of functionalized substrates containing the adamantyl 
scaffold and thusto a wide array of applications in nanomaterials, catalysis and 
pharmaceutical agents. Diamondoids, a special class of hydrocarbons with unique 
characteristics, have been shown to be excellent substrates for the investigation of direct 
and selective C–H activation. Herein, different types of C–H to C–C bond transformations 
of diamondoids using direct functionalization via radical chemistry has been discussed.   
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2.1 - Background 
2.1.1 - Introduction 
Diamondoids are an interesting class of hydrocarbons in which their carbon-carbon 
framework constitutes the fundamental repeating unit in the diamond lattice structure. 
These compounds are distinct due to their unique structure and chemical properties.[1] As 
discussed in Chapter 1, one inherent property that sets these particular hydrocarbons apart 
from others is the high 3̊ C–H bond dissociation energy (BDE) of 99 kcal/mol which 
exceeds the 2̊ C–H BDE of 96 kcal/mol as shown in Figure 2.1.[2] These properties, which 
result from the rigid caged structures, make this class an excellent target for investigating 
selective and direct C–H functionalization.[3–6] Diamondoids, especially adamantane, have 
many applications in nanoscale frameworks, drug delivery, and clinically approved drugs 
(e.g. memantine, an anti-dementia drug).[7–15]  
Diamondoids possess low strain energy making them quite stable. Since all carbon 
atoms are perfectly tetrahedral and all C–C bonds are perfectly staggered, the molecule is 
free from both angle strain and torsional strain.[1] However, despite their chemical and 
thermal stability and lack of notable strain, their inherent properties pose significant 
challenges. One major difficulty is chemoselectively functionalizing adamantanes, a 
challenge which increases with each increasing adamantane unit due to similar types of C–
H bonds.[1,6] When hydrogen atom transfer (HAT) catalysis is used, two reactive species 
can be generated making selective functionalization difficult (Figure 2.1d).[16] Also, 
traditional methods of functionalization can require harsh conditions, typically requires 
multiple steps and generate waste (Figure 2.1e).[17–21] Therefore, a mild, atom-economical 
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method for selectively functionalizing adamantanes is of interest. The selective 
functionalization of one type of C–H bond in the presence of a variety of different C–H 
bonds is a grand challenge in the field of catalysis.[22–25] 
 
Figure 2.1 Smallest members of diamondoid family, specific examples, and difficulties in 
functionalization 
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2.2 - Motivation: C–H functionalization of diamondoids 
The direct functionalization of aliphatic C–H bonds has been an attractive and 
difficult strategy that typically employs the reactivity of weak or activated C–H bonds (ex. 
Tertiary, benzylic or heteroatom-substituted positions) in comparison to diamondoids.[26–
30] The functionalization of unactivated C–H bonds still poses a challenge today. 
Specifically, the selective activation of strong alkane C–H bonds is difficult due to the high 
kinetic barrier associated with their cleavage. New methods that favor unactivated aliphatic 
positions would broaden the applications of C–H functionalization. A compelling 
candidate for testing direct C–H functionalization is the diamondoids. Here we discuss two 
different functionalization reaction of diamondoids (alkylation and acylation). 
 
Figure 2.2 Proposed idea for selective C–H functionalization of diamondoids 
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Our motivation was to overcome previous limitations though the systematic study 
of adamantanes by identifying a catalyst system that can target strong C–H bonds in the 
presence of weaker activated bonds. Although there are two different types of C–H bonds 
in adamantane, we were interested in selectively mono-functionalizing diamondoids at the 
tertiary position. For the first part of this chapter, we will discuss a new alkylation method 
for the direct functionalization of diamondoids that is highly selective for the tertiary 
position on adamantane (2.11).[31]  
Figure 2.2a shows the proposed idea in which both photoredox and H–atom transfer 
catalysis are necessary for excellent chemoselectivity for the strong 3̊ C–H bonds using a 
Giese-type reaction. We evaluated a variety of alkene substrates and substituted 
adamantanes in the alkylation reaction as well as investigated the reaction mechanism. The 
mechanistic proposal is shown in Scheme 2.1. Following HAT, the adamantyl radical 2.13 
adds to an alkene to generate a new radical species 2.14. This is then reduced to give anion 
intermediate 2.15 followed by protonation to give the desired product. 
 
 
Scheme 2.1 Mechanistic proposal for functionalized adamantanes 
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The second part of this chapter focuses on the selective acetylation of diamantane 
(2.10) (Figure 2.2b). As opposed to adamantane, which has one type of tertiary position 
due to symmetry, diamantane becomes increasingly more difficult to selectively 
functionalize due to its two distinct tertiary positions, referred to as apical (C4) and medial 
(C1). This substrate is also much less explored than the smallest diamondoid, adamantane 
and has potential application in medicinal chemistry and nanomaterials. There is currently 
only one selective and direct C–H acetylation of diamantane.[32] However, this particular 
reaction requires the use of high energy ultra-violet (UV) irradiation and is low yielding. 
We propose a photoacetylation reaction that proceeds via a different mechanism and 
provides different selectivity with diamantane. 
2.3 - Alkylation: Results and Discussion 
2.3.1 - Optimization Studies/Control Experiments 
Inspired by reports of C–H functionalization reactions via heteroatom-stabilized 
radicals by MacMillan and coworkers, we focused our attention on optimizing around 
quinuclidines as HAT catalysts due to the strong N-H bond generated (> 100 kcal/mol) and 
either a transition metal or organic photocatalyst.[33–36] A few examples of the catalysts 
investigated (including non-quinuclidine based catalysts) are shown in Figure 2.3. 
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Figure 2.3 Investigated HAT and photoredox catalysts 
We began the investigation with ethyl acrylate (2.29) as the alkene substrate of 
choice. Different solvents, HAT catalysts and photocatalysts were tested (shown in Table 
2.1). An issue that arose was the insolubility of adamantane in many of the more polar 
solvents (e.g. DMF or DMSO). Entries 1-3 tested different solvents commonly used in 
photocatalytic reactions and known to improve the solubility of adamantane. In all cases, 
conversion of starting materials were low and the desired product was not obtained. We 
continued the investigation with DCE as the solvent due to improved solubility of all 
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reagents. With Ru(bpy)3Cl2 (2.23) as the photocatalyst (Entries 1-4), the functionalized 
adamantane product 2.30 was not observed and only polymerization of ethyl acrylate was 
detected. This was most likely due to incompatible redox potentials and the high reactivity 
of ethyl acrylate.  
Table 2.1 Optimization with ethyl acrylate 
 
N-hydroxyphthalimide (NHPI) (2.21) and tetrachloro-N-hydroxyphthalimide 
(Cl4NHPI) (2.22) were used as a non-quinuclidine based hydrogen atom transfer catalyst 
in conjunction with K2HPO4 as base. The role of the base was to deprotonate NHPI, making 
it easier to oxidize to the more reactive PINO radical which can then participate in HAT 
catalysis. This particular HAT catalyst was unsuccessful directing us back to the amine 
based quinuclidine catalysts. We then tested different iridium based photocatalysts (2.24 
and 2.25) and HAT catalysts (2.17 – 2.22) previously shown to undergo C–H 
abstraction.[18,36,37] To our delight, a dual catalytic system using a quinuclidine catalyst in 
combination with Ir((df(CF3)ppy)2dtbbpy)PF6 (2.25) gave improved yields of 17% for 
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acetoxy-quinuclidine (2.18) and 19% for quinuclidine (2.19). Unfortunately, due to low 
starting material conversion and high polymerization of ethyl acrylate when exposed to 
light, we directed our attention to determining a more promising alkene substrate for 
optimization. 
With a potential dual catalytic system using an iridium photocatalyst and a 
quinuclidine based catalyst in mind, Dr. Haibin Yang tested a variety of alkene substrates 
and ultimately, vinyl sulfonyl benzene 2.31 was the ideal alkene of choice due to its 
benchtop stability and ease of handling. A variety of solvents were tested (Table 2.2, 
Entries 1-7) and although trifluorotoluene seemed promising (Entry 6), the optimal solvent 
was DCE due to higher yields and increased solubility of adamantane (Entry 7). In all cases 
except when using acetonitrile as solvent, both unsaturated product 2.32 and decomposition 
product 2.33 was observed albeit in low yields. Interestingly, the proper combination of 
catalyst affected both yield and conversion of starting material indicating a synergistic 
relationship between the two catalysts. When using the HAT catalyst quinuclidine 2.19 
with Ir catalyst 2.24 (Entry 7), we obtained a 30% yield but the previously reported acetoxy 
quinuclidine 2.18 with iridium catalyst 2.24 lowered the conversion to 97% and yield to 
27% (Entry 8).  
In Entry 9, the yield reduced to 18% when 2.17 was used and there was a slight 
increase in the unsaturated product 2.32 and decomposition product 2.33. An alternative, 
more oxidizing iridium photocatalyst 2.25 was synthesized using known procedures and 
then tested with three different quinuclidine based catalysts (Entry 10-12). With this 
particular photocatalyst, a synergistic effect with a quinuclidine base was observed. In 
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combination with photocatalyst 2.24, quinuclidine 2.18 gave the desired product but in low 
yield. A synergistic effect was observed with 2.19 and 2.18. 2.17 was a better quinuclidine 
catalyst for this transformation, giving the desired product in 62% yield in a dual catalytic 
reaction with photocatalyst 2.25. 
Table 2.2 Optimization using vinyl sulfonyl benzene 
 
We then proceeded to test different light sources using excess adamantane, 
acrylonitrile 2.34 as the alkene source and the optimized catalytic system. The initial light 
source, the Kessil H150 blue LED lamp, seemed like a viable candidate due to its 
widespread emission in the visible region however we were interested in determining the 
optimal wavelength to further optimize the reaction. When using a single wavelength 
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(Kessil PR 160 LED light sources), 390 nm was the least successful of the tested 
wavelengths (Table 2.3, Entry 2) giving low conversion and a 14% yield. Conversion and 
yield increased as the wavelength increased however the optimal wavelength was 
irradiating the reaction with 456 nm for 48 hours which gave a 99% conversion of 
acrylonitrile and a 90% yield. 
Table 2.3 Evaluation of different light sources 
 
Although optimistic about the current optimized conditions, we were interested in 
whether an additive would improve reaction yields, in particular for slower and more 
difficult substrates. With the help of Dr. Haibin Yang, an extensive protic additive screen 
was performed (Examples shown in Table 2.4) using 2 mol% Ir 2.24, 20 mol% 2.19 HAT 
catalyst and 1 equivalent of additive. Both diones 2.36 and 2.37 were unsuccessful giving 
no desired product and with benzamide 2.38, the yield was 27%. N-acetylamide 2.39 
increased the yield to 43% while trifluoroethanol 2.40 gave a promising yield of 63%. We 
tested water 2.41 as an additive and saw a greater improvement to 73% yield using one 
equivalent of water. After testing different equivalents of water, we discovered that 2 
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equivalents was optimal. Without water, the yield decreased to 50%. We hypothesized that 
the protic additive potentially acts as a proton shuttle. This was further studied in deuterium 
labeling studies described below. 
Table 2.4 Investigation of different additives 
 
Next, a variety of organic and transition-metal photocatalysts were screened with 
quinuclidine as HAT catalyst (some examples shown in Table 2.5). Ru(bpy)3Cl2 2.23 was 
the first catalyst tested with the ethyl acrylate system but was not successful and when 
tested in the new system, desired product was not observed. Ir 2.24 was the initial iridium 
catalyst of choice and the first successful photocatalyst however when tested under 
standard conditions, the conversion was high (97%) but the yield was only 60% for 
functionalized product 2.09. Both the unsaturated product 2.32 and decomposition product 
2.33 were observed in lower yields. Inspired by the photocatalytic C–H functionalization 
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reported by Nicewicz et. al.[38], we explored the highly oxidizing acridinium photocatalyst, 
2.26. Unfortunately, it provided 77% conversion of starting material, but we observed the 
desired product in very low yields (1%). Other organic photocatalysts such as 
pentacenetetrone 2.27 and 2-chloroanthroquinone 2.28 were also unsuccessful with the 
substrates studied.  
Table 2.5 Evaluation of different photocatalysts 
 
An alternative quinuclidine based HAT catalyst 2.17 was synthesized and tested 
against the photocatalysts in Table 2.5. The results were similar however when used 
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simultaneously with Iridium catalyst 2.25, the yields improved to 72%. Further studies 
were performed using this catalytic system. Ultimately, the two catalytic systems shown in 
Figure 2.4 were identified as being optimal, depending on the substrate used in the reaction 
and therefore the potential required in the key redox steps. 
 
Figure 2.4 Dual catalytic systems 
 
Finally, control reactions were run to test the limitations of the catalytic system 
using excess adamantane (3 equivalents), 1 equiv. phenyl vinyl sulfone 2.31 and DCE as 
solvent (Table 2.6). Without the iridium photocatalyst or quinuclidine HAT catalyst, 
conversions were 36% and 30%, respectively and product was not observed. This indicates 
both are required for the reaction to produce the expected product, however some 
background side-reaction of the sulfone can occur. With both catalysts present and no light 
source, conversion of starting material was a rather low 6% and the desired product was 
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not observed. Pleasingly, the photocatalyst, HAT catalyst and light are all necessary for the 
reaction to proceed efficiently. 
Table 2.6 Control reactions 
 
A summary of the optimization studies is shown in Table 2.7. Standard conditions 
employ the catalysts system 1; HAT catalyst 2.17 and iridium photocatalyst 2.25 (Entry 1), 
using 3 eq. of adamantane, phenyl vinyl sulfone 2.31 as the limiting reagent, 2 equiv of 
water as an additive. When using the catalyst system 2 with this particular alkene, the yield 
was slightly reduced to 66% (Entry 2). Solvent was a key variable in the reaction as shown 
in Entry 2. DCE was the optimal solvent as it readily solubilized adamantane; upon 
switching to acetonitrile, both the yield and conversion lowered. The additive (H2O) 
improved the reaction and is hypothesized to act as a proton shuttle.  
The combination of photocatalyst and HAT catalyst was important as shown in 
Entries 5 and 6. Using a ruthenium based photocatalyst was unsuccessful (Entry 7) and 
gave no desired product. Redox potentials were an important aspect of this catalytic system 
and due to Ru(bpy)3Cl2’s lower oxidation potential (less positive), the reaction was 
unsuccessful when compared to the highly oxidizing iridium catalysts. Another important 
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feature was the stoichiometry of the reagents. Optimal results were obtained with 3 
equivalents of adamantane and phenyl vinyl sulfone as the limiting reagent. When 
reversing the stoichiometry (Entry 8) the yield reduced to 55% with decomposition product 
2.33 as the byproduct. To our delight, when reducing the catalyst loading to 0.5 mol%, the 
yield was still very good (Entry 9). 
Table 2.7 Summary of optimization studies and variation from optimal conditions 
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2.3.2 - Substrate Scope 
With optimal catalytic conditions in hand, we investigated the scope of the 
alkylation reaction. A number of alkenes with different electron withdrawing groups 
including sulfones, nitriles, ketones and esters were effective coupling partners giving a 
single regioisomer of product (2.09, 2.42-2.52, Table 2.8). In all examples 
functionalization occurred at the tertiary position with no indication of alkylation at the 
secondary position. When using vinyl sulfonyl benzene 2.31 as alkene, the product 2.09 
was obtained in an isolated yield of 72% and when using 1.5 equivalents of adamantane, 
the yield was reduced to 64% indicating that the reaction was still effective with excess 
starting material. Although ethyl acrylate was an issue in the beginning of the optimization 
studies, when applied to the optimized conditions, it was much more successful (product 
2.45). In this case we employed the second catalyst system (Ir 2.24 and Q 2.19) to provide 
a 57% yield. When using the first catalyst system, the yield was reduced to 48% yield. We 
hypothesize that this particular catalytic system helped facilitate the more challenging 
reduction step (2.14 – 2.15, Scheme 2.1).  
Other alkenes were also investigated and high yields were obtained. When using 
cyclohexenone as substrate, the desired product 2.44 was isolated in 65% yield. A 
dehydroalanine derivative 2.47 was an excellent substrate in this C–H alkylation, giving 
amino acid derivative 2.47 in 89% yield. Olefins with two electron withdrawing groups 
were effective including the more sterically hindered 1,2-disubstituted and trisubstituted 
variants (2.46-2.52, 82-94% yield). Adjacent tertiary and quaternary centers are formed, 
which highlights the power of radical chemistry to generate highly congested centers. 
 63 
Overall, the isolated yields were quite high (57- 94%) and all products are formed as a 
single regioisomer. 
Table 2.8 Substrate scope: Testing of different alkenes 
 
We also investigated the scope of adamantane coupling partners using vinyl 
sulfonyl benzene as the alkene partner as shown in Table 2.9. A broad range of substituted 
adamantanes were well tolerated including dimethyl adamantane 2.53 which gave an 
isolated yield of 69%. When 1.5 equivalents of this adamantane was used, the yield was 
not affected (68% yield). Arylated (2.54 and 2.57), hydroxylated (2.56) and halogenated 
adamantanes (2.59) were also well tolerated and gave the desired alkylated product in good 
yields (70%-72%). Cyanoadamantane product 2.58 was successfully isolated in 64% yield 
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when the reaction was performed in acetonitrile. Electron-deficient 2-adamantanone 2.60 
and 1-acetyladamantane 2.61, also performed in acetonitrile as solvent, were alkylated in 
60% and 75% yield, respectively.  
Table 2.9 Substrate scope: Testing of substituted adamantanes 
 
We then turned our attention to more complicated diamondoid structures as shown 
in Table 2.10. Clinically approved drug derivatives 2.62-2.64 were initially investigated. 
We employed N-Boc protected amantadine 2.62 and memantine 2.63 which gave the 
desired alkylated product in 63% and 74% yields, respectively. N-Boc-memantine 2.63 
was used as the limiting reagents with two equivalents of vinyl sulfonyl benzene in 
acetonitrile as solvent and at elevated temperatures (38 ̊C) as the reaction proceeded more 
efficiently. A precursor to the anti-acne medication differin 2.64 underwent alkylation at 
the tertiary position using the second catalytic system and without significant interference 
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of the electron rich aryl and methoxy groups (51% yield). Next, we tested the selectivity 
of the amine catalyst Q 2.17 on polyfunctional substrates 2.65-2.67 to investigate whether 
the reaction conditions were still selective for the tertiary position on adamantane in the 
presence of multiple C(sp3)–H bonds.  
Boc-protected rimantadine 2.65 was monoalkylated in 68% yield with no 
functionalization at the tertiary position adjacent to the N-Boc group. Interestingly, an 
adamantane ester 2.66, which possesses an additional tertiary site and functionalizable 
secondary position adjacent to the ester oxygen, underwent selective alkylation on the 
adamantane group to produce 2.66 in a 70% yield (>20:1 r.r). Aldehyde 2.67 was 
monoalkylated in 70% yield with only 3% of the ketone product resulting from activation 
of the weak aldehyde C–H bond. Functionalization at the secondary position adjacent to 
the ester was not observed. Notably, Glorius and coworkers described a carboxyl radical 
HAT system that shows the opposite selectivity in closely related substrates, favoring 
activation of the weaker aldehyde and 3̊ C–H bonds.[39] Diamantane, the simplest higher 
ordered diamondoid, gave the corresponding sulfone product 2.68 and 2.68’ in 62% yield 
and succinate product 2.69 and 2.69’ in 65% yield as a 1.1-1.2:1 mixture of regioisomers. 
This implies a moderate inherent selectivity (~3:1) for the apical position.  
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Table 2.10 Substrate scope: synthesis of other diamondoids 
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2.3.3 - Intermolecular Competition Experiments 
Intermolecular competition experiments were performed with prototypical 
substrates for HAT methodologies including alkanes, ethers, aldehydes and amides (2.70-
2.77, Table 2.11). In all cases, the reactivity of adamantane was dominant and 46-80% of 
alkylation product 2.09 was obtained. Other tertiary C–H bonds such as those in 
norbornane 2.72 and 2,2,4-trimethylpentane 2.73 were virtually unreactive. Only octanal 
2.75, THF 2.76 and isopropanol 2.77 gave significant amounts of product (14-27%), but 
alkylated adamantane product 2.09 was still the major product. This increase in yield was 
attributed to their very electronically activated C–H bonds. 
We then performed a competition experiment with polyfunctional natural products 
and observed high chemoselectivity. Menthol (2.78) was essentially unreactive, providing 
only 4% of the corresponding product along with 75% of 2.09. Sclareolide, progesterone 
and limonin (2.79-2.81) were also tested and no alkylation products detected using catalyst 
Q 2.17 instead only the adamantane product 2.09. The wide range of C–H bonds that 
remain untouched in favor of adamantanes is an interesting demonstration of the 
chemoselectivity that is unique to the quinuclidine catalyst system. 
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Table 2.11 Intermolecular competition studies 
 
Afterwards, we compared the chemoselectivity of amine catalyst 2.17 for the strong 
bonds of adamantane to several previously reported photocatalytic HAT systems (Table 
2.12) using both octanal and THF in separate competition experiments. In the first study, 
we added 3 equivalents each of adamantane and octanal and subjected them under typical 
catalytic conditions. Yields were based on GC results using Bn2O as internal standard and 
selectivity was determined by 1H NMR. Both dual catalytic systems using an iridium 
photocatalyst paired with a quinuclidine based catalyst (Entries 1-2, Table 2.12) provided 
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selectivity for adamantane in a 4.5:1 and 4.2:1 ratio, respectively. The yields for the 
adamantane product was quite high while the ketone product 2.75, although generated, was 
significantly lower. However, all other catalysts investigated were either poorly selective 
or favored functionalization of the weaker C–H bond. The decatungstate photocatalyst 
(TBADT) and carboxyl radical gave moderate yields for the ketone products but a 1:5 ratio 
favoring octanal. For the acridinium catalyst 2.26 and phosphate base, very low yields were 
shown for both the adamantane product and ketone product with a 1:1 selectivity.  
Table 2.12 Competition experiments with octanal 
 
Similar results were observed in THF competitions experiments with the results 
shown in Table 2.13. As with the competition experiments with octanal, the two dual 
catalytic system were both selective for/towards adamantane giving the functionalized 
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adamantane product 2.09 in 46% yield for system 1 (Entry 1) and a 45% for system 2 
(Entry 2). Compared to octanal, the yields were higher for the THF products 2.76. One 
thing to note is that although adamantane is still more reactive than THF using quinuclidine 
HAT catalysts, the selectivity decreased significantly to a 1.6:1 and 1.8:1 ratio. With all 
other catalyst systems, the yields are low for adamantane product 2.09 and THF product 
2.76 but favor THF. Overall, these results indicate that the iridium photocatalyst in 
combination with a quinuclidine HAT catalyst is rather unique. All other catalyst systems 
show a completely different selectivity and only the catalytic system is selective for 
adamantane. 
Table 2.13 Intermolecular studies with THF 
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2.4 - Mechanistic Studies 
In order to understand this new photoredox catalyzed reaction, a series of 
mechanistic experiments were performed including radical trapping, fluorescence studies, 
deuterium labeling and kinetic isotope effect experiments. We began by investigating the 
effect of radical scavengers. When butylated hydroxytoluene (BHT) was used, alkylation 
was inhibited giving a 6% yield of alkylated product 2.09 (shown in Entry 1, Table 2.14). 
When the radical trapping agent, TEMPO, was used, it completely inhibited generation of 
product 2.09 and TEMPO trapped adamantane adduct 2.84 was confirmed by mass 
spectrometry. These two results support the proposal that an adamantyl radical 
intermediate is generated in the reaction.  
Table 2.14 Radical trapping experiments 
 
We then performed Stern ̶Volmer fluorescence quenching experiments to 
determine what is most likely interacting with the photocatalyst excited state. When 
irradiated at 420 nm, luminescence studies shown no quenching by adamantane 2.01 or 
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phenyl vinyl sulfone 2.31 as expected. However, studies showed that the HAT catalyst Q 
2.17 did quench the photocatalyst Ir 2.25 and resulted in a significant decrease in 
luminescence. Results from the Stern ̶ Volmer studies are consistent with the redox 
potentials of these species. Cyclic voltammetry experiments were performed on the newly 
synthesized amine catalyst 2.17 and the oxidative potential increased compared to 
quinuclidine 2.19 due to the introduction of the electron withdrawing group.  
For catalyst system 1, shown in Figure 2.5, the excited photocatalyst Ir 2.25* (E1/2
red 
(*IrIII/IrII)) = +1.68V vs. saturated calomel electrode (SCE in CH3CN) is a sufficiently 
strong oxidant to generate the radical cation from quinuclidine Q 2.17 (E1/2
red = +1.41V vs 
SCE in CH3CN). Similarly for catalyst system 2, photocatalyst Ir 2.24 is well matched with 
quinuclidine Q 2.19. The direct oxidation of adamantane by the photocatalyst or 
quinuclidine radical cation is not favorable (E1/2
red = +2.72V vs SCE in CH3CN), rendering 
a direct oxidation/deprotonation unlikely. 
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Figure 2.5 Catalyst systems and their redox potentials 
We then performed deuterium labeling experiments to investigate the HAT step 
and probe the reversibility of C–H abstraction (Scheme 2.2 Deuterium labeling experiment 
and KIE experiment). The proton exchange between the ammonium salt generated from 
quinuclidine and D2O should result in the corresponding deuterated ammonium salt 2.86-
D. The tertiary position in the adamantane motif of the starting material or product would 
be partially deuterated if C–H abstraction is a reversible process. However, no 
incorporation of deuterium into the starting material or adamantyl C–H bonds of the 
product were observed, suggesting that HAT is irreversible. The deuterated experiment 
yielded a 75% with 39% deuteration at the alpha-position only (product 2.85). 
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Scheme 2.2 Deuterium labeling experiment and KIE experiment 
Both di-deuterated (2.87) and tetra-deuterated (2.90) adamantane were prepared, 
tested and compared in kinetic isotope effect experiments. When adamantane and 
deuterated adamantane were subjected under normal reaction conditions, aliquots were 
carefully removed at ten minute time intervals and analyzed by gas chromatography (GC). 
Small kinetic isotope effect (KIE) values obtained from an intramolecular competition 
experiment with 2.87 (kH/kD = 1.6) and intermolecular competition experiments in parallel 
with tetra-deuterated adamantane gave a KIE of 1.3 indicating that the HAT process is 
likely not the turnover-limiting step in the catalytic cycle. These data are consistent with 
HAT as an irreversible process with an early transition state.  
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2.5 - Proposed Mechanism 
Based on the evidence above, the proposed mechanism is shown in Figure 2.6. 
Upon irradiation (Step A), the iridium photocatalyst 2.25 is excited to give 2.95 which then 
oxidizes the quinuclidine HAT catalyst Q 2.17 generating the radical cation 2.93 (Step B). 
Hydrogen abstraction from adamantane 2.01 (Step C) by the radical cation intermediate 
2.93 gives the corresponding ammonium 2.94 and adamantyl radical 2.13, which rapidly 
adds to the electron-deficient olefin (Step D), in this case ethyl acrylate, to generate αlpha-
acyl radical intermediate 2.14. The reduction of radical 2.14 by iridium (II) intermediate 
2.96 (Step E) and protonation by either quinuclidinium 2.94 or water as a proton shuttle 
provides the final product 2.45 and closes both catalytic cycles. 
 
Figure 2.6 Proposed catalytic cycle  
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2.6 - Conclusions 
Herein, we have developed a highly selective C–H functionalization strategy for 
the direct alkylation of adamantanes. Following extensive optimization studies, we have 
developed two catalytic systems involving an iridium catalyst and amine-based HAT 
catalyst. Importantly, we observed a synergistic effect between the photocatalyst and 
electron-deficient quinuclidine HAT catalyst for the first time. A broad scope of over 25 
diamondoid containing compounds including substituted adamantanes, medicinal 
precursors and diamantanes were synthesized in high yields. Mechanistic studies were 
explored and support a dual catalytic process. 
 
Figure 2.7 Alkylation reaction of adamantane to generate functionalized products 
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2.7 - Introduction ̶ Acetylation of Diamondoids 
As stated before, the selective functionalization of diamondoids poses challenges 
due to their inherent properties. Although there have been previous strategies for direct C–
H functionalization of these rigid structures, more methods need to be developed to expand 
the synthetic toolbox. As outlined above, we have developed a new method for directly 
functionalizing a variety of adamantanes via a dual catalytic alkylation reaction. However, 
we were interested in directly functionalizing the second higher ordered diamondoid, 
diamantane, at the apical position using photocatalytic methods.  
Each successively higher diamondoid increases in structural complexity, however 
there have been some examples of their applications in different fields of science and 
technology like drug delivery and polymer synthesis. Diamantane, the second member of 
the diamondoid family has been shown to be advantageous in polymer chemistry to provide 
increased stiffness and thermal stability.[6] Although potentially useful in a variety of 
applications, directly functionalizing diamantane has previously been shown to be 
challenging. Figure 2.8 shows some of difficulties in functionalizing this higher 
diamondoid. One challenge is the increased number of similar C–H bonds present in 
diamantane. Diamantane has two tertiary positions known as apical and medial and there 
are currently two examples of selective functionalization at the apical position. However, 
these reactions have low conversion, are low yielding and requires high-energy UV light. 
Other methods are poorly selective and lead to multiple inseparable isomers. Another issue 
is the multiple isomers associated with higher diamondoids like tetramantane, making 
selective functionalization increasingly difficult. 
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Figure 2.8 Difficulties in functionalizing higher diamondoids 
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As outlined in Chapter 1, acylated diamondoids are useful intermediates that can 
be further functionalized, for example through a reductive amination or Baeyer ̶Villager 
oxidation.[40,41] Previous methods that have been developed require a pre-functionalized 
substrate and/or harsh conditions. One method in which adamantane is selectively acylated 
as a single regioisomer is by using excess biacetyl under high energy ultraviolet photolysis 
conditions.[17,42] However, the acylation of diamantane has been shown to have low 
conversion of starting material and is low yielding.[32] In higher ordered diamondoids, 
photoacetylation remains selective for the methine (apical) position but is consistently low 
yielding (~20%).[43]  
Unlike adamantane, which features four equivalent methine positions, higher 
ordered diamondoids possess two nonequivalent methine positions for a total of eight 
potential methine functionalization sites. For diamantane, which features two apical and 
six medial positions, photoacetylation using biacetyl favored mono-acetylation at the 
apical position over the medial in a 5.5:1 ratio. This method requires an excessive amount 
of biacetyl 2.11 (46 equivalents) and relies on the use of UV light. We propose a C–H 
functionalization approach using visible light via an oxidation/deprotonation method that 
is selective for the apical position (Scheme 1.1). Here, an investigation into different 
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reaction conditions lead to a new functionalization of diamantane that proceeds with high 
selectivity. 
 
Scheme 2.3 Proposed acetylation strategy with diamantane 
One pathway to functionalize adamantane is to directly oxidize the substrate 
making it more susceptible to reactivity (such as deprotonation) however the oxidation 
potential of adamantane is quite high (E1/2
red = +2.72V vs SCE in CH3CN) making this 
method challenging. Inspired by the work done by Beeler et. al[16] with pyrylium 
photocatalysts, we sought to develop a photocatalyst with the oxidative ability to directly 
oxidize adamantane. Triphenylpyrylium tetrafluoroborate (TPT) 2.97 is a known 
photooxidant[45] with an oxidation potential (E1/2
red = +2.55V vs SCE in CH3CN) and 
although it has one of the highest redox potentials and absorbs light in the visible region, 
it remains highly susceptible to homocoupling or nucleophilic/radical addition. Beeler and 
coworkers considered whether TPT could be chemically modified to make a more robust 
catalyst with an oxidation potential that has the capability of oxidizing more challenging 
reactions and is less susceptible toward unwanted reactivity.  
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Scheme 2.4 Design of the MDPT catalyst 
A photocatalyst developed by Fukuzumi and popularized by Nicewicz,[38,46] N-
methylmesitylacridinium 2.99 has a lower excited state oxidation potential than TPT, 
however it possesses an orthogonal mesityl group which has a protective function for the 
catalyst by minimizing undesirable reactivity towards nucleophiles and transient radicals 
at the acridinium chromophore. It was hypothesized that by replacing the 4-aryl group on 
TPT with a mesityl group, the new photocatalyst will not only possess high photophysical 
properties but a protective environment from the mesityl group. With that in mind, the 4-
mesityl-2,6-diphenylpyrylium tetrafluoroborate (MDPT) 2.98 shown in Scheme 2.4 was 
synthesized and studied for its redox capabilities. MDPT has been shown to have one of 
the highest oxidation potential known with an E1/2
red = +2.62V vs SCE in CH3CN.
[2] 
Therefore, we moved forward with the hopes of directly functionalizing diamondoids via 
an oxidation with the highly oxidizing MDPT photocatalyst. 
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2.8 - Results and Discussion 
Before testing diamantane directly, we sought to optimize reaction conditions using 
adamantane as substrate. A variety of catalysts including TPT 2.97, MDPT 2.98 and an 
MDPT derivative 2.100 (Table 2.15) were initially tested among a variety of solvents and 
bases. 
Table 2.15 Initial optimization studies 
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We tested a variety of protic and aprotic solvents with pyrylium photocatalysts A-
C (Table 2.15). Acetone, THF and MeOH were unsuccessful as shown in Entries 1-9 
however we did see an improvement using DCM which was expected as it is the solvent 
used in the photoacetylation reaction. Dichloroethane (DCE) was the optimal solvent 
yielding 31%, 40% and 64% yield for photocatalysts A, B and C, respectively. Excited 
with these new results, we moved forward with the MDPT photocatalyst and DCE as 
solvent. We then performed an extensive base screen with some results shown in Table 
2.16. A base was hypothesized to increase reactivity by potentially promoting 
deprotonation of the reactive species. Using 10 equivalents of biacetyl, 5 mol% of 
photocatalyst MDPT and 5 equivalents of base, we tested a variety of inorganic bases 
including phosphates and carbonates but interestingly, NaF gave the best results with a 
yield of 67% (entry 9). 
 84 
Table 2.16 Base and wavelength screen 
 
In entries 10-14, a wavelength screen was investigated using both UV light and 
visible light sources. Following a UV-Vis experiment, the MDPT catalyst was shown to 
absorb light at 420 nm however the optimal wavelength was at 456 nm giving a 68% yield 
by gas chromatography (GC). This was followed by testing the equivalents of base, shown 
in Table 2.17. Although, the reaction does work poorly without base, increasing the base 
loading significantly affected the yield. Optimal results are shown in Entry 5 using 7 
equivalents on NaF which gave a 71% yield by GC. Both reaction concentration and 
catalyst loading did not affect the yield. Also, control reactions were performed and the 
reaction does not proceed without light, while without base or catalyst, the reaction 
proceeds poorly.  
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Table 2.17 Optimization with equivalents of base 
 
 With these optimized conditions in hand, we moved forward with the acetylation 
of diamantane. The reactions were monitored by GC and performed on a 0.1 mmol scale. 
After 24 hours, two new peaks appeared by GC at about 10 minutes which was 
hypothesized to be the two regioisomers of the diamantane product 2.12. Initial isolation 
procedures were unsuccessful as conversion of the starting material was low and 
diamantane was not easily separated from the potential product. By scaling the reaction to 
0.5 mmol and a carefully crafted purification system, acetyldiamantane 2.12 was 
successfully isolated in 48% yield with a regioisomeric ratio of 8:1 favoring the apical 
position over the medial. 
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Scheme 2.5 Photoacetylation of diamantane 
2.9 - Future Work / Conclusion 
Despite successful functionalization and isolation of acetyldiamantane 2.12, the 
reaction pathway has not been conclusively determined. Future studies would involve 
investigating the limitations of this reaction by employing various substrates. An in-depth 
mechanistic study needs to be performed in order to better understand this transformation 
and to determine the role of biacetyl, photocatalyst and the base NaF. We hypothesize that 
the proposed oxidation/deprotonation mechanism is responsible for the high apical 
selectivity observed.  
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2.10 - Experimental 
2.10.1 - Materials and Methods: 
1H and 13C NMR spectra were recorded on a Varian Inova 400 MHz spectrometer 
unless otherwise indicated and were internally referenced to residual protio solvent signal 
(note: CDCl3 referenced at 7.26 ppm for 1H NMR and 77.16 ppm for 13C NMR, 
respectively). Data for 1H NMR are reported as follows: chemical shift ( ppm), 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), and 
coupling constant (Hz). Data for 13C NMR are reported in terms of chemical shift and no 
special nomenclature is used for equivalent carbons. IR spectra were recorded on a Bruker 
Alpha FT-IR Spectrometer. High-resolution mass spectrometry data were recorded on an 
Agilent LCTOF instrument using direct injection of samples in dichloromethane into the 
electrospray source (ESI) with positive ionization. GC was performed on a SHIMADZU 
GC-2010 Plus instrument equipped with a flame-ionization detector (FID). Stern-Volmer 
experiments were conducted on a QuantaMasterTM 400 Fluorometer. Cyclic voltammetry 
experiments were performed using a Pine AFP1 potentiostat. 
All reactions were carried out under an inert atmosphere of nitrogen in oven dried 
or flame dried glassware with magnetic stirring, unless otherwise noted. DCE was distilled 
from NaH and t-BuOH was distilled from Na. Other solvents were dried by passage 
through columns of activated alumina. All starting materials were prepared according to 
known literature procedures or used as obtained from commercial sources, unless 
otherwise indicated. LEDs were purchased from Kessil 
(http://www.kessil.com/photoredox/Products.php). Reactions were monitored by thin-
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layer chromatography (TLC) and carried out on 0.25 mm coated commercial silica gel 
plates (Analtech TLC Uniplates, F254 precoated glass plates) using UV light as visualizing 
agent and KMnO4 and heat as a developing agent. Flash chromatography was performed 
on silica gel (Silicycle, SiliaFlash P60, 230-400 mesh).  
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2.10.2 - Optimization Details 
To an 8-mL glass vial equipped with a magnetic stir bar were sequentially added 
photoredox catalyst (2 mol%), hydrogen atom transfer catalyst (20 mol%), adamantane 
(0.750 mmol, 3.0 equiv), phenyl vinyl sulfone or acrylonitrile (0.250 mmol, 1.0 equiv) and 
solvent (2.5 mL). The vial was sealed with a Teflon septum. The resulting mixture was 
degassed via three cycles of “freeze, pump, thaw” operation. The vial was further sealed 
with parafilm and placed approximately 2 inches away from one Kessil® LED (model 456 
blue) or Precise Wavelengths PR160 LED 
(http://www.kessil.com/photoredox/Products.php). The reaction mixture was stirred and 
irradiated for 48 h. The internal temperature was maintained at approximately 28 °C by an 
electric fan placed approximately 5 inches above the vial. After 48 h, the yield was 
determined by GC using Bn2O as an internal standard.  
GC conditions: The initial oven temperature was set to 100 °C, and the ramp rate 
was programmed to 3 °C/min until reaching 250 °C. The temperature is held at 250 °C for 
10 minutes before concluding the run. Retention time: t (2.31) = 8.9 min, t (Bn2O) = 15.3 
min, t (2.09) = 45.1 min, t (2.32) = 45.4 min, t (2.33) = 45.8 min. Relative response factor: 
Rf phenyl vinyl sulfone = 0.630, Rf (Bn2O) = 1, Rf (2.09) = 1.393, Rf (2.32) = 0.945, Rf 
(2.33) = 0.350. 
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2.10.3 - Control Experiments 
“Standard” procedure: To an 8-mL glass vial equipped with a magnetic stir bar 
were sequentially added Ir 2.25 (11.5 mg, 0.010 mmol, 2 mol%), Q 2.17 (26.7 mg, 0.100 
mmol, 20 mol%), adamantane (204.4 mg, 1.500 mmol, 3.0 equiv), phenyl vinyl sulfone 
(84.1 mg, 0.500 mmol, 1.0 equiv), water (18.0 µL, 1.00 mmol, 2.0 equiv) and DCE (5.0 
mL). The vial was sealed with a Teflon septum. The resulting mixture was degassed via 
three cycles of “freeze, pump, thaw” operation. The vial was further sealed with parafilm 
and placed approximately 4 inches away from two Kessil® LEDs (456 nm). The reaction 
mixture was stirred and irradiated for 48 h. The internal temperature was maintained at 
approximately 28 °C by an electric fan placed approximately 5 inches above the vial. After 
8 h, the yield was determined by GC using Bn2O as an internal standard. Control 
experiments were done to explore the effect of reaction parameters.  
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2.10.4 - Synthesis and Characterization of Ir complexes and quinuclidine derivatives 
Ir 2.25, Ir 2.24 and Q 2.18 were synthesized according to the literature.[47–49]  
 
(±)-Quinuclidin-3-yl benzenesulfonate (Q 2.17) 
To a solution of quinuclidin-3-ol (1.27 g, 10.000 mmol, 1.0 equiv) and pyridine 
(1.58 g, 20.000 mmol, 2.0 equiv) in DCM (10.0 mL) were added benzenesulfonyl chloride 
(1.76 g, 10.000 mmol, 1.0 equiv) via syringe at 0 oC. The mixture was further stirred at 0 
°C for 8 h, and then concentrated in vacuo. The residue was diluted with DCM (30.0 mL), 
and washed with saturated aqueous solution of K2CO3 (10.0 mL). The volatiles was 
removed in vacuo and the crude material was purified using silica gel chromatography 
(eluent: 20:1 dichloromethane/ethanol to 100:10:1 dichloromethane: ethanol: 30% 
ammonia solution) to provide Q 2.17 (white solid, 1.20 g, 45% yield). IR (film) 2940, 
2868, 1446, 1360, 1186, 1170, 1094, 928, 884, 814, 764, 718, 690, 621, 577, 549 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.92-7.89 (m, 2H), 7.64 (td, J = 8.0, 1.3 Hz, 1H), 7.54 (t, J = 
8.0 Hz, 2H), 4.65-4.61 (m, 1H), 3.07 (ddd, J = 15.1, 8.3, 2.3 Hz, 1H), 2.92-2.58 (m, 5H), 
2.01-1.97 (m, 1H), 1.89-1.80 (m, 1H), 1.66 (ddt, J = 14.3, 10.1, 4.4 Hz, 1H), 1.48-1.31 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 137.37, 133.80, 129.39, 127.69, 79.77, 55.05, 47.30, 
46.27, 26.26, 24.52, 18.76; HRMS (ESI) m/z calcd for C13H18NO3S (M+H)
+ 268.1002, 
found 268.0992. 
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2.10.5 - Synthesis and Characterization of Products 
 
General Procedure: To an 8-mL glass vial equipped with a magnetic stir bar were 
sequentially added Ir 2.25 (11.5 mg, 0.010 mmol, 2 mol%), Q 2.17 (26.7 mg, 0.100 mmol, 
20 mol%), adamantane (1.500 mmol, 3.0 equiv), alkene (0.500 mmol, 1.0 equiv), water 
(18.0 µL, 1.000 mmol, 2.0 equiv) and DCE (5.0 mL). The vial was sealed with a Teflon 
septum. The resulting mixture was degassed via three cycles of “freeze, pump, thaw” 
operation. The vial was further sealed with parafilm and placed approximately 4 inches 
away from two Kessil® LEDs (456 nm). The reaction mixture was stirred and irradiated 
for the specified time. The solvent was removed in vacuo and the crude residue was purified 
using silica gel chromatography to provide products (2.09, 2.42-2.69) 
 
1-(2-(Phenylsulfonyl)ethyl)adamantane (2.09) 
Prepared according to General Procedure using adamantane and phenyl vinyl 
sulfone as the substrates. Reaction time: 8 h.The crude residue was purified by column 
chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.09 (110.0 mg, 72% yield), 
IR (film) 2896, 2845, 1445, 1299, 1144, 1084, 786, 747, 728, 685, 614, 548, 531 cm-1; 
NMR data are in accordance with literature values:[50] 1H NMR (400 MHz, CDCl3) δ 7.89-
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7.87 (m, 2H), 7.63 (td, J = 7.6, 1.5 Hz, 1H), 7.55 (t, J = 7.6 Hz, 2H), 3.06-3.01 (m, 2H), 
1.91 (brs, 3H), 1.65 (d, J = 12.0 Hz, 3H), 1.54 (d, J = 12.0 Hz, 3H), 1.47-1.43 (m, 2H), 
1.38-1.37 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 139.29, 133.63, 129.29, 128.04, 51.30, 
41.95, 36.83, 35.89, 31.87, 28.45. HRMS (ESI) m/z calcd for C18H25O2S (M+H)
+ 305.1570, 
found 305.1569. 
 
3-(Adamantan-1-yl)propanenitrile (2.42) 
Prepared according to General Procedure using adamantane and acrylonitrile as the 
substrates. Reaction time: 48 h. The crude residue was purified by column chromatography 
on silica gel (EtOAc/Hexanes = 1/10) to afford 2.42 (86.0 mg, 91% yield), IR (film) 2897, 
2846, 2242, 1448, 1360, 1100 cm-1; NMR data are in accordance with literature values3: 
1H NMR (400 MHz, CDCl3) δ 2.25 (t, J = 8.0 Hz, 2H), 1.96 (brs, 3H), 1.70 (d, J = 12.0 
Hz, 3H), 1.60 (d, J = 12.0 Hz, 3H), 1.48-1.44 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 
120.95, 41.67, 39.50, 36.86, 32.15, 28.42, 11.00. HRMS (ESI) m/z calcd for C13H20N 
(M+H)+ 190.1590, found 190.1295 
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4-(Adamantan-1-yl)butan-2-one (2.43) 
Prepared according to General Procedure using adamantane and methyl vinyl 
ketone as the substrates. Reaction time: 24 h. The crude residue was purified by column 
chromatography on silica gel (EtOAc/Hexanes = 1/10) to afford 2.43 (86.2 mg, 84% yield). 
IR (film) 2896, 2844, 1715, 1450, 1361, 1157, 548 cm-1; NMR data are in accordance with 
literature values2: 1H NMR (400 MHz, CDCl3) δ 2.36-2.32 (m, 2H), 2.11 (s, 3H), 1.91 (brs, 
3H), 1.67 (d, J = 12.4 Hz, 3H), 1.58 (d, J = 12.4 Hz, 3H), 1.42-1.41 (m, 6H), 1.33-1.29 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 209.96, 42.23, 37.82, 37.51, 37.15, 31.83, 29.93, 
28.68. 
 
3-(Adamantan-1-yl)cyclohexanone (2.44) 
Prepared according to General Procedure with slight modification (Reaction vial 
was placed approximately 2 inches away from two Kessil® LEDs which led to a higher 
temperature (38 oC)), using adamantane and cyclohex-2-enone as the substrates. Reaction 
time: 84 h. The crude residue was purified by column chromatography on silica gel 
(EtOAc/Hexanes = 1/10) to afford 2.44 (75.2 mg, 65% yield). IR (film) 2894, 2843, 1707, 
1448, 1346, 1228, 523 cm-1; NMR data are in accordance with literature values[50]: 1H NMR 
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(400 MHz, CDCl3) δ 2.41-2.37 (m, 1H), 2.33-2.28 (m, 1H), 2.23-2.14 (m, 1H), 2.09-1.87 
(m, 6H), 1.67 (d, J = 12.3 Hz, 3H), 1.58 (d, J = 12.3 Hz, 3H), 1.54-1.43 (m, 7H), 1.34-1.22 
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 213.44, 49.74, 42.17, 41.62, 39.49, 37.28, 34.51, 
28.71, 25.76, 24.66. 
 
Ethyl 3-(adamantan-1-yl)propanoate (2.45) 
Prepared according to General Procedure with slight modification (Ir 2.25+Q 2.17 
were replaced by Ir 2.24+Q 2.19), using adamantane and ethyl acrylate as the substrates. 
Reaction time: 24 h. The crude residue was purified by column chromatography on silica 
gel (EtOAc/Hexanes = 1/30) to afford 2.45 (66.8 mg, 57% yield). IR (film) 2898, 2846, 
1733, 1450, 1301, 1151, 1103, 1024 cm-1; NMR data are in accordance with literature 
values4: 1H NMR (400 MHz, CDCl3) δ 4.10 (q, J = 7.1 Hz, 2H), 2.25-2.21 (m, 2H), 1.93 
(brs, 1H), 1.68 (d, J = 11.9 Hz, 3H), 1.60 (d, J = 12.1 Hz, 3H), 1.44-1.38 (m, 8H), 1.23 (t, 
J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.80, 60.30, 42.14, 39.08, 37.18, 32.01, 
28.71, 28.30, 14.34. 
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3-(Adamantan-1-yl)-2-phenylpropanenitrile (2.46) 
Prepared according to General Procedure using adamantane and 2-
phenylacrylonitrile as the substrates. Reaction time: 36 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/Hexanes = 1/25) to afford 2.46 (115.4mg, 
87% yield), IR (film) 3069, 3035, 2897, 2848, 2239, 1600, 1495, 1452, 1347, 1101, 1031, 
748, 713, 694, 586, 491, 463 cm-1; NMR data are in accordance with literature values5: 1H 
NMR (400 MHz, CDCl3) δ 7.30-7.17 (m, 5H), 3.71 (dd, J = 10.4, 3.4 Hz, 1H), 1.93 (brs, 
3H), 1.85 (dd, J = 14.3, 10.4 Hz, 1H), 1.67 – 1.55 (m, 12H), 1.42 (dd, J = 14.3, 3.4 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 138.15, 129.21, 127.85, 127.24, 122.46, 51.18, 42.28, 
36.89, 33.11, 31.42, 28.56; HRMS (ESI) m/z calcd for C19H23NNa (M+Na)
+ 288.1723, 
found 288.1729.  
 
Methyl 2-(di(tert-butoxycarbonyl)amino)-3-adamantan-1-yl)-propanoate 
(2.47) 
Prepared according to General Procedure using adamantane and methyl (tert-
butoxycarbonyl)-L-serinate as the substrates. Reaction time: 24 h. The crude residue was 
purified by column chromatography on silica gel (EtOAc/Hexanes = 1/10) to afford 2.47 
(194.3 mg, 89% yield). IR (film) 2979, 2900, 2847, 1744, 1698, 1453, 1366, 1137, 1002, 
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855, 731 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.93 (dd, J = 7.3, 3.6 Hz, 1H), 3.64 (s, 3H), 
2.06 (dd, J = 15.2, 3.6 Hz, 1H), 1.89 (brs, 3H), 1.64 (d, J = 12.3 Hz, 3H), 1.56 (d, J = 12.3 
Hz, 3H), 1.52-1.41 (m, 25H); 13C NMR (100 MHz, CDCl3) δ 172.36, 152.00, 82.90, 54.07, 
52.28, 44.76, 42.14, 36.97, 32.16, 28.57, 28.05; HRMS (ESI) m/z calcd for C24H39NO6Na 
(M+Na)+ 460.2670, found 460.2677. 
 
Dimethyl 2-(adamantan-1-yl)succinate (2.48) 
Prepared according to General Procedure using adamantane and (Z)-dimethyl 
maleate as the substrates. Reaction time: 24 h. The crude residue was purified by column 
chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.48 (132.2 mg, 94% yield). 
IR (film) 2901, 2847, 1726, 1438, 1340, 1304, 1195, 1160, 988, 845 cm-1; NMR data are 
in accordance with literature values[51]: 1H NMR (400 MHz, CDCl3) δ 3.64 (s, 3H), 3.60 
(s, 3H), 2.70 (dd, J = 17.1, 12.3 Hz, 1H), 2.48-2.43 (m, 2H), 1.93 (brs, 3H), 1.66-1.55 (m, 
9H), 1.43-1.40 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 174.32, 173.36, 52.29, 51.75, 
51.28, 39.99, 36.78, 34.42, 30.98, 28.53. 
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2-(Adamantan-1-yl(phenyl)methyl)malononitrile (2.49) 
Prepared according to General Procedure using adamantane and 2-
benzylidenemalononitrile as the substrates. Reaction time: 24 h. The crude residue was 
purified by column chromatography on silica gel (EtOAc/Hexanes = 1/10) to afford 2.49 
(126.9 mg, 87% yield), IR (film) 2903, 2852, 2250, 1499, 1453, 1346, 1315, 975, 711, 646, 
567, 497 cm-1; NMR data are in accordance with literature values[50]: 1H NMR (400 MHz, 
CDCl3) δ 7.42-7.37 (m, 5H), 4.27 (d, J = 5.4 Hz, 1H), 2.82 (d, J = 5.4 Hz, 1H), 2.03 (brs, 
3H), 1.72-1.58 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 135.39, 129.73, 128.59, 128.51, 
113.62, 113.46, 57.93, 40.35, 36.54, 36.36, 28.40, 23.80. 
 
3-(Adamantan-1-yl(phenyl)methyl)pentane-2,4-dione (2.50) 
Prepared according to General Procedure using adamantane and 3-
benzylidenepentane-2,4-dione as the substrates. Reaction time: 48 h. The crude residue 
was purified by column chromatography on silica gel (EtOAc/Hexanes = 1/10) to afford 
2.50 (132.2 mg, 82% yield). IR (film) 2973, 2898, 2844, 1693, 1453, 1353, 1141, 1087, 
1046, 880, 768, 717, 534, 471 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.21-7.10 (m, 4H), 6.86 
(brs, 1H), 4.43 (d, J = 11.0 Hz, 1H), 3.45 (d, J = 11.0 Hz, 1H), 2.30 (s, 3H), 1.88 (brs, 3H), 
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1.58 (d, J = 15.6 Hz, 3H), 1.48-1.37 (m, 9H), 1.32 (d, J = 13.9 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 204.28, 203.65, 138.58, 132.58, 129.29, 127.69, 126.70, 72.44, 55.52, 
40.49, 36.71, 36.40, 30.53, 28.59, 26.74; HRMS (ESI) m/z calcd for C22H28O2Na (M+Na)
+ 
347.1982, found 347.1988. 
 
Diethyl 2-(adamantan-1-yl(phenyl)methyl)malonate (2.51) 
Prepared according to General Procedure using adamantane and diethyl 2-
benzylidenemalonate as the substrates. Reaction time: 48 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/Hexanes = 1/20) to afford 2.51 (178.5 
mg, 93% yield), IR (film) 2972, 2901, 2852, 1754, 1722, 1448, 1366, 1305, 1249, 1169, 
1120, 1032, 775, 708, 626, 611, 556 cm-1; NMR data are in accordance with literature 
values[50]: 1H NMR (400 MHz, CDCl3) δ 7.20-7.07 (m, 5H), 4.26-4.12 (m, 2H), 3.97 (d, J 
= 10.7 Hz, 1H), 3.72-3.60 (m, 2H), 3.31 (d, J = 10.7 Hz, 1H), 1.88 (brs, 3H), 1.58 (d, J = 
12.3 Hz, 3H), 1.50-1.46 (m, 9H), 1.26 (t, J = 7.1 Hz, 3H), 0.75 (t, J = 7.1 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 169.59, 168.32, 138.82, 127.20, 126.44, 61.64, 61.09, 56.07, 
53.55, 39.92, 36.72, 36.11, 28.58, 13.96, 13.39. 
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Diethyl 2-(1-(adamantan-1-yl)ethyl)malonate (2.52) 
Prepared according to General Procedure using adamantane and diethyl 2-
ethylidenemalonate as the substrates. Reaction time: 48 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/Hexanes = 1/20) to afford 2.52 (138.5 
mg, 86% yield), IR (film) 2980, 2901, 2848, 1752, 1728, 1447, 1367, 1147, 1031 cm-1; 
NMR data are in accordance with literature values[50]: 1H NMR (400 MHz, CDCl3) δ 4.17-
4.10 (m, 4H), 3.52 (d, J = 5.0 Hz, 1H), 2.02 (qd, J = 7.3, 5.0 Hz, 1H), 1.92 (brs, 3H), 1.64 
(d, J = 12.4 Hz, 3H), 1.56 (d, J = 12.4 Hz, 3H), 1.51-1.43 (m, 6H), 1.22 (q, J = 7.0 Hz, 6H), 
0.94 (d, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.38, 169.78, 61.32, 60.88, 
51.85, 43.12, 39.41, 37.07, 35.27, 28.66, 14.10, 14.07, 10.40. 
 
1,3-Dimethyl-5-(2-(phenylsulfonyl)ethyl)adamantane (2.53) 
Prepared according to General Procedure using 1,3-dimethyladamantane and 
phenyl vinyl sulfone as the substrates. Reaction time: 24 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.53 (114.7 mg, 
69% yield), IR (film) 2941, 2891, 2838, 1448, 1303, 1147, 1087, 807, 739, 690, 609, 533, 
432 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.1 Hz, 2H), 7.63 (t, J = 7.4 Hz, 1H), 
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7.54 (t, J = 7.6 Hz, 2H), 3.05-3.01 (m, 2H), 1.99 (h, J = 3.2 Hz, 1H), 1.51-1.47 (m, 2H), 
1.28-1.20 (m, 6H), 1.11-0.94 (m, 6H), 0.75 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 139.32, 
133.64, 129.30, 128.05, 51.47, 50.97, 48.30, 43.07, 40.55, 35.20, 33.56, 31.24, 30.51, 
29.52; HRMS (ESI) m/z calcd for C20H28O2SNa (M+Na)
+ 355.1702, found 355.1709. 
 
(3-(2-(Phenylsulfonyl)ethyl)adamantan-1-yl)methyl benzoate (2.54) 
Prepared according to General Procedure using adamantan-1-ylmethyl benzoate 
and phenyl vinyl sulfone as the substrates. Reaction time: 24 h. The crude residue was 
purified by column chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.54 
(145.7 mg, 66% yield), IR (film) 2900, 2847, 1713, 1447, 1304, 1268, 1147, 1113, 1069, 
1025, 710, 687, 619, 533 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 7.6 Hz, 2H), 
7.88 (d, J = 7.7 Hz, 2H), 7.63-7.40 (m, 6H), 3.89 (s, 2H), 3.07-3.03 (m, 2H), 2.05 (brs, 2H), 
1.62-1.23 (m, 14H); 13C NMR (100 MHz, CDCl3) δ 166.48, 139.12, 133.64, 132.93, 
130.33, 129.49, 129.26, 128.40, 127.98, 73.72, 51.19, 43.79, 41.21, 38.65, 36.06, 35.45, 
34.27, 32.25, 28.17; HRMS (ESI) m/z calcd for C26H30O4SNa (M+Na)
+ 461.1757, found 
461.1764. 
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1-Phenyl-3-(2-(phenylsulfonyl)ethyl)adamantane (2.57) 
Prepared according to General Procedure using 1-phenyladamantane and phenyl 
vinyl sulfone as the substrates. Reaction time: 24 h. The crude residue was purified by 
column chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.57 (136.8 mg, 
72% yield), IR (film) 2898, 2846, 1495, 1446, 1303, 1146, 1086, 931, 741, 688, 617, 532 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.94-7.91 (m, 2H), 7.66 (t, J = 7.4 Hz, 1H), 7.57 (t, J 
= 7.7 Hz, 2H), 7.36-7.32 (m, 4H), 7.21-7.18 (m, 1H), 3.13-3.09 (m, 2H), 2.18 (p, J = 3.0 
Hz, 2H), 1.89-1.42 (m, 14H); 13C NMR (100 MHz, CDCl3) δ 150.13, 139.24, 133.66, 
129.30, 128.23, 128.03, 125.84, 124.77, 51.31, 47.80, 42.26, 41.11, 36.88, 35.91, 35.65, 
32.94, 29.04; HRMS (ESI) m/z calcd for C24H28O2SNa (M+Na)
+ 403.1702, found 
403.1709. 
 
3-(2-(Phenylsulfonyl)ethyl)adamantan-1-ol (2.56) 
Prepared according to General Procedure using adamantan-1-ol and phenyl vinyl 
sulfone as the substrates. Reaction time: 24 h. The crude residue was purified by column 
chromatography on silica gel (EtOAc/Hexanes = 1/1) to afford 2.56 (114.7 mg, 72% yield), 
IR (film) 3348, 2971, 2905, 2850, 1447, 1301, 1147, 1086, 1047, 727, 688, 617, 533 cm-1; 
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1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 7.7 Hz, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.53 (t, J 
= 7.7 Hz, 2H), 3.03-2.99 (m, 2H), 2.11 (brs, 2H), 1.94 (brs, 1H), 1.62-1.40 (m, 8H), 1.30-
1.21 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 139.01, 133.72, 129.30, 127.94, 68.50, 51.28, 
49.30, 44.41, 40.52, 35.38, 35.22, 34.83, 30.39; HRMS (ESI) m/z calcd for C18H24O3SNa 
(M+Na)+ 343.1338, found 343.1345. 
 
1-Chloro-3-(2-(phenylsulfonyl)ethyl)adamantane (2.59) 
Prepared according to General Procedure with slight modification (DCE was 
replaced by CH3CN), using 1-chloroadamantane and phenyl vinyl sulfone as the substrates. 
Reaction time: 48 h. The crude residue was purified by column chromatography on silica 
gel (EtOAc/Hexanes = 1/5) to afford 2.59 (118.0 mg, 70% yield), IR (film) 2972, 2904, 
2861, 1445, 1302, 1147, 1086, 1046, 804, 739, 688, 602, 534 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.88-7.86 (m, 2H), 7.64 (t, J = 7.4 Hz, 1H), 7.55 (t, J = 7.6 Hz, 2H), 3.04-3.00 
(m, 2H), 2.14 (brs, 2H), 2.04 (d, J = 12.1 Hz, 2H), 1.94 (d, J = 12.1 Hz, 2H), 1.75 (s, 2H), 
1.60-1.46 (m, 4H), 1.36-1.35 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 139.07, 133.79, 
129.37, 128.00, 67.92, 51.69, 51.13, 46.82, 40.00, 36.23, 34.78, 34.72, 31.35; HRMS (ESI) 
m/z calcd for C18H23ClO2SNa (M+Na)
+ 361.0999, found 361.1006. 
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3-(2-(Phenylsulfonyl)ethyl)adamantane-1-carbonitrile (26.58) 
Prepared according to General Procedure with slight modification (DCE was 
replaced by CH3CN), using adamantane-1-carbonitrile and phenyl vinyl sulfone as the 
substrates. Reaction time: 48 h. The crude residue was purified by column chromatography 
on silica gel (EtOAc/Hexanes = 1/3) to afford 2.58 (104.8 mg, 64% yield), IR (film) 2972, 
2905, 2860, 2233, 1444, 1301, 1140, 1085, 1047, 880, 806, 740, 687, 604, 531, 435 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.88-7.86 (m, 2H), 7.67-7.62 (m, 1H), 7.55 (t, J = 7.6 Hz, 
2H), 3.03-2.98 (m, 2H), 2.06 (brs, 2H), 1.95 (d, J = 12.6 Hz, 2H), 1.85 (d, J = 12.6 Hz, 
2H), 1.65-1.61 (m, 3H), 1.55-1.51 (m, 3H), 1.43-1.36 (m, 4H); 13C NMR (100 MHz, 
CDCl3) δ 138.97, 133.84, 129.39, 127.97, 124.47, 50.83, 43.95, 40.10, 39.16, 34.93, 34.85, 
31.73, 30.75, 27.32; HRMS (ESI) m/z calcd for C19H23NO2SNa (M+Na)
+ 352.1342, found 
352.1348. 
 
5-(2-(Phenylsulfonyl)ethyl)adamantan-2-one (2.60) 
Prepared according to General Procedure with slight modification (Reaction vial 
was placed approximately 2 inches away from two Kessil® LEDs which led to a higher 
temperature (38 oC) and DCE was replaced by CH3CN), using adamantan-2-one and 
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phenyl vinyl sulfone as the substrates. Reaction time: 96 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/DCM = 1/10) to afford 2.60 (95.0 mg, 
60% yield), IR (film) 2973, 2921, 2856, 1708, 1446, 1297, 1139, 1086, 1048, 880, 807, 
740, 688, 585, 522, 474 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.88-7.84 (m, 2H), 7.63 (t, J 
= 8.0 Hz, 1H), 7.54 (t, J = 8.0 Hz, 2H), 3.03-2.99 (m, 2H), 2.47 (brs, 2H), 2.08 (brs, 1H), 
1.93-1.86 (m, 4H), 1.68-1.54 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 217.11, 138.96, 
133.84, 129.38, 127.97, 51.31, 46.06, 42.81, 40.55, 38.50, 34.06, 31.92, 27.58; HRMS 
(ESI) m/z calcd for C18H22O3SNa (M+Na)
+ 341.1182, found 341.1188. 
 
1-(3-(2-(Phenylsulfonyl)ethyl)adamantan-1-yl)ethenone (2.61) 
Prepared according to General Procedure with slight modification (DCE was 
replaced by CH3CN), using 1-(adamantan-1-yl)ethanone and phenyl vinyl sulfone as the 
substrates. Reaction time: 48 h. The crude residue was purified by column chromatography 
on silica gel (EtOAc/Hexanes = 1/3) to afford 2.61 (129.6 mg, 75% yield), IR (film) 2916, 
2854, 1695, 1446, 1298, 1150, 1085, 806, 741, 688, 586, 533 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.85 (d, J = 7.6 Hz, 2H), 7.61 (t, J = 7.4 Hz, 1H), 7.52 (t, J = 7.7 Hz, 2H), 3.04-
2.99 (m, 2H), 2.05 (brs, 2H), 2.02 (s, 3H), 1.74-1.70 (m, 2H), 1.58-1.48 (m, 6H), 1.39-1.29 
(m, 6H); 13C NMR (100 MHz, CDCl3) δ 213.20, 139.09, 133.69, 129.29, 127.96, 51.10, 
47.08, 42.21, 40.83, 37.64, 35.66, 35.42, 32.22, 28.09, 24.46; HRMS (ESI) m/z calcd for 
C20H26O3SNa (M+Na)
+ 369.1495, found 369.1502. 
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1-(2-(Phenylsulfonyl)ethyl)diamantine + 4-(2-
(phenylsulfonyl)ethyl)diamantane (2.68 and 2.68’) 
Prepared according to General Procedure with slight modification (Ir 2.25 + Q 2.17 
were replaced by Ir 2.24+Q 2.19), using diamantane and phenyl vinyl sulfone as the 
substrates. Reaction time: 24 h. The crude residue was purified by column chromatography 
on silica gel (EtOAc/Hexanes = 1/5) to afford 2.68 and 2.68’ (97.5 mg, 62% yield, 1.2:1 
ratio of regioisomers). 1-(2-(Phenylsulfonyl)ethyl)diamantane was synthesized via 
debromo-alkylation of 1-bromo diamantane, and 1-(2-(phenylsulfonyl)ethyl)diamantane 
was determined as the major isomer via 1H NMR spectra comparison of pure 1-(2-
(phenylsulfonyl)ethyl)diamantane and regioisomers. 1H NMR (400 MHz, CDCl3) δ 7.93-
7.89 (m, 2H), 7.65 (t, J = 7.4 Hz, 1H), 7.57 (t, J = 7.6 Hz, 2H), 3.08-3.04 (m, 2H), 3.01-
2.96 (m, 2H), 1.87-1.25 (m, 21H); 13C NMR (100 MHz, CDCl3) δ 139.28, 133.62, 129.28, 
128.03, 51.57, 50.98, 42.64, 41.86, 39.63, 38.76, 38.25, 37.92, 37.71, 37.65, 37.62, 36.88, 
35.78, 34.96, 32.44, 29.94, 29.60, 27.42, 25.62, 25.48; HRMS (ESI) m/z calcd for 
C22H28O2SNa (M+Na)
+ 379.1702, found 379.1709. 
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1-(2-(Dimethylsuccinate)diamantane + 4-(2-(dimethylsuccinate)diamantane 
(2.69 and 2.69’) 
Prepared according to General Procedure with slight modification (Ir 2.25 + Q 2.17 
were replaced by Ir 2.24+Q 2.19), using diamantane and dimethylmaleate as the substrates. 
Reaction time: 24 h. The crude residue was purified by column chromatography on silica 
gel (EtOAc/Hexanes = 1/5) to afford 2.69 and 2.69’ (108 mg, 65% yield), IR (film) 2989, 
2900, 2848, 1729, 1160 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.64 (d, J = 2.8 Hz, 6H), 3.62 
(d, J = 3.28 Hz, 6H), 2.80-2.65 (m, 2H), 2.55-2.42 (m, 2H), 2.41 (d, J = 13.6 Hz, 1H), 2.32 
(dd, J = 2.9 Hz, 16.7 Hz, 1H), 1.95-1.30 (m, 18 H); 13C NMR (100 MHz, CDCl3) δ 174.56, 
174.48, 173.67, 173.39, 51.78, 51.49, 51.38, 51.31, 44.50, 40.75, 39.12, 39.01, 38.71, 
38.61, 37.95, 37.75, 37.60, 37.41, 37.14, 36.80, 32.65, 32.54, 32.32, 31.28, 30.21, 27.22, 
25.61, 25.50; HRMS (ESI) m/z calcd for C20H28O4Na (M+Na)
+ 355.1880, found 355.1887. 
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tert-Butyl (3-(2-(phenylsulfonyl)ethyl)adamantan-1-yl)carbamate (2.62) 
Prepared according to General Procedure using tert-butyl adamantan-1-
ylcarbamate and phenyl vinyl sulfone as the substrates. Reaction time: 24 h. The crude 
residue was purified by column chromatography on silica gel (EtOAc/Hexanes = 1/2) to 
afford 2.62 (133.2 mg, 63% yield), IR (film) 3338, 2975, 2910, 2863, 1685, 1523, 1448, 
1362, 1302, 1146, 1086, 1046, 879, 739, 687, 613, 552, 532 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.84 (d, J = 7.7 Hz, 2H), 7.61 (t, J = 7.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 4.39 
(brs, 1H), 3.02-2.98 (m, 2H), 2.05 (brs, 2H), 1.80 (d, J = 12.0 Hz, 2H), 1.68 (d, J = 12.0 
Hz, 2H), 1.57-1.43 (m, 6H), 1.35-1.29 (m, 13H); 13C NMR (100 MHz, CDCl3) δ 154.12, 
139.09, 133.66, 129.27, 127.98, 78.78, 51.24, 50.90, 45.57, 41.20, 40.70, 35.60, 35.04, 
33.89, 29.28, 28.44; HRMS (ESI) m/z calcd for C23H33NO4SNa (M+Na)
+ 442.2023, found 
442.2030. 
 
tert-Butyl (3,5-dimethyl-7-(2-(phenylsulfonyl)ethyl)adamantan-1-
yl)carbamate (2.63) 
Prepared according to General Procedure with slight modification (Reaction vial 
was placed approximately 2 inches away from two Kessil® LEDs which led to a higher 
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temperature (38 oC) and DCE was replaced by CH3CN), using Boc-protected Memantine 
and phenyl vinyl sulfone as the substrates. Reaction time: 48 h. The crude residue was 
purified by column chromatography on silica gel (EtOAc/DCM = 1/100-1/30) to afford 
2.63 (165.7 mg, 74% yield), IR (film) 3368, 2971, 2896, 2864, 1697, 1499, 1448, 1364, 
1302, 1151, 1086, 916, 880, 732, 689, 610, 534 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.88 
(d, J = 7.2 Hz, 2H), 7.65 (t, J = 7.4 Hz, 1H), 7.56 (t, J = 7.6 Hz, 2H), 4.38 (brs, 1H), 3.06-
3.01 (m, 2H), 1.59-1.53 (m, 2H), 1.49 (d, J = 11.2 Hz, 3H), 1.40-1.37 (m, 12H), 1.12-0.95 
(m, 6H), 0.82 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 154.29, 139.22, 133.75, 129.36, 
128.10, 78.97, 52.56, 51.50, 50.07, 47.38, 47.32, 44.45, 35.16, 34.53, 32.77, 29.70, 28.53; 
HRMS (ESI) m/z calcd for C25H37NO4SNa (M+Na)
+ 470.2336, found 470.2343 
 
4-(3-(5-Bromo-2-methoxyphenyl)adamantan-1-yl)butan-2-one (2.64) 
Prepared according to General Procedure with slight modification (Ir 2.25 + Q 2.17 
were replaced by Ir 2.24+Q 2.19), using defferin precursor and methyl vinyl ketone as the 
substrates. Reaction time: 48 h. The crude residue was purified by column chromatography 
on silica gel (EtOAc/Hexanes = 1/5) to afford 2.64 (100.2 mg, 51% yield), IR (film) 2900, 
2846, 1712, 1482, 1356, 1280, 1231, 1177, 1093, 1026, 868, 805, 731, 621, 491 cm-1; NMR 
data are in accordance with literature values[38]: 1H NMR (400 MHz, CDCl3) δ 7.19-7.16 
(m, 2H), 6.64 (d, J = 8.5 Hz, 1H), 3.71 (s, 3H), 2.33 (t, J = 8.2 Hz, 2H), 2.10-2.04 (m, 5H), 
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1.92-1.86 (m, 4H), 1.65-1.61 (m, 3H), 1.54 (d, J = 12.4 Hz, 1H), 1.42-1.33 (d, J = 14.2 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ 209.82, 157.86, 140.18, 129.69, 129.49, 113.40, 
113.29, 55.27, 44.87, 41.48, 39.86, 37.90, 37.70, 37.54, 36.41, 32.73, 29.99, 29.27. 
 
tert-Butyl (1-((3-(2-(phenylsulfonyl)ethyl)adamantan-1-yl)ethyl)carbamate 
(2.65) 
Prepared according to General Procedure using Boc-protected Rimantadine and 
phenyl vinyl sulfone as the substrates. Reaction time: 48 h. The crude residue was purified 
by column chromatography on silica gel (EtOAc/Hexanes = 1/5) to afford 2.65 (152 mg, 
68% yield), IR (film) 3395, 2902, 2849, 1733, 1165 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.92-7.84 (m, 2H), 7.64 (t, J = 7.4 Hz, 1H), 7.55 (t, J = 7.9 Hz, 2H), 4.3 (d, J = 9.8 Hz, 
1H), 3.33 (m, 1H), 3.05 (m, 2H), 2.02 (s, 2H), 1.60-1.20 (m, 21H), 1.13 (d, J = 12.1 Hz, 
1H), 1.08 (d, J = 12.0 Hz, 1H) 0.97 (d, J = 6.84 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
155.81, 139.27, 133.71, 129.34, 128.09, 79.04, 60.45, 54.22, 51.37, 42.92, 41.42, 41.39, 
37.82, 37.34, 36.97, 36.25, 35.69, 32.49, 28.52, 15.04; HRMS (ESI) m/z calcd for 
C25H37NO4SNa (M+Na)
+ 470.2336, found 470.2343. 
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4-Methylpentyl 3-(2-(phenylsulfonyl)ethyl)adamantane-1-carboxylate (2.66) 
Prepared according to General Procedure, using 4-methylpentyl adamantane-1-
carboxylate and phenyl vinyl sulfone (0.2 mmol scale) as the substrates. Reaction time: 48 
h. The crude residue was purified by column chromatography on silica gel 
(EtOAc/Hexanes = 1/4) to afford 2.66 (60.9 mg, 70% yield), 1H NMR (400 MHz, CDCl3) 
δ 7.89 (d, J = 7.1 Hz, 2H), 7.65 (t, J = 7.5 Hz, 1H), 7.56 (t, J = 7.6 Hz, 2H), 3.99 (t, J = 6.8 
Hz, 2H), 3.07-3.03 (m, 2H), 2.06 (brs, 2H), 1.83 (d, J = 11.8 Hz, 2H), 1.71 (d, J = 12.6 Hz, 
2H), 1.65-1.51 (m, 9H), 1.42-1.34 (m, 4H), 1.24-1.16 (m, 2H), 0.87 (d, J = 6.6 Hz, 6H); 
13C NMR (100 MHz, CDCl3) δ 177.20, 139.28, 133.77, 129.39, 128.12, 64.80, 51.29, 
43.07, 41.47, 41.02, 38.30, 35.77, 35.48, 35.09, 32.33, 28.26, 27.77, 26.58, 22.63. HRMS 
(ESI) m/z calcd for C25H37O4S (M+H)
+ 433.2407, found 433.2401. 
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4-Formylphenyl 2-(3-(2-(phenylsulfonyl)ethyl)adamantan-1-yl)acetate (2.67) 
Prepared according to General Procedure (DCE was replaced by CH3CN), using 4-
formylphenyl 2-(adamantan-1-yl)acetate and phenyl vinyl sulfone as the substrates. 
Reaction time: 24 h. The crude residue was purified by column chromatography on silica 
gel (EtOAc/Hexanes = 2/1) to afford 2.67 (163.2 mg, 70% yield), 1H NMR (400 MHz, 
CDCl3) δ 9.96 (s, 1H), 7.90-7.83 (m, 4H), 7.63 (t, J = 7.4 Hz, 1H), 7.54 (t, J = 7.8 Hz, 2H), 
7.22 (d, J = 8.3 Hz, 2H), 3.06-3.02 (m, 2H), 2.31 (s, 2H), 2.06 (brs, 2H), 1.70-1.50 (m, 8H), 
1.41-1.31 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 190.88, 169.10, 155.18, 139.10, 133.89, 
133.64, 131.12, 129.25, 127.92, 122.41, 51.14, 47.90, 46.60, 41.48, 40.86, 35.69, 35.32, 
33.76, 32.65, 28.57. HRMS (ESI) m/z calcd for C27H31O5S (M+H)
+ 467.1887, found 
467.1892. 
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4-(3-(Phenylsulfonyl)propanoyl)phenyl 2-(adamantan-1-yl)acetate 
Obtained from the formyl alkylation of 4-formylphenyl 2-(adamantan-1-yl)acetate 
and purified by column chromatography on silica gel (EtOAc/Hexanes = 5/1, 7.0 mg, 3% 
yield), 1H NMR (400 MHz, CDCl3) δ 7.96-7.95 (m, 4H), 7.67 (t, J = 7.5 Hz, 1H), 7.58 (t, 
J = 7.7 Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 3.58-3.54 (m, 2H), 3.49-3.45 (m, 2H), 2.32 (s, 
2H), 2.02 (brs, 3H), 1.78-1.64 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 194.32, 169.62, 
155.08, 139.12, 134.12, 133.32, 129.82, 129.58, 128.12, 122.31, 51.10, 48.81, 42.57, 
36.78, 33.46, 31.47, 28.70. HRMS (ESI) m/z calcd for C27H31O5S (M+H)
+ 467.1887, found 
467.1881. 
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2.10.6 - Characterization of byproducts  
 
1-((E)-2-(Phenylsulfonyl)vinyl)adamantane (2.32) 
Obtained as a mixture of compound 2.32 and 2.09. NMR data are in accordance 
with literature values[52]: 1H NMR (400 MHz, CDCl3) δ 7.87-7.84 (m, 2H), 7.62-7.59 (m, 
1H), 7.54-7.50 (m, 2H), 6.83 (d, J = 15.3 Hz, 1H), 6.13 (d, J = 15.3 Hz, 1H), 2.00 (brs, 
3H), 1.74-1.60 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 156.17, 141.03, 133.22, 127.59, 
126.51, 40.80, 36.44, 36.21, 27.95. 
 
1,3-Bis(2-(phenylsulfonyl)ethyl)adamantane  
1H NMR (400 MHz, CDCl3) δ 7.91-7.88 (m, 4H), 7.66 (td, t, J = 7.7, 1.3 Hz, 2H), 
7.56 (t, J = 7.7 Hz, 4H), 3.02-2.97 (m, 4H), 2.00 (brs, 2H), 1.52-1.46 (m, 6H), 1.35 (d, J = 
12.2 Hz, 4H), 1.23 (d, J = 13.1 Hz, 4H), 1.02 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 
139.20, 133.77, 129.38, 128.06, 51.25, 46.44, 41.15, 35.94, 35.40, 32.64, 28.55; HRMS 
(ESI) m/z calcd for C26H32O4S2Na (M+Na)
+ 495.1634, found 495.1641. 
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1,2-Bis(phenylsulfonyl)ethane (2.33) 
IR (film) 2988, 2900, 2845, 1447, 1299, 1144, 1082, 742, 685, 616, 569 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.7 Hz, 4H), 7.72 (t, J = 7.5 Hz, 2H), 7.61 (t, J = 
7.7 Hz, 4H), 3.44 (s, 4H); 13C NMR (100 MHz, CDCl3) δ 138.16, 134.73, 129.88, 128.23, 
49.65; HRMS (ESI) m/z calcd for C14H14O4S2Na (M+Na)
+ 333.0226, found 333.0232. 
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2.10.7 - Kinetic Isotope Effects Experiment 
Dideuterated adamantane and tetradeuterated adamantane were prepared according 
to previous procedure[53,54]. Dideuterated adamantane 2.87: 1H NMR (400 MHz, CDCl3) 
δ 1.88 (p, J = 3.1 Hz, 2H), 1.76-1.74 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 37.91, 
37.78, 37.65, 28.43, 27.95 (t, J = 20.3 Hz); Tetradeuterated adamantane 2.90: 1H NMR 
(400 MHz, CDCl3) δ 1.75-1.73 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 37.66, 27.88 (t, 
J = 20.0 Hz).  
 
Intramolecular KIE experiment: To an 8-mL glass vial equipped with magnetic 
stir bar were sequentially added Ir 2.25 (4.58 mg, 0.004 mmol, 2 mol%), Q 2.17 (10.69 
mg, 0.040 mmol, 20 mol%), dideuterated adamantane 2.87 (83.0 mg, 0.600 mmol, 3.0 
equiv), phenyl vinyl sulfone (33.6 mg, 0.200 mmol, 1.0 equiv), water (7.2 µL, 0.400 mmol, 
2.0 equiv) and DCE (2.0 mL). The resulting mixture was degassed via three cycles of 
“freeze, pump, thaw” operation. The vial was placed approximately 4 inches away from 
two Kessil® LEDs (456 nm) for 8 h. The internal temperature was maintained at 
approximately 28 °C by an electric fan placed approximately 5 inches above the vial. The 
products were isolated by flash column chromatography (5/1 hexanes/EtOAc). No 
deuterium was detected at the α position of the sulfonyl group according to 1H-NMR 
analysis. So, the ratio of 2.88 to 2.89 can be calculated via MS-ESI analysis. MS-ESI+ 
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observed abundances: 2.89 [328.1458 (M+Na)] = 112. Theoretical isotopic natural 
abundance ratio of M+1/M+2 for 2.89 = 100/19.5. To account for the contribution of 2.89 
M+2 in the 2.88 M+H, the following formula was used: [329.1520 (M+Na)] = 205-
(112×0.195) = 183. kH/kD = 183/112 = 1.6. 
 
Intermolecular KIE experiment: To an 8-mL glass vial equipped with magnetic 
stir bar were sequentially added Ir 2.25 (4.58 mg, 0.004 mmol, 2 mol%), Q 2.17 (10.69 
mg, 0.040 mmol, 20 mol%), adamantane (81.7 mg, 0.600 mmol, 3.0 equiv) (tetradeuterated 
adamantane 2.90 (105.3 mg, 0.600 mmol, 3.0 equiv，80% purity)), phenyl vinyl sulfone 
(33.6 mg, 0.200 mmol, 1.0 equiv), naphthalene (25.6 mg, 0.200 mmol, 1.0 equiv, internal 
standard), water (7.2 µL, 0.400 mmol, 2.0 equiv) and DCE (2.0 mL). The resulting mixture 
was degassed via three cycles of “freeze, pump, thaw” operation. The vial was placed 
approximately 4 inches away from two Kessil® LEDs (456 nm). The internal temperature 
was maintained at approximately 28 °C by an electric fan placed approximately 5 inches 
above the vial. At the indicated time points, the reaction mixture was placed in the dark 
and an aliquot was removed by syringe and analyzed by GC (same GC condition as in the 
section of Optimization details. Retention time: t(naphthalene) = 3.33, Relative response 
factor: Rf (2.91) = 1.939). Each data point represents an average value determined from 
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two separate experiments. Linear regression of product yield against time is done in 
Microsoft Excel. kH/kD (1.3) was calculated based on ratio of slopes.  
Note: The reaction was kept under positive N2 pressure during these experiments. 
The rate of the reaction became slower when O2 was introduced. 
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2.10.8 - Probing the reversibility of C–H abstraction 
 
To an 8-mL glass vial equipped with magnetic stir bar were sequentially added Ir 
2.25 (4.58 mg, 0.004 mmol, 2 mol%), Q 2.17 (10.69 mg, 0.040 mmol, 20 mol%), 
adamantane (81.7 mg, 0.600 mmol, 3.0 equiv), phenyl vinyl sulfone (33.6 mg, 0.200 mmol, 
1.0 equiv), D2O (7.2 µL, 0.400 mmol, 2.0 equiv) and DCE (2.0 mL). The resulting mixture 
was degassed via three cycles of “freeze, pump, thaw” operation. The vial was placed 
approximately 4 inches away from two Kessil® LEDs (456 nm) for 8 h. The internal 
temperature was maintained at approximately 28 °C by an electric fan placed 
approximately 5 inches above the vial.  
Because the proton exchange between ammonium salt 2.86 resulting from Q 2.17 
and D2O will yield the corresponding ammonium salt 2.86-D, the tertiary position in the 
adamantane motif of starting material or product will be partially deuterated if C–H 
abstraction is a reversible process. However, we didn’t detect obvious deuterium at that 
positions based on NMR analysis which demonstrated the C–H abstraction step was likely 
irreversible. 
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2.10.9 - Intermolecular competitive experiments between adamantane and compound 
incorporating weaker C(sp3)–H 
To an 8-mL glass vial equipped with magnetic stir bar were sequentially added Ir- 
2.25 (4.58 mg, 0.004 mmol, 2 mol%), Q 2.17 (10.69 mg, 0.040 mmol, 20 mol%), 
adamantane (81.74 mg, 0.600 mmol, 3.0 equiv), compound incorporating weaker C(sp3)–
H (0.600 mmol, 3.0 equiv), phenyl vinyl sulfone (33.64 mg, 0.200 mmol, 1.0 equiv), water 
(7.2 µL, 0.400 mmol, 2.0 equiv) and DCE (2.0 mL). The vial was sealed with a Teflon 
septum. The resulting mixture was degassed via three cycles of “freeze, pump, thaw” 
operation. The vial was further sealed with parafilm and placed approximately 4 inches 
away from two Kessil® LEDs (456 nm). The reaction mixture was stirred and irradiated 
for 24 h. The internal temperature was maintained at approximately 28 °C by an electric 
fan placed approximately 5 inches above the vial. The yield was determined by GC using 
Bn2O as an internal standard. The samples were performed in the same GC condition as 
the section of Optimization details. 
 
(1S,4R)-2-(2-(phenylsulfonyl)ethyl)bicyclo[2.2.1]heptane (2.72) 
IR (film) 3054, 2959, 2930, 1264, 730 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.90 (d, 
J = 7.5 Hz, 2H), 7.65 (t, J = 7.4 Hz, 1H), 7.57 (t, J = 7.7 Hz, 2H), 3.07 – 3.01 (m, 2H), 2.18 
(s, 1H), 1.89 (s, 1H), 1.72 – 1.62 (m, 1H), 1.52 – 1.18 (m, 7H), 1.12 – 1.04 (m, 3H), 0.97 
– 0.86 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 133.74, 129.39, 128.15, 55.22, 41.18, 40.99, 
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37.80, 36.60, 35.30, 29.95, 29.11, 28.63. HRMS (ESI) m/z calcd for C15H21O2S (M+H)
+ 
265.1257, found 265.1248 
 
N-Methyl-N-(3-(phenylsulfonyl)propyl)acetamide (2.74) 
1H NMR (400 MHz, CDCl3) δ 7.90-7.85 (m, 2H), 7.69-7.53 (m, 3H), 3.45-3.40 (m, 
2H), 3.09-3.04 (m, 2H), 2.95 (s, 3H), 2.84 (s, 3H), 2.05-1.92 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 171.06, 170.51, 139.12, 138.88, 134.17, 133.90, 129.61, 129.45, 128.07, 128.03, 
53.89, 53.13, 48.96, 45.74, 36.14, 33.06, 21.90, 21.59, 21.37, 20.71. HRMS (ESI) m/z calcd 
for C12H18NO3S (M+H)
+ 256.1002, found 256.1008 
 
 
 
(2S,5R)-2-Isopropyl-5-methyl-1-(2-(phenylsulfonyl)ethyl)cyclohexanol (2.78) 
1H NMR (400 MHz, CDCl3) δ 7.90-7.86 (m, 2H), 7.74-7.55 (m, 3H), 3.04-3.00 (m, 
2H), 2.26-2.21 (m, 1H), 2.07-1.60 (m, 8H), 1.46-1.25 (m, 3H), 0.98 (d, J = 6.3 Hz, 6H), 
0.92 (d, J = 6.9 Hz, 6H), 1.01-0.75 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 139.19, 138.15, 
134.72, 133.79, 129.87, 129.40, 128.21, 128.18, 57.69, 52.48, 52.40, 49.64, 36.36, 34.74, 
34.02, 31.86, 28.21, 24.64, 24.49, 22.41. HRMS (ESI) m/z calcd for C18H29O3S (M+H)
+ 
325.1832, found 325.1828  
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2.10.10 - Stern-Volmer Fluorescence Quenching Experiment 
Stern-Volmer experiments were conducted on a QuantaMasterTM 400 Fluorometer, 
using a 0.3 mM solution of Ir 2.25 (or Ir 2.24) in 1,2-dichloroethane and variable 
concentrations (0, 3.0, 6.0, 9.0 and 12.0 mM) of quencher. The samples were prepared in 
3.0 mL quartz cuvettes equipped with PTFE stoppers, purged with N2 for 10 min and then 
sealed with Parafilm. The solutions were irradiated at 420 nm and luminescence was 
measured at 585 nm (Ir 2.25) or 469 nm (Ir 2.24). Linear regression of I0/I against 
concentration is done in Microsoft Excel. These experiments indicated that only Q 2.17 (or 
Q 2.19) will quench excited state of Ir 2.25 (or Ir 2.24). 
Rates of quenching (kq) were determined using Stern-Volmer kinetics (eq 1).  
I0/I = 𝑘𝑞𝜏0[Quencher] (1) 
Where I0 is the luminescence intensity without the quencher, I is the intensity with 
the quencher, and 𝜏0 is the lifetime of the photocatalyst (279 ns for Ir 2.25[47]and 2300 ns 
for Ir 2.24[60]). 
Constant [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 Ir 2.25 (0.3 mM) and varied phenyl 
vinyl sulfone 2.31 (0, 3.0, 6.0, 9.0 and 12.0 mM). 
 
 
[2.31] (mM) 0 3.0 6.0 9.0 12.0 
I0/I 1.0000 1.0074 0.9954 1.026 0.9945 
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Stern-Volmer plot of [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 and variable phenyl vinyl sulfone 
2.31. 
Constant [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 Ir 2.25 (0.3 mM) and varied adamantane 2.01 
(0, 3.0, 6.0, 9.0 and 12.0 mM). 
[2.01] (mM) 0 3.0 6.0 9.0 12.0 
I0/I 1.0000 1.0176 1.0115 1.0199 1.0307 
 
y = 0.0003x + 1.0031
R² = 0.0086
0.8
0.85
0.9
0.95
1
1.05
1.1
1.15
1.2
0 2 4 6 8 10 12 14
I 0
/I
[7] (mM)
Ir-1 + 7Ir 2.25 + 2.31 
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Stern-Volmer plot of [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 and variable adamantane 2.01. 
Constant [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 Ir 2.25 (0.3 mM) and varied Q 2.17 (0, 3.0, 
6.0, 9.0 and 12.0 mM). 
[2.17] (mM) 0 3.0 6.0 9.0 12.0 
I0/I 1.0000 2.0399 3.1498 4.4757 5.9478 
 
 
y = 0.0021x + 1.0032
R² = 0.7955
0.8
0.85
0.9
0.95
1
1.05
1.1
1.15
1.2
0 2 4 6 8 10 12 14
I 0
/I
[1] (mM)
Ir-1 + 1Ir 2.25 + 2.01 
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Stern-Volmer plot of [Ir(dF(CF3)ppy)2(d(CF3)bpy)]PF6 and variable Q 2.17 (kq = 
1.47 × 109 M-1 s -1). 
Constant [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 Ir 2.24 (0.3 mM) and Q 2.19 (0, 3.0, 6.0, 9.0 and 
12.0 mM). 
[2.19] (mM) 0 3.0 6.0 9.0 12.0 
I0/I 1.0000 4.3944 8.7857 12.3013 15.6163 
 
 
y = 0.411x + 0.8564
R² = 0.9945
0
1
2
3
4
5
6
7
0 2 4 6 8 10 12 14
I 0
/I
[Q-1] (mM)
Ir-1 + Q-1Ir 2.25 + 2.17 
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Stern-Volmer plot of [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 and variable Q 2.19 (kq = 5.38 × 10
8 
M-1 s -1). 
2.10.11 - Cyclic voltammetry experiment 
Cyclic voltammetry experiments were performed using a Pine AFP1 potentiostat. 
The cell consisted of a glassy carbon working electrode, a Pt wire auxiliary electrode and 
a Pt wire pseudo-reference electrode. All potentials are measured in a MeCN solution of 
tetrabutylammonium hexafluorophosphate, using the Fc/Fc+ couple as an internal 
standard. The data was subsequently adjusted to the saturated calomel electrode (SCE) by 
addition of +0.38 V[61]. The oxidative potential of quinuclidine increases with the 
introduction of electron-withdrawing group at 3-position of quinuclidine. 
 
 
y = 1.238x + 0.9916
R² = 0.9977
0
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I 0
/I
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Ir-2 + Q-3Ir 2.24 + 2.19
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CV of Q 2.19 (E1/2
red = +0.72 V vs Fc/Fc+ in CH3CN; E1/2
red = +1.10 V vs SCE in CH3CN; 
This value matches the literature[33]).  
 
CV of Q 2.18 (E1/2
red = +0.83 V vs Fc/Fc+ in CH3CN; E1/2
red = +1.21 V vs SCE in CH3CN; 
This value matches the literature[34]). 
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CV of Q 2.17 (E1/2
red = +1.03 V vs Fc/Fc+ in CH3CN; E1/2
red = +1.41 V vs SCE in CH3CN) 
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Chapter 3 - Total Synthesis of Earthworm Metabolite Malylglutamate 
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3.1 - Introduction 
Soil health can be negatively affected by factors such as pesticides, pollutants and 
other soil contaminants and they must be monitored closely to avoid serious environmental 
damage. By studying the metabolism of earthworms, it is possible to monitor ecotoxicity 
and ecological stress.[1] Recently, Larive et. al[2] studied the metabolic material in 
earthworm coelomic fluid, coelomocytes, and tissue from the species Eisenia fetida using 
NMR spectroscopy and high-resolution MS/MS. Fifty-nine metabolites, with some shown 
in Figure 3.1, were identified from the earthworm species and one newly discovered 
metabolite, known as malylglutamate (3.01, Figure 3.1). Due to the current limited scope 
of NMR-based metabolic profiling for earthworms, this new metabolite was further studied 
to expand the utility of this approach and also to investigate the metabolites’ association 
with environmental stress. Malylglutamate is hypothesized to be a store for glutamic acid 
and malic acid, and may also be involved in chelation due to its similarity in structure to 
-citrylglutamate 3.03, a known chelator.[3,4] It is a relatively abundant metabolite, present 
at an average of 7 µg/mg in whole-earthworm extracts, and is similar in structure to 
metabolites like N-acetylaspartylglutamate (NAAG) 3.02.  
 
Figure 3.1 Proposed malylglutamate structure and other discovered metabolites 
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Malylglutamate is prominent in the NMR metabolite profiles of earthworm 
coelomic fluid and coelomocyte extracts. Coelomic fluid is a biofluid that fills the body 
cavity of the worm and is critical for movement, excretion, metabolism, and nutrient 
storage, while coelomocytes are free-moving immune and liver-like cells in the coelomic 
fluid.[2] Malyglutamate is a suggested anionic osmolyte, acting as a charge-balance 
counterpart to betaine analogs in earthworms, which are known cationic osmolytes and 
helps provide electrolyte balance in earthworms.[5] Due to the difficulty in isolating a pure 
naturally sourced sample and the complexity of the NMR spectra of the earthworm, we 
sought to confirm the proposed structure 3.01 and fully assign the relative and absolute 
configuration of malylglutamate synthetically.  
3.2 - Results and Discussion 
3.2.1 - Retrosynthesis of Originally Proposed Structure 
The proposed structure of malylglutamate possesses two chiral centers thus all 
diastereomeric and enantiomeric possibilities must be carefully considered and controlled. 
We envisioned the synthesis of malylglutamate to involve a traditional peptide coupling as 
the key step where both enantiopure L- and D-isomers of the corresponding amino acid 
starting materials can be incorporated. The retrosynthetic plan for the proposed structure is 
shown in Scheme 3.1. Beginning with the reported target molecule 3.01, we propose it is 
derived from a fully benzylated intermediate 3.05 which is subjected to a global 
deprotection by hydrogenolysis. This is followed by a peptide coupling reaction (main 
disconnection shown in Scheme 3.1) between di-benzylated glutamic acid 3.06 and mono-
benzylated malic acid 3.08. A Fischer esterification of L- and D-glutamic acid 3.07 with 
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benzyl alcohol gives the double protected intermediate as the tosylate salt. The malic acid 
intermediate is obtained after selective mono-benzylation. With this plan in hand, we set 
out for the initial synthesis. 
 
Scheme 3.1 Retrosynthesis of proposed structure 
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3.2.2 - Synthesis and Optimization of Proposed Metabolite 
We began the synthesis with an acid catalyzed benzylation of both L- and D-isomers 
of glutamic acid 3.07 using 2.0 equivalents of benzyl alcohol in toluene to give the doubly 
protected tosylate salts in good yields (3.06 and 3.06’, Scheme 3.2Scheme 3.2).[6] We then 
focused our attention on selectively mono-protecting the L-malic acid isomer 3.09 using 
2,2-dimethoxypropane and p-toluenesulfonic acid. Fortunately, we were able to selectively 
protect malic acid in good yields preferentially giving the desired five membered acetonide 
protected product 3.10 over the six.[7] This was followed by a benzylation of the free acid 
to give protected intermediate 3.11 in an 86% yield. Selective hydrolysis of the acetonide 
intermediate 3.11 with a 3:1 ratio of acetic acid and water gave the mono-benzyl ester 3.12 
in 79% yield. 
 
Scheme 3.2 Benzylation of amino acid starting materials 
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With both benzylated intermediates in hand, 3.06 and 3.12, we investigated 
different known peptide coupling conditions shown in Table 3.1. Ye et. al. used N,N,N′,N′- 
tetramethylchloroformamidinium hexafluorophosphate (TCFH) and N-methylimidazole 
(NMI) as a mild method for in situ generation of highly reactive acyl imidazoliums which 
can then be used to make peptide bonds in high yields.[8] We attempted the peptide coupling 
reaction using TCFH with and without the imidazole. No reaction was observed in the 
absence of NMI, however with both TCFH and NMI, the reaction proceeded in a modest 
51% yield. Commonly used coupling reagents, such as DIC and DCC, were tested with 
HOBT; however, only low yields were obtained. When using HCTU as a coupling reagent 
the yield increased slightly to 32%. Ultimately, using both EDCI and HOBT in the presence 
of Et3N gave the desired fully benzylated amide 3.05 in an acceptable 73% yield.  
Table 3.1 Optimization of peptide coupling reaction 
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Following the peptide coupling reaction, global deprotection of the fully benzylated 
species 3.05 using hydrogen and palladium on carbon gave the proposed malylglutamate 
3.01 in good yields (Scheme 3.3). Deprotection of each ester was monitored conveniently 
by mass spectrometry. Initially, 5.0 mol% of Pd/C in various solvents were tested however 
optimal conditions involved 10 mol% Pd/C in degassed ethanol and required no further 
purification. Both L, L- and L,D -malylglutamate were synthesized in 73% and 71% yields, 
respectively.  
 
Scheme 3.3 Hydrogenation of fully benzylated compound 
Once synthesized and isolated, the proton NMR of both synthetic samples and the 
natural samples were compared in D2O as the deuterated solvent. Unfortunately, neither 
synthetic compounds matched that of the natural one. Based on NMR studies performed 
by our collaborator, Dr. Corey Griffith, the glutamate carbonyl peaks showed the correct 
assignment however the malyl moiety of the synthetic samples did not correspond to the 
natural samples. This indicated that the malyl moiety is possibly attached to the glutamate 
in the β position as opposed to the proposed α position. Based on the NMR data, a similar 
yet alternative structure was proposed, compound 3.15. This revised structure was 
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therefore synthesized using a different protecting group strategy for both malic acid 
isomers (Scheme 3.4). 
3.2.3 - Synthesis of Both Diastereomers of Revised Malylglutamate 
Although the glutamate moiety remained the same in the revised synthesis, the α- 
hydroxy acid of malic acid now needed to be mono-benzylated instead of the β-hydroxy 
acid as was done previously. Selective benzylation of the β-hydroxy acid 3.13 was achieved 
using a known procedure with trifluoroacetic acid and benzyl alcohol (Scheme 3.4).[9] This 
was followed by a peptide coupling to give the fully benzylated intermediates 3.14 and 
finally deprotection of the benzyl groups to give 3.15, similar to the procedures for the 
synthesis of the first proposed structure. Purification of the intermediates proved to be 
easier in these cases most likely due to the reduced steric hinderance of the hydroxyl group. 
Both the L,L- and D,L - malylglutamate isomers were synthesized and used for 
comparison with the natural product. The natural sample was once again spiked against 
both isomers of malylglutamate in D2O. With the revised synthesis, the synthetic L,L- 
malylglutamate 3.15 isomer matched in chemical shift and J-coupling. Comparisons of the 
natural sample, synthetic sample and spiked samples are shown in Figure 3.2. Once 
synthesized and confirmed, the absolute configuration of L,L-malylglutamate was 
determined using liquid chromatography-mass spectrometry (LC-MS) via a chiral phase 
chromatography method. This method allowed for excellent separation of the L,L- and D,D 
-isomers. Finally, the specific rotation of synthetic L,L-malylglutamate was determined to 
be [α]25D -13.6 (c 1.0, MeOH) establishing the correct natural product to be (-)-β-L-malyl-
L-glutamate. 
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Scheme 3.4 Alternative synthesis of malylglutamate 
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Figure 3.2 NMR's of natural and synthetic samples 
3.3 - Conclusion 
The synthesis of the metabolite from the earthworm species Eisenia Fetida, 
malylglutamate, was of interest due to the correlation between earthworm metabolites and 
ecological stress. The synthesis of the metabolite involved selective benzylations, a key 
peptide coupling and a hydrogenation of a fully benzylated intermediate. The initial 
synthesis of both stereoisomers of the proposed structure proved to be incorrect once 
compared and spiked with the natural sample. An alternative synthesis was devised and 
was similar to that of the first synthesis but involved selective benzylation of the opposite 
carboxylic acid in the amino acid malic acid. Reaction conditions for the peptide coupling 
and hydrogenation remained the same. Both isomers L,L- D,L-malylglutamate were 
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synthesized leading to a total of four proposed isomers of malylglutamate to be synthesized 
(Figure 3.3). When the samples were compared to the natural sample and both the absolute 
configuration and optical rotation were determined, the correct isomer of the natural 
product was (-)-β-L-malyl-L-glutamate. 
 
Figure 3.3. NMR's of synthesized malylglutamate  
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3.4 - Experimental Section 
3.4.1 - Materials and Methods 
All reactions were carried out under an inert atmosphere of nitrogen in oven dried 
or flame dried glassware with magnetic stirring, unless otherwise noted. Solvents were 
dried by passage through columns of activated alumina. All starting materials were 
prepared according to known literature procedures or used as obtained from commercial 
sources, unless otherwise indicated. Reactions were monitored by thin-layer 
chromatography (TLC) and carried out on 0.25 mm coated commercial silica gel plates 
(Analtech TLC Uniplates, F254 precoated glass plates with organic fluorescent binder) 
using UV light as visualizing agent and KMnO4 and heat as a developing agent. Flash 
chromatography was performed on silica gel (Silicycle, SiliaFlash P60, 230-400 mesh). 
Hydrogenation was monitored using Mass Spectrometry 
3.4.2 - Synthesis and Characterization of Benzylated Compounds 
General Procedure for Peptide Coupling Reactions (A): To a flame dried flask 
equipped with a magnetic stir bar were sequentially added acid (1.0 eq), amine (1.2 eq), 
HOBT (1.2 eq), EDCI (2.0 eq) and DMF (60 mM). The vial was sealed with a septum and 
degassed. The reaction mixture was stirred for 10 minutes followed by addition of Et3N 
(4.0 eq) dropwise. The reaction was stirred for 24 hours followed by extraction with EtOAc 
and dried over Na2SO4. The solvent was removed in vacuo and the crude residue was 
purified using silica gel chromatography to provide benzylated products as a white solid. 
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(S)-Dibenzyl 2-((S)-4-(benzyloxy)-2-hydroxy-4-oxobutanamido)pentanedioate 
(3.05) 
Prepared according to General Procedure A using acid L-3.12 (22 mg, 0.10 mmol) 
and amine L-3.06 (60 mg, 0.12 mmol) as the substrates. Reaction time: 24 h. The crude 
residue was purified by column chromatography on silica gel using EtOAc to afford L,L-
3.05 as a white solid (22 mg, 42% yield). IR (film) 3388, 3063, 3032, 1735, 1731 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 1.98-2.10 (m, 1H), 2.20-2.34 (m, 1H), 2.35-2.50 (m, 2H), 2.82 
(dd, J = 7.88, 17.44 Hz, 1H), 2.94 (dd, J = 3.88, 17.48 Hz, 1H), 3.60-3.66 (m, 1H), 4.40-
4.42 (m, 1H), 4.64-4.72 (M, 1H), 5.10 (s, 2H), 5.13 (s, 2H), 5.16 (s, 2H), 7.27-7.39 (m, 
15H); 13C NMR (100 MHz, CDCl3) δ 172.6, 172.4, 172.2, 171.4, 135.9, 135.4, 135.3, 
133.9, 128.8, 128.7, 128.7, 128.6, 128.5, 128.4, 128.4, 77.5, 77.2, 76.9, 72.2, 68.6, 67.5, 
67.5, 67.0, 66.7, 51.6, 38.8, 38.4, 30.3, 29.3, 27.4, 27.3; HRMS (ESI) m/z calcd. for 
C30H32NO8 (M+H)
+ 534.2122, found 534.2140. 
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(R)-Dibenzyl 2-((S)-4-(benzyloxy)-2-hydroxy-4-
oxobutanamido)pentanedioate (3.05) 
Prepared according to General Procedure A using acid L-3.12 (100 mg, 0.446 
mmol) and amine D-3.06 (267 mg, 0.535 mmol). Reaction time: 24 h. The crude residue 
was purified by column chromatography on silica gel with EtOAc to afford L,D-3.05 as a 
white solid (63 mg, 26% yield). IR (film) 3389, 3033, 2948, 1731, 1715 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 2.00-2.10 (m, 1H), 2.20-2.33 (m, 1H), 2.35-2.50 (m, 2H), 2.74 (dd, J 
= 8.72, 17.44 Hz, 1H), 2.94 (dd, J = 3.6, 17.56 Hz, 1H), 3.65 (d, J = 4.92 Hz, 1H), 4.40-
4.48 (m, 1H), 4.62-4.72 (m, 1H), 5.09 (s, 2H), 5.15 (s, 2H), 5.16 (s, 2H), 7.28-7.40 (m, 
15H); 13C NMR (100 MHz, CDCl3) δ 172.6, 172.0, 171.4, 164.9, 138.6, 135.9, 135.4, 
133.9, 128.8, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 128.0, 127.8, 77.5, 77.2, 76.9, 72.3, 
68.6, 67.6, 67.3, 67.1, 66.7, 51.6, 38.3, 29.9, 27.4; HRMS (ESI) m/z calcd. for C30H32NO8 
(M+H)+ 534.2122, found 534.2137. 
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(S)-Dibenzyl 2-((S)-4-(benzyloxy)-3-hydroxy-4-oxobutanamido)pentanedioate 
(3.14) 
Prepared according to General Procedure A using acid L-3.13 (500 mg, 2.23 mmol) 
and amine L-3.06 (1.34 g, 2.67 mmol). Reaction time: 24 h. The crude residue was purified 
by column chromatography on silica gel using EtOAc to afford L,L-3.14 as a white solid 
(868 mg, 73% yield). IR (film) 3360, 2915, 1745, 1715, 1170 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 1.94-2.06 (m, 1H), 2.16-2.27 (m, 1H), 2.33-2.48 (m, 1H), 2.62 (dd, J = 7.16, 
15.32 Hz, 1H), 2.72 (dd, J = 3.68, 15.32 Hz, 1H), 3.61 (bs, 1H), 4.50 (dd, J = 3.72, 7.12 
Hz, 1H), 4.63-4.70 (m, 1H), 5.09 (s, 2H), 5.15 (s, 2H), 5.20 (s, 2H), 6.56 (d, J = 7.84, 1H), 
7.28-7.39 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 173.3, 172.8, 171.6, 170.0, 135.8, 
135.2, 128.8, 128.7, 128.7, 128.6, 128.5, 128.5, 77.5, 77.2, 67.9, 67.8, 67.8, 67.6, 66.7, 
51.9, 40.0, 31.0, 30.3, 27.3; HRMS (ESI) m/z calcd. for C30H32NO8 (M+H)
+ 534.2122, 
found 534.2119. 
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(S)-Dibenzyl 2-((R)-4-(benzyloxy)-3-hydroxy-4-
oxobutanamido)pentanedioate (3.14) 
Prepared according to General Procedure A using acid D-3.13 (400 mg, 1.78 mmol) 
and amine L-3.06 (1.07 g, 2.14 mmol). Reaction time: 24 h. The crude residue was purified 
by column chromatography on silica gel EtOAc to afford D,L-3.14 as a white solid (683 
mg, 72% yield). IR (film) 3352, 3065, 2853, 1733 cm-1; 1H NMR (400 MHz, CDCl3) δ 
1.94-2.06 (m, 1H), 2.16-2.28 (m, 1H), 2.32-2.48 (m, 2H), 2.63 (dd, J = 7.12, 15.28 Hz, 
1H), 2.72 (dd, J = 3.72, 15.32 Hz, 1H), 3.55 (d, J = 5.52 Hz, 1H), 4.47-4.53 (m, 1H), 4.62-
4.70 (m, 1H), 5.09 (s, 2H), 5.15 (s, 2H), 5.21 (s, 2H), 6.53 (d, J = 7.92 Hz, 1H), 7.30-7.39 
(m, 15H); 13C NMR (100 MHz, CDCl3) δ 177.7, 173.3, 172.3, 170.4, 135.5, 135.1, 128.70, 
128.6, 128.5, 128.4, 128.4, 128.3, 77.5, 77.3, 76.9, 67.7, 67.4, 66.8, 66.8, 51.8, 38.8, 30.8, 
30.2, 27.2, 23.5; HRMS (ESI) m/z calcd. for C30H32NO8 (M+H)
+ 534.2122, found 
534.2130. 
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3.4.3 - Synthesis and Characterization of Natural Products 
General Procedure for Hydrogenolysis (B): To a flame dried flask equipped with 
a magnetic stir bar were sequentially added fully benzylated precursor and Pd/C (10%, 5.0 
mol%). The vial was sealed with a septum and pumped and back filled 3 times with 
nitrogen. This was followed by addition of dry ethanol (0.026 M) and careful addition of 
H2 via balloon. The reaction mixture was stirred for 6 hours and then filtered through celite 
with DCM. Solvent was removed in vacuo without further purification. 
 
(S)-2-((S)-3-Carboxy-2-hydroxypropanamido)pentanedioic acid (3.01) 
Prepared according to General Procedure B using L,L-3.05 (126 mg, 0.236 mmol) 
to afford LL-3.01 as a white solid (46 mg, 73% yield). IR (film) 3396, 2844, 1710, 1450, 
1361 cm-1; 1H NMR (400 MHz, D2O) δ 4.58 (dd, J = 4.0, 8.0 Hz, 1H), 4.47 (dd, J = 4.0, 
8.0 Hz, 1H), 2.90 (dd, J = 4.0, 16 Hz, 1H), 2.79 (dd, J = 4.0, 16 Hz), 2.50 (t, J = 8.0 Hz, 2 
H), 2.22-2.32 (m, 1H), 2.00-2.12, (m, 1H); 13C NMR (100 MHz, D2O) δ 177.1, 176.8, 
174.6, 71.4, 66.9, 38.5, 28.7; HRMS (ESI) m/z calcd. for C9H14NO8 (M+H)
+ 264.0714, 
found 264.0710. 
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(R)-2-((S)-3-Carboxy-2-hydroxypropanamido)pentanedioic acid (3.01) 
Prepared according to General Procedure B using L,L-3.05(63 mg, 0.118 mmol) to 
afford LL-3.01 (22 mg, 71% yield). IR (film) 3396, 2844, 1710, 1450, 1361, cm-1; 1H NMR 
(400 MHz, D2O) δ 4.57 (dd, J = 4.0, 8.0 Hz, 1H), 4.48 (dd, J = 4.0, 8.0 Hz, 1H), 2.90 (dd, 
J = 4.0, 16 Hz, 1H), 2.77 (dd, J = 4.0, 16 Hz), 2.50 (t, J = 8.0 Hz, 2 H), 2.22-2.32 (m, 1H), 
2.04-2.12, (m, 1H); 13C NMR (100 MHz, D2O) δ 177.1, 176.7, 174.6, 133.7, 127.1, 71.4, 
66.9, 38.6, 28.8; HRMS (ESI) m/z calcd. for C9H14NO8 (M+H)
+ 264.0714, found 264.0719 
 
(S)-2-((S)-3-Carboxy-3-hydroxypropanamido)pentanedioic acid (3.15) 
Prepared according to General Procedure B using L,L-3.14 (20 mg, 0.038 mmol) 
to afford LL-3.15 (9 mg, 82% yield). IR (film) 3352, 3034, 1733, 1536, 1386, cm-1; 1H 
NMR (400 MHz, D2O) δ 4.60 (dd, J = 4.5, 7.8 Hz, 1H), 4.46 (dd, J = 4.7, 8.2 Hz, 1H), 
3.20-3.33 (m, 1H), 2.82 (dd, J = 4.5, 15.2, 1H), 2.70-2.77 (m, 1H), 2.35-2.55 (m, 3H), 
2.15-2.34 (m, 1H), 1.90-2.05 (m, 1H); 13C NMR (100 MHz, D2O) δ 177.2, 175.3, 174.9, 
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174.5, 67.9, 66.9, 57.5, 51.9, 48.9, 38.6, 29.9, 16.8.; HRMS (ESI) m/z calcd for C9H14NO8 
(M+H)+ 264.0714, found 264.0721. The specific rotation [α]24D = -13.6° (c 0.1, MeOH). 
 
(R)-2-((R)-3-Carboxy-3-hydroxypropanamido)pentanedioic acid (3.15) 
Prepared according to General Procedure B using D,D-3.14 (20 mg, 0.038 mmol) 
to afford D,D-3.15 (8 mg, 80% yield). IR (film) 3352, 3034, 1733, 1536, 1386, cm-1; 1H 
NMR (400 MHz, D2O) δ 4.60 (dd, J = 4.5, 7.8 Hz, 1H), 4.46 (dd, J = 4.7, 8.2 Hz, 1H), 
3.20-3.33 (m, 1H), 2.82 (dd, J = 4.5, 15.2, 1H), 2.70-2.77 (m, 1H), 2.35-2.55 (m, 3H), 
2.15-2.34 (m, 1H), 1.90-2.05 (m, 1H); 13C NMR (100 MHz, D2O) δ 177.2, 175.3, 174.9, 
174.5, 67.9, 66.9, 57.5, 51.9, 48.9, 38.6, 29.9, 16.8.; HRMS (ESI) m/z calcd for C9H14NO8 
(M+H)+ 264.0714, found 264.0718.  
 
(S)-2-((R)-3-Carboxy-3-hydroxypropanamido)pentanedioic acid (3.15) 
Prepared according to General Procedure B using D,L-3.14 (10 mg, 0.019 mmol) 
to afford D,L-3.15 (3.8 mg, 78% yield). IR (film) 3350, 2853, 1730, 1260, 1170, cm-1; 1H 
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NMR (400 MHz, D2O) δ 4.59 (dd, J = 4.4, 7.8 Hz, 1H), 4.46 (dd, J = 5.1, 9.0 Hz, 1H), 
2.83 (dd, J = 4.5, 15.2, 1H), 2.77 (dd, J = 7.9, 15.2, 1H), 2.51 (t, J = 7.5, 2H), 2.15-2.28; 
13C NMR (100 MHz, D2O) δ 177.1, 175.3, 174.8, 174.5, 67.9, 57.4, 51.7, 38.5, 29.9, 25.6, 
16.7; HRMS (ESI) m/z calcd for C9H14NO8 (M+H)
+ 264.0714, found 264.0720. 
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Chapter 4 - Investigations Toward the Synthesis of the Flavalin Family of Natural 
Products 
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4.1 - Introduction 
4.1.1 - Background 
Neurodegenerative diseases are debilitating conditions that result in the 
degeneration and/or death of nerve cells.[1] Disorders like Alzheimer’s, Huntington’s, and 
Parkinson’s disease affect an estimated 22 million people world-wide with symptoms that 
can include memory loss, cognitive decline and movement impairment.[2,3] The devastating 
effects of neurodegenerative diseases and their prevalence in today’s aging population 
make the search for effective treatments critical. Many natural products have displayed 
neuroprotective properties against neurodegeneration, making them desirable candidates 
for therapeutic treatment.[4] Thus, there is a strong interest in developing new synthetic 
methods to access bioactive natural products as effective therapeutic leads.  
 
Figure 4.1 Cis-dimethyldecalin core found in many terpenes including eremophilare and 
nardosinane sesquiterpenes 
A wide variety of terpene natural products that commonly have diverse bioactivity 
contain a decalin substructure. These decalins often possess methyl or isopropyl 
substituents along with additional rings and various patterns of oxidative modification. In 
particular, many natural products share a vicinal cis-dimethyldecalin core structure 4.01 
(>15000 natural products), including a significant number of sesquiterpenes (Figure 4.1). 
Sesquiterpenoids are a diverse class of natural products and are comprised of C15 
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compounds that are formed by the condensation of three isoprene units. This class includes 
the eremophilane skeleton 4.02 and nardosinane skeleton 4.03 which are represented by 
nootkatone (4.04) and flavalin E (4.05).[4–6] 
4.1.2 - Biosynthesis of cis-dimethyldecalin Sesquiterpenes 
Sesquiterpenoids are derived biosynthetically from the 15-carbon precursor, 
farnesyl pyrophosphate (FPP) 4.06, Scheme 4.1.[5] FPP undergoes a cyclase phase, 
specifically a set of carbocation cascade reactions where a diverse range of these polycyclic 
hydrocarbon structures are formed. This is followed by an oxidase phase where 
functionality is introduced in the sesquiterpenoid natural products. An example of the 
biosynthesis of the eremophilane skeleton, a well-known class of sesquiterpenes, is shown 
in Scheme 4.1a and involves loss of pyrophosphate to make carbocation intermediates 
followed by hydride shifts, a cyclization and methyl migrations to give the eremophilane 
core (4.06-4.11). This polycyclic structure can then be further functionalized to give natural 
products like (+)-nootkatone (4.04).[5]  
A plausible biosynthetic pathway to nardosinane natural products, particularly 
those from the flavalin family, is shown in Scheme 4.1b.[6] Beginning with the natural 
product aristolene (4.12), a proposed precursor of the nardosinanes,[7] an oxidative 
cleavage gives ketone intermediate 4.13. A hydration or treatment with methanol followed 
by lactolization gives dihydrofuran nardosinanol A (4.14). This is followed by an 
oxidation/acetalization reaction to give flavalin E (4.05) with its cis-dimethyl 
stereochemistry intact. Intermediate 4.13 can also be epoxidized at the less hindered double 
bond followed by a rearrangement and an allylic oxidation to give nardosinanol C (4.15). 
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From this intermediate, an allylic rearrangement followed by a cyclization reaction gives 
the structurally complicated flavalin B (4.18). An alternative pathway to synthesizing 
another member of the flavalin family begins with nardosinanol C and involves reduction 
of the ketone to give the alcohol intermediate which can then cyclize to give the lactol 
intermediate followed by an allylic rearrangement to give elongatol E (4.16). Finally, a 
cyclization reaction of the lactol gives flavalin A (4.17).  
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Scheme 4.1 Biosynthesis of eremophilane core and proposed biosynthesis of flavalin natural 
products 
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4.1.3 - Previous syntheses of cis-dimethyldecalin compounds 
 
Previous syntheses of nardosinane and eremophilane sesquiterpenes have 
classically involved a Robinson annulation to construct one 6-membered ring, however 
other different and creative strategies for synthesizing individual members of this family 
have also been reported.[8–12] For example, in 1984 Valenta et. al. [13] synthesized 
dimethyldecalin 4.21 and 4.22 via a Diels-Alder reaction using trans-piperylene (4.19) and 
2-methyl-2-cyclohexenone (4.20) (Scheme 4.2a). By using excess diene and stirring in 
BF3-etherate for 48 hours at 20 °C, they obtained a mixture of the vicinal dimethyl adducts 
in an 80% yield, albeit favoring trans-product 4.21 over the cis-dimethyl motif 4.22. 
Ketone 4.22, was isolated when eluted with 5% ether in hexane on a silver nitrate 
impregnated silica gel column in a 25% yield. AlCl3 has also been employed as the catalyst 
however the reaction time increased to 72 hours. Following an identical purification as 
above, the dimethyl decalins 4.21 and 4.22 were isolated in 62% and 18% yield, 
respectively.  
More recently, Pipelier and coworkers[12] investigated the stereoselective synthesis 
of nardosinane derivatives (Scheme 4.2b). Starting from (S)-(+)-carvone 4.23, the methyl 
group was introduced to the β-position via a diastereoselective Michael addition using 
lithium dimethyl cuprate. The isopropenyl group was then removed using a Criegee 
rearrangement by ozonolysis and treatment of the peroxy ester intermediate with cupric 
acetate and ferric sulfate. This gave a mixture of unsaturated ketones but upon treatment 
with DBU, enone 4.24 was ultimately isolated in an overall 50% yield from (S)-(+)-
carvone. Αn α-allylation with intermediate 4.24 was quite tedious and typically resulted in 
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low yields however optimal results were achieved with sequential addition of LDA at  ̶ 
78 ̊C followed by warming up to  ̶ 40 ̊C and adding HMPA. Finally, after an hour, allyl 
iodide was added and stirred for 12 hours to give the cis-dimethyl enone 4.25 with 90:10 
d.r. in an 80% yield. After allylation, a total of six steps are needed to form the desired cis-
dimethyl diene 4.26 in an overall 14% yield. 
 
Scheme 4.2 Relevant synthetic approaches for cis-dimethyldecalin motif 
Other natural products containing cis-dimethyl moieties, such as the eremophilane 
(+)-nootkatone (4.04), are abundant, yet introduction of this specific dimethyl 
stereochemistry has proven difficult because of complicated syntheses, toxic reagents and 
low yields. Previous syntheses of (+)-nootkatone (4.04) have been shown to be dangerous 
if not carefully monitored and carried out at low temperatures.[14] Although there have been 
several representative literature examples for synthesizing dimethyl motifs, most give 
mixtures of inseparable products, generally have a high step count and are typically low 
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yielding. The stereoselective construction of the cis-dimethyldecalin core 4.01 still poses a 
challenge and new, more efficient synthetic approaches would be of significant value. 
4.1.4 - 6π-Electrocyclization 
Although there are previous methods to synthesize natural products with the decalin 
core, we were attracted to the possibility of generating the nardosinane cis-dimethyldecalin 
substructure using a 6π-electrocyclization reaction. A 6π-electrocyclization is a pericyclic 
reaction in which the net result is the intramolecular conversion of a π-bond to a σ-bond 
via an acyclic ring closure. Such reactions have been shown to display high regio- and 
stereocontrol in making complicated polycyclic molecules.[15] According to the 
Woodward-Hoffman rules, the stereochemical outcome is dependent on the symmetry of 
the orbitals involved in the electrocyclization reaction.[16]  
In Figure 4.2, the HOMO and the LUMO are shown for both a 4π-system and a 6π-
system. For a 4π-system, the HOMO has the proper symmetry to undergo a conrotatory 
ring closure to achieve constructive orbital overlap. When the molecule is excited by 
absorption of a photon to promote one electron from the HOMO to the LUMO, the LUMO 
dictates that the electrocyclization will occur in a disrotatory fashion. Conversely, in order 
to have proper orbital overlap, the 6π-system will undergo a disrotatory ring closure from 
the ground state (thermal manifold) but when excited, it does a conrotatory ring closure 
(photochemical manifold). 
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Figure 4.2 Woodward-Hoffmann rules in electrocyclization reactions 
Nature efficiently utilizes biosynthetically facilitated 6π-electrocyclizations to 
produce complex natural products. Compounds like the endriandric acids undergo 8π- 
followed by 6π- electrocyclizations to generate their complex cores[17,18] while the 
biosynthesis of vitamin D involves a conrotatory 6π-electrocyclic ring-opening 
reaction.[19,20] Quite a few natural products recently have been synthesized using 6π-
electrocyclizations as the key step via thermal and photochemical methods.[15,21–23]  
Scheme 4.3a describes the synthesis of the natural product rubriflordilactone A 
(4.32) which begins with cyclopentenone 4.27.[15,21] Following a series of steps, the triene 
core 4.30 is synthesized via a Stille-Migita cross-coupling reaction between iodo ester 4.28 
and tin intermediate 4.29 in great yields. It then undergoes a thermal 6π-electrocyclization 
when heated to 145 ̊C in DMSO followed by aromatization in one pot procedure to give 
the arene intermediate 4.31 in 73% yield. After 3 subsequent steps, the final stage of the 
synthesis of rubriflordilactone A was completed.  
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Another example of a 6π-electrocyclization was reported by Li and coworkers in 
their total synthesis of the natural product alkaloid, daphenylline (4.38) (Scheme 
4.3b).[15,22] Although complicated in structure, the Li group was able to synthesize the 
daphenylline core structure using a photochemical 6π-electrocyclization as the key step. 
Beginning with hydroxy enone 4.33, the triene precursor 4.34 was constructed in 8 steps. 
Upon irradiation using a 500 W Hg lamp at low temperatures, intermediate 4.35 was in the 
proper cis configuration to do a 6π-electrocyclization. After irradiating for 15 mins, diene 
4.36 was obtained as a single diastereomer in 71% yield. Aromatization was achieved using 
DBU and air to give arene 4.37 in 67% yield followed by 9 steps to give the desired natural 
product, daphenylline.  
Finally, a concise total synthesis of calothrixin A (4.44) is shown in Scheme 4.3c 
which was done by Ishikura and co-workers in 2011. The synthesis utilizes a 
cyclization/cross-coupling cascade reaction to obtain the 6π-precursor.[15,23] Treatment of 
borate salt 4.40, which is generated in situ from 1-methoxyindole and n-BuLi followed by 
Et3B, with diene intermediate 4.41 generates triene 4.42 in 68% yield. After removal of the 
THP group with camphorsulfonic acid (CSA), the triene efficiently underwent a copper(II) 
triflate catalyzed 6π-electrocyclization/aromatization to give carbazole 4.43 in 75% yield. 
An additional 4 steps give the natural product calothrixin A. As these examples show, the 
6π-electrocyclization is a powerful transformation and was used as the key step in the 
aromatization of these complex natural products.  
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Scheme 4.3 Examples of 6π-electrocyclizations in natural product synthesis  
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4.1.5 - Visible light [2+2] cycloaddition via Energy Transfer 
 
Typically pericyclic reactions allow for efficient regio- and stereocontrol for 
complex molecules. However, syntheses using this strategy require the use of high energy 
ultraviolet (UV) light. The need for UV light in most organic photochemical reactions not 
only limits the practicality, due to specialized glassware and safety concerns, but is not 
beneficial when used on industrial scales.[24] UV light is high energy which can cause 
unwanted decomposition of complex molecules. An alternative and attractive method to 
using UV light is the usage of visible light because it is benign to humans, generates no 
inherent waste, is readily renewable and poses a lower risk of molecular 
decomposition.[24,25] In the past ten years there has been a surge in the area of visible light 
photocatalysis.[26–30] Unfortunately, most organic compounds do not absorb visible light, 
however, this has been overshadowed with the rising use of transition metal complexes as 
visible light absorbing photocatalysts. Despite the practicality of using photocatalysis as a 
strategy to synthesize complex molecules, visible light-mediated pericyclic reactions 
provide a safer and more convenient alternative and are not well investigated.  
 
Figure 4.3 Energy transfer mediated [2+2] cycloaddition 
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 In 2014, Tehshik Yoon and coworkers introduced a photocatalytic strategy for a 
[2+2] cycloaddition of 1,3-dienes (Figure 4.3).[31] Typically, the direct photoexcitation of 
dienes requires high energy UV light. However, this poses an issue when these high energy 
photons are not compatible with organic substrates that are highly functionalized. As 
predicted, the use of high-energy UVC radiation resulted in decomposition of the dienes 
after 30 minutes. However, when an iridium photocatalyst and visible light was used, they 
obtained their [2+2] cyclized product 4.46 in 89% yield. The proposed mode of action is 
based on an energy transfer mechanism. Energy transfer relies on the triplet state energies 
of the catalyst and substrate(s).[28] Most visible light reactions use photoredox activation 
with a transition metal photocatalyst, which relies on the redox potentials of the 
photocatalyst and the substrate(s) of interest.  
Yoon and coworkers took advantage of the incompatabilty of the redox potentials, 
because the lowest lying triplet states of the photocatalyst and diene were quite similar (55-
60 kcal/mol) allowing the reaction to proceed efficiently via energy transfer.[32] Overall, 
they were able to synthesize a variety of cycloadducts using dienes with different functional 
groups well tolerated under the visible light conditions which would otherwise be prone to 
decomposition under UV conditions. With this in mind, we wondered whether transition 
metal-mediated visible light catalysis via energy transfer could also be applied as the key 
step in the synthesis of the flavalin family of natural products. 
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4.2 - Motivation 
 
4.2.1 - Flavalin Natural Products 
 
We were attracted to synthesizing nardosinane-type natural products containing the 
cis-dimethyldecalin core. One particular family of sesquiterpenoid marine natural 
products, known as flavalins, has recently been discovered and all new members contain 
this cis-dimethyl motif ( 
Figure 4.4). Flavalins were extracted from the Formosan soft coral Lemnalia flava 
off the coast of Taiwan by Sheu and his team, and although they have not been explored 
synthetically, some of the natural products have shown promising bioactivity.[6,33] After 
testing several of the flavalins for biological activity, flavalin A (4.17) and B (4.18) were 
shown to possess cytotoxic, anti-inflammatory and neuroprotective properties. In a 
neuroprotective assay, using a toxic dose of 6-hydroxydopamine in neuroblastoma cells, 
cytotoxicity of the cells was significantly reduced after pre-treatment with flavalin A and 
B.[6]  
The structures of flavalins are comprised of two different classes: flavalins A-D 
(4.17, 4.18, 4.47, 4.48) possess an oxa-cage ring system core while all members of the 
second class, flavalins E-H (4.05, 4.49-4.51) all contain a fused tetrahydrofuran-type 
functional group. These natural products are complex due to their multiple quaternary and 
fully-substituted centers, contiguous stereogenic centers, and cis-dimethyl stereochemistry. 
The biosynthesis of selected flavalins is shown in Scheme 4.1 and in all cases the common 
intermediate for both classes is ketone 4.13. A series of oxidations and a lactolization give 
the tetrahydrofuran flavalin core while cyclization reactions give the oxa-cage core. 
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Although these natural products are bioactive and have interesting structures, making them 
synthetically poses an issue due to the complexity of the structures and the poor outcomes 
in previous syntheses of cis-dimethyl natural products. An alternative route in which the 
flavalin core can be generated in few steps stereoselectively would be highly desirable. 
 
 
Figure 4.4 Newly discovered nardosinane-type sesquiterpenoids: flavalins 
We were interested in the possibility of generating the dimethyldecalin substructure 
via a 6π-electrocyclization using visible light which would substantially simplify the target. 
The proposed 6π-electrocyclization reaction would allow for the introduction of both the 
tertiary and quaternary stereocenters in a single step, where the stereochemical outcome 
would be predictable based on the choice of reaction conditions (thermal or photochemical) 
based on the Woodward–Hoffmann rules.  
Figure 4.5 shows the two potential trans products, 4.53 and 4.54, when triene 4.52 
is placed under thermal conditions which theoretically undergoes disrotatory ring closure 
while under photochemical conditions, it undergoes conrotatory ring closure giving the two 
cis cyclohexadiene products, 4.55 and 4.56. This powerful strategy would hypothetically 
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facilitate the synthesis of a variety of eremophilane, nardosinane and related sesquiterpenes 
through a unified approach.  
 
Figure 4.5 Thermal and photochemical outcomes for triene core 4.52 
 
Figure 4.6shows the proposed mechanism for the 6π-electrocyclization. 
Ru(bpy)3
2+, which is a commonly used visible light absorbing transition metal 
photocatalyst, is irradiated to generate the singlet exited state. After undergoing metal to 
ligand charge transfer (MLCT) and intersystem crossing (ISC) the excited triplet state is 
generated. The catalyst can then excite the ground state of the substrate of interest to its 
lowest lying triplet state while decaying back to its original ground state. The excited 
substrate then undergoes a 6π-electrocyclization to give the desired cyclized product. With 
this in mind, prior to synthesizing the flavalin core, the photochemical 6π-
electrocyclization strategy was tested on a simplified model system. 
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Figure 4.6 Proposed mechanism via energy transfer 
4.3 - Results and Discussion for First Model System 
4.3.1 - First Model System: Testing the Photochemical Electrocyclization 
A simplified model system was developed to determine the feasibility of the 
photochemical electrocyclization using energy transfer. Scheme 4.4a shows the two 
potential cyclohexadiene products 4.58 and 4.59 when subjected under different reaction 
conditions, thermal and photochemical, and the two key disconnections in the proposed 
synthesis; a Wittig olefination generates the central alkene and a Horner-Wadsworth-
Emmons olefination followed by a DIBAL-H reduction gives the E-alkene selectively. The 
synthetic plan, shown in Scheme 4.4b, uses known procedures to make the triene. The 
synthesis begins with commercially available and inexpensive starting material, 1,4-
butanedione (4.60). Following mono-benzylation with benzyl bromide and a Swern 
oxidation, benzyl protected hydroxybutanal 4.61 was synthesized in 86% yield. A Horner-
Wadsworth-Emmons olefination with triethyl phosphonoacetate gave the α,β-unsaturated 
ester 4.62 which led to a DIBAL-H reduction at low temperatures to give the desired allylic 
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alcohol 4.63 in 94% yield. Afterwards, a MnO2 oxidation in hexanes gave the E-α,β-
unsaturated enal 4.64 in 88% yield. In order to synthesize the desired triene 4.57, a Wittig 
olefination involving crotyl triphenylphosphonium bromide was used. A mixture of both 
inseparable isomers (81:19 ratio of E/Z) of the crotyl salt were made using 
triphenylphosphine and crotyl bromide. Despite the inability to separate these two isomers, 
we moved forward to the next step.   
 
Scheme 4.4 Potential diene products and first model system  
Triene 4.57 was obtained by a Wittig olefination using the crotyl salt to give a 
modest 52% yield. Analysis by gas chromatography (GC) indicated the presence of three 
products in a 45:50:5 ratio, which are the triene isomers. Table 4.1b shows the mixture of 
isomers that were predicted based on the mechanism of Wittig olefinations. The enal 
precursor 4.64 was set to the E-isomer however the crotyl salt was a mixture of two isomers 
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favoring the E-alkene. We suspected the major product to be the E,Z,E isomer with the 
minor two to be the E,E,E and the E,E,Z isomer. By lowering the temperature of the 
reaction, the selectivity improved to a 66:31:3 ratio at  ̶ 70 ̊C (Table 4.1a). Ultimately, it 
was necessary to isolate the E,Z,E isomer as it is the only isomer with the proper geometry 
to do the 6π-electrocyclization. Impregnated silver nitrate was employed to separate the 
alkene isomers with no success, as well as a variety of other separation techniques 
(alumina, etc).  
After testing a variety of high boiling solvents including toluene, DMF and xylenes 
to induce the thermal electrocyclization, DMF proved to be the most optimal solvent for 
this task. The thermal 6π-electrocyclization reaction gave an authentic sample of the cis 
diene product 4.65 in a 26% yield 4.1c. Although the triene contained three different 
isomers, it is expected that the thermal cyclized product can only be obtained through a 
thermal 6π-electrocyclization with the E,Z,E isomer, GC analysis showed the consumption 
of one of the three isomeric peaks and the appearance of a new peak corresponding to the 
product. After isolation by column chromatography, the new GC peak was confirmed to 
be the cyclized product by GC and 2D NMR techniques. COSY NMR was used to assign 
proper chemistry of the cis diene and NOESY NMR showed that the methylene and the 
methyl group adjacent to the cyclized diene had an nOe correlation with each other.  
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Table 4.1 Temperature controlled Wittig olefinations, triene isomers and thermal 
electrocyclization 
To obtain the photochemical product, a photocatalyst must absorb light at the 
appropriate wavelength. Initial conditions for the photochemical reactions were: 10 mol% 
of [Ru(bpy)3](Cl2) which absorbs light at 452 nm, DMSO as solvent and blue LED lights 
(emission maximum = 450 nm). The photochemical reactions showed a relatively small 
new peak by GC that did not correspond to the thermal product but had a similar retention 
time. Similar to the thermal electrocyclization reaction, the consumption of one of the 
isomers occurred by GC. The new peak was hypothesized to be the photochemical product 
since without a light source or photocatalyst, this new GC peak did not form. Although, 
the other alkene isomers could not be separated out, we performed a set of optimization 
reactions varying the solvent, photocatalyst and temperature.  
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Unfortunately, when the reaction was subjected to photochemical conditions, the 
main reaction was the isomerization of the alkene trienes to the more thermodynamically 
favorable isomer, the E,E,E triene isomer which was confirmed by the increase in area of 
one of the major GC peaks, and the larger coupling constant for the alkene protons in the 
proton NMR. After using different concentrations of silver nitrate, solvents for 
impregnation, and solvents for thin layer chromatography, isolation of any potential 
product, particularly the smallest peak by GC, could not be achieved. With this in mind, 
we decided that a more efficient and stereoselective synthesis must be devised and a new 
model system more closely related to the flavalins would be more valuable. 
4.4 - Flavalin Core Model System 
4.4.1 - Previous Synthesis of triene precursor 
The lack of E/Z-selectivity and inability to isolate the product in the alkyl model 
system led to a search for a more selective synthetic strategy. We set out to develop an 
efficient synthesis of conjugated triene precursor 4.52 because of its similarity to the 
nardosinane flavalin core. Ketotriene 4.52 was previously synthesized by Ramage and 
Satter using the Stork-Danheiser protocol (Scheme 4.5).[34] Ramage’s synthesis begins with 
the reaction between vinylogous ester 4.66 and the Grignard derivative of alkyne 4.67 
followed by acid treatment to give acetylenic alcohol 4.68. A two-step dehydration with 
POCl3–pyridine followed by treatment with Oediger’s base gave intermediate 4.69 as a 
mixture of products in a 4:1 ratio (shown in step 3, Scheme 4.5). The trans isomer, Product 
B, was much less stable than the cis isomer and degraded rapidly when stored at 0 ̊C 
however the cis isomer was separated from the trans isomer by g.l.c. A partial 
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hydrogenation using Lindlar’s catalyst in heptane gave an inseparable mixture of the 
desired all cis-trienone 4.52, 20% starting material XX and 10% of the over reduced 
product.  
 
Scheme 4.5 Synthesis of ketotriene by Ramage and Sattar 
We devised an alternative synthesis for trienone 4.52 using recent developments in 
cross-coupling to stereospecifically synthesize the ketotriene through a Suzuki coupling 
beginning with stereodefined alkene building blocks.[35] We were inspired by Martin Burke 
et al.’s research involving the stereoselective synthesis of polyene natural products using 
iterative cross coupling reactions.[36,37,37,38] Burke and co-workers developed a strategy that 
utilizes N-methyliminodiacetic acid (MIDA) boronates (Scheme 4.6) due to their high 
benchtop stability, easy purification and commercial availability. We envisioned using 
these MIDA boronates as the building blocks to synthesize the triene precursor 
stereoselectively with the flavalin core in mind as the final target. Stereospecificity is 
critical to ensure the Z-geometry about the central alkene which is necessary for the 6π-
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electrocyclization and using MIDA boronates as the building blocks in Suzuki cross 
coupling reactions seemed like the ideal strategy for accomplishing this. Once the triene 
with the correct stereochemistry is synthesized, the photochemical 6π-electrocyclization 
can be tested followed by further functionality to make the flavalin natural products. 
4.4.2 - Synthesis of ketotriene via Suzuki cross-coupling reactions using MIDA 
boronates 
 
Scheme 4.6 shows a retrosynthetic route for the triene precursor. It relies on 
utilizing the MIDA boronates as the building blocks and performing Suzuki cross-coupling 
reactions to control the stereochemistry of the triene. The triene 4.52 results from a Suzuki 
reaction between vinyl bromide 4.70 that has an E-alkene incorporated in its structure along 
with diene MIDA boronate 4.71. The diene is the result of another Suzuki cross coupling 
reaction between a boronic acid 4.72 and a Z-vinyl bromide 4.73. The vinyl bromide comes 
from bis-borylated alkene 4.74 and finally the starting material, commercially available 
ethynyl MIDA boronate 4.75.[39,40]  
 
Scheme 4.6 Retrosynthesis of triene core 
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The synthesis began with the hydroboration of ethynyl MIDA boronate 4.75 using 
dicyclohexyl borane (synthesized from cyclohexene and borane) and pinacol borane 
(Scheme 4.7a). Bis-borylated alkene intermediate 4.74 undergoes a two-step 
bromination/elimination to give Z-MIDA boronate 4.73 in 81% yield and high Z-
selectivity. Optimal yields occurred when Na2HPO4 was used as the base as opposed to 
K3PO4. This was followed by the first Suzuki cross-coupling reaction to generate diene 
MIDA boronate 4.71 using propenyl boronic acid, Pd(OAc)2 and XPhos. Two isomers are 
formed (in a 1:1 ratio which resulted from the mixture of E- and Z-propenyl Grignard 
reagent used to generate the E,Z-propenylboronic acid 4.72. We attempted to separate the 
two dienyl MIDA boronate isomers via crystallization and chromatography but with no 
success. This four-step sequence proceeded in an overall 63% yield. 
 
Scheme 4.7 Synthesis of diene and triene precursors 
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As shown in Scheme 4.7b, we focused our attention on optimizing the Suzuki 
coupling involving the dienyl MIDA boronate 4.71 and β-bromoenone 4.70. We employed 
optimized conditions reported by Burke and coworkers for in situ hydrolysis/coupling with 
catalytic Pd(OAc)2, SPhos, and aqueous K3PO4 in dioxane at room temperature. Under 
these conditions, we observed two different triene isomers that were isolated in a 65% 
yield. The two isomers differed at the double bond distal to the carbonyl group, as was 
expected starting from the mixture of E- and Z-MIDA boronates.  
After inspecting the 1H NMR spectra, we noticed a large J-value (JHH = 15.6 Hz) 
in the alkene region corresponding to the central alkene, suggesting it has E-
stereochemistry. Although the stereochemistry for the central alkene should have been Z-
selective based on its precursor, the NMR showed no indication that the desired E,Z-triene 
4.52 was formed. These results indicated that a triene was generated but contained alkenes 
with a higher coupling constant most likely corresponding to the E,E isomer 4.76. 
Ultimately, we discovered that during the Suzuki cross-coupling reaction between the β-
bromoenone and the dienyl MIDA boronate, the previously set Z-alkene in the diene had 
isomerized to the E-alkene. Although we were unable to isolate an authentic sample of the 
desired triene in order to test the 6 π-electrocyclization reaction using this strategy, we were 
interested in determining the cause of the isomerization of the double bonds in the Suzuki 
reaction. 
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4.4.3 - Suzuki Cross Coupling Experiments 
 
The isomerization of the Z-alkene to the E-alkene was of interest not only because 
it inhibited us from moving forward with the synthesis, but also because of the surprising 
outcome when placed under standard, widely-employed Suzuki coupling conditions. To 
verify the outcome, we synthesized an authentic sample of the E,E triene in order to 
compare it to the previously made sample (Scheme 4.8).  
 
Scheme 4.8 Synthesis of authentic E,E triene 
We began the synthesis with commercially available E-bromo MIDA boronate 4.78 
and cross-coupled it with the previously synthesized propenyl boronic acid. This gave us 
two isomeric dienes, E,E-4.79 and Z,E-4.79, however in this case, the alkene adjacent to 
the B(MIDA) was set as the E-isomer as opposed to the Z-isomer from the previous 
synthesis. When performing the second Suzuki reaction, the same two triene products 
which were both isomeric at the alkene distal to the ketone were obtained, ultimately 
confirming the structure of the E,E triene. Also, carrying out the reaction with the rigorous 
exclusion of light had no effect on this isomerization process, suggesting that it is not a 
photochemical isomerization.  
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Scheme 4.9 Related structures for standard Suzuki coupling 
The Suzuki cross-coupling reactions were then tested under standard conditions 
using variations of the vinyl bromide coupling partner. In Scheme 4.9a, the less hindered 
bromoenone 4.80, which lacks the α-methyl substituent, was cross-coupled with the dienyl 
MIDA boronate 4.71 and gave 4.82 in 72% yield. Once again, we did not observe the 
desired E,Z triene but the isomerized product (4.82). The JHH value obtained by NMR was 
15.6 Hz indicating isomerization of the Z-alkene to the E-alkene. These results suggest that 
steric hinderance α to the carbonyl in the triene does not cause the isomerization. One 
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possible mechanism for isomerization is a deprotonation/reprotonation of the moderately 
acidic methyl group in conjugated products 4.81 and 4.82, which is a process that would 
require the presence of the ketone to acidify the position. We synthesized the simpler Z-
dienyl MIDA boronate 4.83 in Scheme 4.9b which lacks the terminal methyl group. After 
subjecting it to typical Suzuki conditions with bromoenone 4.80, we again observed 
isomerization where the JHH value obtained by NMR was 15.2 Hz suggesting that 
deprotonation is not required for isomerization.  
We synthesized a more electron-rich vinyl bromide by replacing the ketone with an 
allylic alcohol group to investigate whether isomerization was due to an electronic effect 
as opposed to a steric effect (Scheme 4.9c,d). The Suzuki reaction with the dienyl MIDA 
boronate 4.71 and the allylic alcohol without the methyl group 4.86 gave the desired E,Z- 
and Z,Z- triene 4.87 in a 58% yield. When testing the allylic alcohol with the methyl group 
4.88, we obtained the E,Z- and Z,Z-triene in a 45% yield. Both reactions proceeded with 
retention of stereochemistry and sterics slightly effected the yield for allyl alcohol 4.89. 
The JHH value obtained by NMR was 11.6 Hz for both alcohols 4.87 and 4.89 indicating 
the Z-alkene at the central position had not isomerized.  
 
Scheme 4.10 Attempted synthesis of desired trienone 4.81 
With access to the cis-allylic alcohol products, we sought to reach the target 
trienones by an alternative route (Scheme 4.10). The allylic alcohol intermediates were 
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somewhat unstable and decomposed under a variety of oxidation conditions as evidenced 
by the lower yields. A Dess-Martin oxidation of the alcohol 4.87 appeared to give E,Z and 
Z,Z 4.81 which was one of the original target trienones, however in low yield. These two 
isomeric products differed from the previously synthesized-E,E and Z,E-4.82, however we 
were unable to obtain a pure sample and measure the coupling constants accurately due to 
the instability of this compound.  
Cis/trans isomerization, although rarely observed in Pd catalyzed cross-coupling 
reactions, have in some cases been shown where electron deficient conjugated π-systems 
are used.[41–45] An early report by Mavrov discusses the synthesis of dienoate 4.92 using 
catechol borane 4.90 and alkenyl halide 4.91 under Suzuki conditions. (Scheme 4.11)[35] 
The reaction with (Z)-β-bromoacrylate gave a mixture of stereoisomers, however by 
changing the ligand source, temperature, and the reaction time, isomerization was 
significantly reduced favoring the expected E,Z isomer over the E,E isomer. 
 
Scheme 4.11 Example of Pd catalyzed isomerization 
4.5 - Conclusions  
The decomposition of cis-trienes supports the hypothesis that isomerization of the 
double bonds occurs post Suzuki coupling which is facilitated by the electron withdrawing 
ketone and is driven by the formation of the more stable trans products. Based on previous 
reports and the results of the synthesis, we favor isomerization of the electron-deficient 
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product via a palladium hydride species or a Pd(II) species.[46–48] Although the unexpected 
isomerization of polyenes is not new, the process observed here defines a current challenge 
for the synthesis of conjugated polyenes that are electron deficient using the iterative cross-
coupling strategy. Overall, the synthesis of a variety of trienes and trienones using an 
iterative Suzuki coupling strategy is described. We observed an unexpected isomerization 
of electron-poor conjugated trienones under mild Suzuki conditions. This isomerization led 
to loss of stereoselectivity and complicated the exploration of an electrocyclization strategy 
to making the dimethyldecalin substructure present in flavalin natural products. In the face 
of these challenges, we decided to pursue other, more fruitful investigations. 
  
 184 
4.6 - Experimentals 
4.6.1 - Materials and Methods: 
1H and 13C NMR spectra were recorded on a Varian Inova 400 MHz or Bruker 700 
MHz spectrometer unless otherwise indicated and were internally referenced to residual 
protio solvent signal (note: CDCl3 referenced at 7.26 ppm for 1H NMR and 77.1 ppm 
for 13C NMR, respectively. Acetone-D6 referenced at 2.05 ppm for 1H NMR and 29.3 
ppm for 13C NMR, respectively). Data for 1H NMR are reported as follows: chemical shift 
( ppm), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), and coupling constant (Hz). Data for 13C NMR are reported in terms of chemical 
shift and no special nomenclature is used for equivalent carbons. IR spectra were recorded 
on a Bruker Alpha FT-IR Spectrometer. High-resolution mass spectrometry data were 
recorded on an Agilent LCTOF instrument using direct injection of samples in 
dichloromethane into the electrospray source (ESI) with positive ionization.  
All reactions were carried out under an inert atmosphere of nitrogen in oven dried 
or flame dried glassware with magnetic stirring, unless otherwise noted. Solvents were 
dried by passage through columns of activated alumina. All starting materials were 
prepared according to known literature procedures or used as obtained from commercial 
sources, unless otherwise indicated. Reactions were monitored by thin-layer 
chromatography (TLC) and carried out on 0.25 mm coated commercial silica gel plates 
(Analtech TLC Uniplates, F254 precoated glass plates) using UV light as the visualizing 
agent and KMnO4 and heat as a developing agent. Flash chromatography was performed 
on silica gel (Silicycle, SiliaFlash P60, 230-400 mesh).  
 185 
4.6.2 - Experimental Procedures: 
 
General Procedure A: Suzuki Cross-Coupling to form Dienes: 
To a flask containing 5 mol% Pd(OAc)2 and 10 mol% XPhos was added THF 
(0.05M). The resulting solution was stirred for 15 minutes and then added to a flask 
containing bromo MIDA boronate (4.73) (1 equiv), propenyl boronic acid (1.2 equiv), and 
Cs2CO3 (3.55 equiv). The reaction was stirred for 24 hours at room temperature. The 
reactions were tracked by TLC (100% EtOAc). Upon completion, the crude reaction 
mixture was filtered through celite, concentrated, and then diluted with EtOAc. The organic 
layer was washed with brine and dried with Na2SO4. Volatiles were removed under reduced 
pressure to afford a crude yellow oil. The crude material was purified using silica gel 
chromatography with 100% EtOAc. 
 
General Procedure B: Suzuki Cross-Coupling to form Trienes: 
To a flask containing vinylbromide (1 equiv), diene MIDA boronate (4.71) (1.2 
equiv), 5 mol% Pd(OAc)2 and 10 mol% SPhos was added dioxane (0.08M). The resulting 
solution was sparged with nitrogen for 30 minutes at room temperature. Aqueous K3PO4 
(3M) was then added and the reaction was stirred for 24 hours at room temperature. The 
reactions were tracked by TLC. Upon completion, the crude reaction mixture was filtered 
through celite, concentrated, and then diluted with EtOAc. The organic layer was washed 
with brine and dried with Na2SO4. Volatiles were removed under reduced pressure to afford 
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a crude yellow oil. The crude material was purified using silica gel chromatography with 
1:5 EtOAc/hexanes. 
 
 
Modified procedure for MIDA boronate Z-4.73 
Synthesis conducted according to literature procedure[39] using E-diboronate E-
4.74 (1 g, 3.24 mmol), substituting K3PO4 with anhydrous Na2HPO4 (4.27 g, 30.78 mmol) 
in the elimination step, to give the desired product Z-4.73 (0.685 g, 81%). Spectral data 
were consistent with literature values. 
MIDA boronate (E,Z-4.71 + Z,Z-4.71) 
Prepared according to general procedure A using 5 mol% Pd(OAc)2 (28 mg, 0.127 
mmol), 10 mol% XPhos (121 mg, 0.254 mmol), Z-MIDA boronate (Z-4.73) (666 mg, 2.54 
mmol, 1 equiv), propenyl boronic acid (570 mg, 6.64 mmol, 2.61 equiv), Cs2CO3 (2.94 g, 
9.02 mmol, 3.55 equiv) in THF (51 mL). Purification afforded the product as a pale yellow 
solid (524 mg, 2.34 mmol, 92%) in a 1:1 ratio of isomers as determined by 1H NMR. IR 
(film) 2998, 1758, 1739, 1639, 1450, 983 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.11 (t, J = 
13.2 Hz, 1H), 6.73 (t, J = 12.8 Hz, 1H), 6.50 (m, 2H), 5.82 (dq, J = 13.7, 6.8 Hz, 1H), 5.70 
(dtt, J = 10.8, 7.2, 1.4 Hz, 1H), 5.27 (d, J = 14.4 Hz, 1H), 5.13 (d, J = 13.6 Hz, 1H), 3.88 
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(dd, J = 16.4, 2.8 Hz, 2H), 3.71 (dd, J = 16.4, 0.8 Hz, 2H), 2.86 (d, J = 1.6 Hz, 3H), 1.78 
(dt, J = 4.8, 1.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 167.7, 146.3, 140.4, 134.8, 130.6, 
130.1, 127.3, 61.7, 46.9, 18.4, 13.0; HRMS (ESI) m/z calcd for C10H15BNO4 (M+H)
+ 
224.1050, found 224.1059.  
 
MIDA boronate (E,E-4.79 + Z,E-4.79) 
Prepared according to general procedure A using 5 mol% Pd(OAc)2 (4 mg, 0.019 
mmol), 10 mol% XPhos (18 mg, 0.038 mmol), E-MIDA boronate (E-4.78) (100 mg, 0.382 
mmol, 1 equiv), propenyl boronic acid (86 mg, 0.996 mmol, 2.61 equiv), Cs2CO3 (442 mg, 
1.356 mmol, 3.55 equiv) in THF (8 mL). Purification afforded the product as a pale yellow 
solid (40 mg, 0.015 mmol, 47%) in a 1:1 ratio of isomers as determined by 1H NMR. IR 
(film) 3058, 2961, 1762, 1641, 1449 cm-1; 1H NMR (700 MHz, CDCl3) δ 7.01 (dd, J = 
17.5, 10.5 Hz, 1H), 6.64 (dd, J = 17.5, 10.5 Hz, 1H), 6.13 (dd, J = 14.7, 10.5 Hz, 1H), 6.08 
(dt, J = 11.2, 1.4 Hz, 1H), 5.83 (dq, J = 14.7, 7 Hz, 1H), 5.61 (dq, J = 10.5, 7 Hz, 1H), 5.54 
(d, J = 16.8 Hz, 1H), 5.42 (d, J = 17.5 Hz, 1H), 3.82 (d, J = 16.1 Hz, 2H) 3.68 (d, J = 16.8 
Hz, 2H), 2.85 (s, 3H), 1.79 (dd, J = 7, 1.4 Hz). 13C NMR (176 MHz, Acetone-d6) δ 168.9, 
168.9, 144.70, 138.8, 132.75, 131.9, 129.1, 128.6, 62.3, 47.2, 18.23, 12.8.; HRMS (ESI) 
m/z calcd for C10H15BNO4 (M+H)
+ 224.1050, found 224.1058.  
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2-methyl-3-penta-1,3-dien-1-yl)cyclohex-2-enone (E,E-4.82 + Z,E-4.82)  
Prepared according to general procedure B using 3-bromo-2-methylcyclohex-2-
enone (4.80) (46 mg, 0.244 mmol, 1 equiv), diene MIDA boronate (E,Z-4.71 + Z,Z-4.71) 
(66 mg, 0.292 mmol, 1.2 equiv), 5 mol% Pd(OAc)2 (2.7 mg, 0.012 mmol), 10 mol% SPhos 
(0.024mmol, 10 mg), and 3.05 mL of dioxane. After sparging with nitrogen for 30 minutes 
at room temperature, aqueous K3PO4 (3M, 1.83 mmol, 7.5 equiv) was added. Purification 
afforded the product as a pale yellow oil (28 mg, 0.159 mmol, 65%) in a 39:61 ratio of 
isomers as determined by 1H NMR. IR (film) 3053, 2957, 1652, 1596, 1264 cm-1; 1H NMR 
(700 MHz, CDCl3) δ 6.93 (dd, J = 15.4, 11.2 Hz, 1H), 6.71 (d, J = 15.4 Hz, 1H), 6.61 – 
6.58 (m, 1H), 6.26 – 6.21 (m, 1H), 6.19 (dt, J = 10.5, 0.9 Hz, 1H), 5.94 (dq, J = 15.4, 7 Hz, 
1H), 5.74 (dq, J = 10.5, 7.7 Hz), 2.57 – 2.39 (m, 4H), 2.03 – 1.80 (m, 8H); 13C NMR (176 
MHz, CDCl3) δ 199.4, 149.9, 149.8, 135.4, 134.2, 132.2, 131.8, 131.3, 130.7, 129.9, 129.8, 
129.7, 127.9, 37.8, 26.0, 22.0, 18.5, 13.8, 10.5; HRMS (ESI) m/z calcd for C12H17O (M+H)
+ 
177.1279, found 177.1285. 
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2-methyl-3-penta-1,3-dien-1-yl)cyclohex-2-enone (E,E-4.76 + Z,E-4.77)  
Prepared according to general procedure B using 3-bromo-2-methylcyclohex-2-
enone (4.70) (28 mg, 0.148 mmol, 1 equiv), diene MIDA boronate (E,E-4.79 + Z,E-4.79) 
(40 mg, 0.179 mmol, 1.2 equiv), 5 mol% Pd(OAc)2 (1/7 mg, 0.008 mmol), 10 mol% SPhos 
(6 mg, 0.015 mmol), and 1.86 mL of dioxane. After sparging with nitrogen for 30 minutes 
at room temperature, aqueous K3PO4 (3M, 1.12 mmol, 7.5 equiv) was added. Purification 
afforded the product as a pale yellow oil (15 mg, 0.08 mmol, 56%) as a mixture of triene 
isomers. The characterization data matches that of the products of the reaction between the 
same vinyl bromide (4.70) and diene MIDA boronate (E,Z-4.71 + Z,Z-4.71). 
 
3-((1E)-penta-1,3-dien-1-yl)cyclohex-2-enone (4.82) 
Prepared according to general procedure B using 3-bromocyclohex-2-enone (4.80) 
(123 mg, 0.703 mmol, 1 equiv), diene MIDA boronate (E,Z-4.82 + Z,Z-4.82) (189 mg, 
0.843 mmol, 1.2 equiv), 5 mol% Pd(OAc)2 (8 mg, 0.035 mmol), 10 mol% SPhos (29 mg, 
0.070 mmol) and 9 mL of dioxane. After sparging with nitrogen for 30 minutes at room 
temperature, aqueous K3PO4 (3M, 5.27 mmol, 7.5 equiv) was added. Purification afforded 
the product as a pale yellow oil (85 mg, 0.521 mmol, 72%). IR (film) 3026, 2931, 2867, 
1657, 986 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.95 (dd, J = 15.6, 11.2 Hz, 1H), 6.62 (dd, 
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J = 15.6, 10.4 Hz, 1H), 6.29 (d, J = 15.6 Hz, 1H), 6.22 – 6.07 (m, 1H), 6.02-5.85 (m, 1H), 
5.75 (dq, J = 10.8, 7.2 Hz, 1H) 2.55 – 2.30 (m, 4H), 2.08 – 1.95 (m, 2H), 1.88 – 1.75 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 200.1, 157.5, 157.4, 136.1, 135.2, 132.7, 131.7, 131.5, 
130.6, 130.4, 129.1, 127.5, 127.1, 37.7, 24.9, 22.4, 18.6, 13.9; HRMS (ESI) m/z calcd for 
C11H15O (M+H)
+ 163.1117, found 163.1119. 
 
3-((1Z)-penta-1,3-dien-1-yl)cyclohex-2-enol (4.87) 
Prepared according to general procedure B using 3-bromocyclohex-2-enol (4.86) 
(88 mg, 0.288 mmol, 1 equiv), 134 mg diene MIDA Boronate (E,Z-4.71 + Z,Z-4.71) 
(0.596 mmol, 1.2 equiv.), 5 mol% Pd(OAc)2 (3 mg, 0.144 mmol), 10 mol% SPhos (12 mg, 
0.029 mmol), and 3.60 mL of dioxane After sparging with nitrogen for 30 minutes at room 
temperature, aqueous K3PO4 (3M, 2.16 mmol, 7.5 equiv) was added. Purification afforded 
the product as a pale yellow oil (47 mg, 0.288 mmol, 58%). IR (film) 3333, 2933, 2861, 
1646, 956 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.65 – 6.43 (m, 2H), 6.28 (t, J = 11.8 Hz, 
1H), 6.17 – 6.12 (m, 1H), 5.95 (t, J = 11.6 Hz, 1H), 5.82 – 5.68 (m, 3H), 5.62 (d, J = 11.6 
Hz, 1H), 5.61 – 5.50 (m, 1H), 4.31 (s, 1H), 2.28 – 2.10 (m, 2H), 1.89 – 1.55 (m, 10H); 13C 
NMR (100 MHz, CDCl3) δ 139.1, 131.9, 131.5, 131.0, 130.4, 129.8, 129.6, 129.1, 128.6, 
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128.1, 126.2, 124.2, 67.2, 66.2, 35.3, 31.7, 30.7, 29.2, 20.6, 19.3, 18.4, 13.1; HRMS (ESI) 
m/z calcd for C11H17O (M+H)
+ 164.1201, found 164.1196. 
 
2-methyl-3-((1Z)-penta-1,3-dien-1-yl)cyclohex-2-enol (4.89) 
Prepared according to general procedure B using 3-bromo-2-methylcyclohex-2-
enol (4.88) (90 mg, 0.470 mmol, 1 equiv.), 126 mg diene MIDA boronate (E,Z-4.89 + Z,Z-
4.89) (0.564 mmol, 1.2 equiv.), 5 mol% Pd(OAc)2 (5.3 mg, 0.024 mmol), 10 mol% SPhos 
(19 mg, 0.047 mmol), and 5.89 mL of dioxane. After sparging with nitrogen for 30 minutes 
at room temperature, aqueous K3PO4 (3M, 3.53 mmol, 7.5 equiv) was added. Purification 
afforded the product as a pale yellow oil (38 mg, 0.213 mmol, 45%). IR (film) 3433, 3054, 
2933, 2852, 1659 cm-1; 1H NMR (700 MHz, CDCl3) δ 6.30 (t, J = 11.2 Hz, 1H), 6.10 (t, J 
= 12.6 Hz, 1H), 6.03 (t, J = 11.2 Hz, 1H), 5.96 (t, J = 11.2 Hz, 1H), 5.87 (d, J = 11.2 Hz, 
1H), 5.77 – 5.68 (m, 2H), 5.59 – 5.49 (m, 1H), 4.10 (s, 1H), 2.57 – 2.43 (m, 2H), 2.12 – 
1.95 (m, 2H), 1.80 – 1.60 (m, 10H); 13C NMR (176 MHz, CDCl3) δ 134.0, 132.7, 131.3, 
130.7, 130.3, 129.4, 128.8, 128.2, 127.1, 126.4, 124.7, 124.0, 70.0, 69.4, 36.7, 32.1, 31.6, 
30.3, 20.5, 20.0, 18.4, 17.5; HRMS (ESI) m/z calcd for C12H19O (M+H)
+ 178.1358, found 
178.1353. 
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MIDA boronate Z-4.83 
To a Schlenk flask containing Pd(OAc)2 (8.6 mg, 10 mol%), XPhos (36.2 mg, 20 
mol%), Cs2CO3 (436 mg, 3.5 equiv), bromo MIDA boronate (4.73) (100 mg, 1 equiv), was 
added DMSO (7.6 mL, 0.05M). The resulting solution was stirred for 15 minutes and then 
added to a flask containing vinyl boronic acid (133 µL, 2 equiv), and the reaction was 
stirred for 24 hours at room temperature. The reactions were tracked by TLC (100% 
EtOAc). Upon completion, the crude reaction mixture was filtered through celite, 
concentrated, and then diluted with EtOAc. The organic layer was washed with brine and 
dried with Na2SO4. Volatiles were removed under reduced pressure to afford a crude 
yellow oil. The crude material was purified using silica gel chromatography with 100% 
Et2O, then 1.5% MeOH/Et2O, then 50% acetone/hexanes to give a light yellow oil (15.2 
mg, 0.073 mmol, 19%). Spectral data were consistent with literature values. 
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(E)-3-(buta-1,3-dien-1-yl)cyclohex-2-enone (4.85) 
Prepared according to general procedure B using 3-bromocyclohex-2-enone (4.80) 
(10 mg, 0.058 mmol, 1 equiv), diene MIDA boronate (Z-4.83) (14 mg, 0.069 mmol, 1.2 
equiv), 10 mol% Pd(OAc)2 (1.3 mg, 0.006 mmol), 20 mol% SPhos (4.7 mg, 0.070 mmol) 
and 723 µL of dioxane. After sparging with nitrogen for 30 minutes at room temperature, 
aqueous K3PO4 (3M, 0.4335 mmol, 7.5 equiv) was added. Purification afforded the product 
as a pale yellow oil (3.8 mg, 44%). IR (film) 2929, 2852, 1667, 1590, 1250 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 6.70 – 6.55 (m, 1H), 6.44 (dt, J = 10.4 Hz, 1H), 6.37 (d, J = 15.2 Hz, 
1H), 5.97 (s, 1H), 5.47 (d, J = 16.8 Hz, 1H), 5.36 (d, J = 10.0 Hz, 1H), 2.50 (t, J = 6.4 Hz, 
2H), 2.43 (t, J = 6.4 Hz, 2H), 2.10 – 2.00 (m, 2H); HRMS (ESI) m/z calcd for C10H13O 
(M+H)+ 149.0961, found 149.0959. 
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